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Introduction
Abstract
The concept o f cyc lic  enediyne-contain ing am ino acids is in troduced, 
fo llow ed  by a synopsis covering  the m ost re levan t elem ents of the h istory, 
ch em istry  and b io logy o f n a tu ra lly  occu rring  enediynes. In  addition, a 
concise o ve rv iew  o f app lications o f ace ty len ic  am ino acids re levan t to th is  
thesis is provided. An outline o f the thesis concludes the chapter.
1
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1.1 General introduction
N a tu ra l ened iynes are  com pounds conta in ing  a (Z)-hexa-3-en-1,5-diyne 
(1, F ig u re  1) o r a c lo se ly re la ted  stru ctu ra l m otif, and th ey ran k  am ong 
the m ost pow erfu l an titum or and an tib io tic  agents found in  N atu re . 
T h e ir active  p rin cip le  re lies  on the therm al generation  of rad ica ls. These  
are  capab le  o f dam aging n earb y D N A  by ab straction  o f hydrogen atom s 
from  deoxyribose un its o f the sugar phosphate backbone, causing  single- 
and double-strand scissions and u ltim ate ly  ce ll death. Fu rtherm ore, 
n a tu ra lly  o ccu rring  ened iynes belong - from  a scien tist's  po int o f v ie w  - 
to the m ost fascinating  chem ica l en tities eve r iso lated ; th e ir chem istry, 
m ode o f action  and p robab ly also th e ir s tru ctu ra l com plexity have  
bew itched  and in trigued  m any a chem ist.
C onsidering  the trem endous cytotoxic p roperties o f the n a tu ra l 
com pounds, m aking ava ilab le  sim p lified  ened iynes endow ed w ith  
ve rsa tile  handles fo r d eriva tization  o r for accom m odation in  functional 
com plexes is o f genera l in terest. The inco rpo ration  o f am ino acids into  
enediynes w ould  m eet the dem ands fo r such ve rsa tility  by v irtu e  o f the  
am ino and the carboxylic acid  functionalities. In  line  w ith  our 
longstand ing experience in  the ap p lication  o f ace ty len ic  am ino acid s ,2,3 
w e envisaged  th a t th is class o f am ino acids w ould  m ake for su itab le  
bu ild ing  b locks fo r enediyne-contain ing am ino acids. F in a lly , as the  
a c tiv ity  of the ened iyne core benefits from  confinem ent into a cyc lic  
stru ctu re  (vide infra), the idea o f cyc lic  enediyne-contain ing am ino acids 
w as conceived  (2, F ig u re  1).
1 2
(Z)-hexa-3-en-1,5-diyne cyclic enediyne-containing
amino acids
Figure 1
1.2 Naturally occurring enediynes
1.2.1 H is to ry
The sto ry o f the na tu ra l enediynes, as fa r as hum ankind is concerned, 
began in  1965 w hen  Ish id a  et  al. reported  the iso lation  of 
neocarz inostatin  (N C S ), an "an titum or an tib io tic o f h igh  m o lecu lar 
w eig h t" as they put it, from  S trep to m y ces  carzinostaticus  var. F-41.4 Th is  
com pound w as la te r characterized  as a 1 :1  com plex of a p ro te in
2
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com ponent (apoprote in ) and a chrom ophoric m olecule, and it w as  
estab lished  th a t the cyto tox icity  o f neocarz inostatin  m ain ly resided  on the  
chrom ophore .5 D esp ite the in terestin g  b io log ical activ ity , tw en ty  years  
had to pass before the stru ctu re  of the chrom ophore w as e lucidated  by 
Edo et  al. in  1985 (3, F ig u re  2 ).6
NCS
neocarzinostatin chromophore 
Figure 2 The neocarzinostatin chromophore.
E ven  a fte r the e lucidation  o f the in trigu ing  enyne-cum ulene  
m oiety, the in te rest o f the syn thetic com m unity in  neocarz inostatin  
rem ained  lukew arm . Aside from  the then  unreso lved  absolute  
stereochem istry, the stru ctu re  qu ite possib ly seem ed too u n like ly  to the  
m ajo rity o f chem ists. Th is situation  changed in  one swoop in  1987 w ith  
the d isclosure o f the structu res of the ca licheam ic in s (4, com m only 
ab breviated  as C A L ) by research ers  o f Led erle  Lab o rato ries and the  
structu res o f the esperam icins (E S P , 5 ) by scien tists o f Bristo l-M yers in  
the sam e M ay issue o f the Jo u rn a l o f  th e  A m erica n  C h em ical S o ciety  
(F ig u re  3). Bo th  com pounds had been iso lated  in  p revious years  from  
A ctinom adura  v erru co so sp o ra  (esp eram icin ) and M icrom onospo ra  
ech in o sp o ra  ssp. ca lich en sis  (ca lich eam ic in ) and proved to be the m ost 
potent an titum or agents so fa r d iscovered .
esperamicin Aí
Figure 3 The structures of calicheamicin y1I and esperamicin A1.
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N ow  that th e ir structu res had been reso lved , one com m on featu re  
im m ed iate ly caught the atten tion : a (Z)-3-ene-1,5-diyne m oiety, id es t  an  
enediyne. M oreover, the authors o f both papers suggested a mode of 
action  by w h ich  the ened iynes could exert th e ir b io log ica l activ ity . They  
proposed the ened iynes to undergo a so-called Bergm an  C yclization  (B C ), 
th ereb y generating  a benzenoid a,a-1,4-dirad ical w h ich  should be capab le  
of ab stractin g  hydrogen atom s from  n earb y DNA.
Th is cycloarom atization  reactio n  had been described  in  d eta il m ore
than  a decade e a rlie r by Bergm an  et  al.9 and, in  fact, had been p reviously
10 11 observed  by M asam une as w e ll as Sondheim er and W ong during  th e ir
studies o f annulenes. In  1972, Bergm an  had published a study about the
therm al behavior o f (Z)-3-hexene-1,5-diyne (1, Schem e 1).9 U nder
e levated  tem peratu res, it w as transform ed  into benzene d eriva tives 7
depending on the so lvent used. Based  on his findings, Bergm an
concluded th a t a h igh ly reactive  benzenoid a,a-1,4-dirad ical (6 ) should
12act as in term ed iate .
Scheme 1 Bergman's study of the thermal behavior of (Z)-3-hexene-1,5-diyne (1).
N eocarz inostatin  now  rece ived  renew ed  in te rest because o f its 
s im ila rity  to the n ew ly  characterized  ened iynes in  term s o f stru ctu re  and  
b io log ical activ ity . It  w as evid en t th at its an titum or p roperties w ere  also  
re la ted  to its ab ility  to form  rad ica ls  in  a reaction  sequence th a t w as
13 14independently proposed by M yers and Saito . In  th is case, cyclization  
proceeds via enyne-allenes afford ing  to luene d eriva tives via an  
in term ed iate  a,3-didehydrotoluene rad ica l (9, Schem e 2). An a lte rna tive , 
fu lvene rad ical-generating  pathw ay fo r enyne-allenes has been d isclosed  
by Sch m itte l and co-workers15 (8 ^ 1 0 ). In  analogy to th is Schm itte l 
C yclization , Sch re in e r et  al. suggested , 16 based on th eo re tica l 
calcu lations, th at fu lvene d irad ica ls  could  also be form ed from  ened iynes
i majorproduct
X solvent X Y
hydrocarbon H H
CCl4 Cl Cl
toluene H Bn
Y
7
( 1 ^ 1 1 ).
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8 8
Myers-Saito
Cyclization
Schmittel
Cyclization
Schreiner
Cyclization
9 10 11
Scheme 2 The Myers-Saito Cyclization and the Schmittel Cyclization of enyne-allenes 
and the Schreiner Cyclization of enediynes.
1.2.2 Is o la te d  n a tu r a lly  o c c u r r in g  e n e d iy n e s
In  the fo llow ing  years, a grow ing num ber o f n a tu ra lly  o ccu rring  
ened iynes w as iso lated , a ll o f w h ich  possessed e ith e r a nine- o r a ten- 
m em bered core structu re. As o f now, the set of the nine-m em bered  
ened iynes (F ig u re  4) com prises neocarz inostatin  (3 ),6 C-1027 (12 , also  
ca lled  lid am ycin ),17 kedarcid in  (1 3 ),18 m aduropeptin  (1 4 ), 19 N1999A2  
(1 5 ),20 actinoxanth in , largom ycin , aurom om ycin and sporam ycin .1a'21 
W h ile  a ll those ened iynes' chrom ophores conta in  a b icyclo[7.3.0]-  
dodecad iynene core, on ly com pounds 3 and 12-15 are  s tru ctu ra lly  fu lly  
elucidated . It  is also w o rth  noting that a ll nine-m em bered enediynes, w ith  
the exception o f N1999A2, have been iso lated  as non-covalent com plexes 
w ith  a stab iliz ing  apoprotein .
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Figure 4 Structurally characterized nine-membered ring enediyne chromophores.
The set o f ten-m em bered ened iynes has also seen a grow ing  
num ber o f m em bers (F ig u re  5): N am enam icin  (1 6 )22 and sh ish ijim icin
23( 1 7 r are  s im ila r to C A L and E S P  in  th a t th ey share the sam e enediyne- 
conta in ing  fram ew ork  and also featu re  an  extended sugar part. 
D ynem icin  (1 8 )24 and u n cia lam ycin  (1 9 )25 on the o ther hand com bine an  
ened iyne w ith  an  anthraqu inone core.
6
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shishijimicin A
CO2H
OMe
OH O OH dynemicin A
OH O HN „¿TX OH 
‘ " O^ T "H  
OH
19
OH O OH uncialamycin
Figure 5 Ten-membered ring naturally occurring enediynes whose structures have been 
elucidated.26
S
1.2 .3  M o d e  o f a c t io n
i
A ll n a tu ra lly  occu rring  ened iynes share th ree  com m on features:
1) A  conjugated  system  consisting  of tw o trip le  bonds flank ing  a 
double bond o r an in c ip ien t double bond. Th is so-called "w arhead " 
is confined  into a stra ined  ring  system  o f e ith e r nine o r ten  atom s 
in  o rd er to lo w er the energy o f activa tio n  of the c ru c ia l 
cycloarom atization  reaction .
2) A  kind of lock ing  and trig g erin g  device  th a t stab ilizes the enediyne  
tow ard  un in ten tiona l activation . M ost n a tu ra lly  o ccu rring  
enediynes w ill be unlocked by a - typ ica lly  sulfur-contain ing - 
b ionucleophile.
3) A  m oiety th a t is capab le  o f in te rca la tin g  into the m inor groove of 
D N A  th ereb y acting  as a d e livering  device. F o r ened iynes 4, 5, 16 
and 17, the sugar p arts act as D N A  b inders, and in  ened iynes 18
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and 19, the anthraqu inone takes over th at role. In  the case o f the  
nine-m em bered enediynes, both the sugar residues and the  
naphthoate o r benzoate groups con tribu te  to D N A  com plexation.
Schem e 3 illu stra tes  the mode o f action  o f ened iynes 4, 5, 16 and 17. 
Upon in te rca la tio n  w ith  DN A, a b ionucleoph ile  (e .g . g lu tath ione) c leaves  
the ened iyne 's trisu lfid e  m oiety. The resu lting  th io late  (2 1 ) adds 
in tram o lecu la rly  in  a conjugate fashion to the b ridg ing  cyclohexanone  
ring  th at is locking the ened iyne w arhead . B y  the action  o f th is  
nucleoph ilic addition, a rehyb rid ization  o f the attacked  b ridgehead
2 3carbon  takes p lace, th ereb y converting  from  sp  to sp  (2 1 ^ 2 2 ). The  
change in  geom etry in creases the stra in  on the 1 0 -m em bered enediyne- 
conta in ing  ring  and at the sam e tim e a llow s the acetylene  te rm in i to 
com e in  close v ic in ity  o f each  o ther (c-d d istance). B C  can  now  take p lace  
and w ill produce the benzenoid d irad ica l 23 w h ich  sequ en tia lly  abstracts  
tw o hydrogen atom s from  the sugar phosphate backbone of DNA. 
M o lecu la r oxygen reacts w ith  the D N A  rad ica ls  lead ing  u ltim ate ly  to 
oxidative c leavag e of the D N A  strands. The p re fe rred  sites for the  
generation  of D N A  rad ica ls  a re  at C (5 ') o f deoxyribose and to a m inor 
extent a t C (1 ') and C (4 ').1c'27
- NHCO2Me . u __  2 rehybridization NHCO2Me
Sugar
21
24
7
DNA
L
HO-«
22 Sugar
BC
DNA diradical
23DNA damage
Scheme 3 Mode of action of the ten-membered ring, sugar-containing enediynes. The 
inset indicates the preferred sites of radical formation on the sugar phosphate backbone 
of DNA.
The m ode of action  of the anthraquinone-based ened iynes is 
dep icted  in  Schem e 4. A fte r b io reduction  o f the in itia l quinone 26, the  
epoxide 27 opens and a llow s for the a ttack  o f a b ionucleoph ile in  a 
conjugate add ition  type fashion. In  analogy to ca licheam icin , th is process
8
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leads to a change in  geom etry around the ened iyne core (2 8 ^ 2 9 ) thereb y  
paving  the w ay fo r the BC .
26 27
BC
30 29
Scheme 4 Mode of action of anthraquinone-based enediynes dynemicin (18) and 
uncialamycin (19).
There  is less un ifo rm ity in  the mode o f action  of the nine- 
m em bered ring  enediynes. N C S  (3 ) and N1999A2 (1 5 ) generate an  
enyne-cum ulene in term ed iate  (32 , Schem e 5) upon nucleoph ilic a ttack  on
the paren t com pound 31; arom atization  p roceeds via a M yers-Sa ito
28C yclization . M aduropep tin  (1 4 ) rearran ges into a p roper ened iyne by 
in tram o lecu la r a ttack  o f the m acrocyclic  am ide n itrogen  onto its a lly l 
m ethyl e th e r (3 4 ^ 3 5 ). K ad arc id in  (1 3 ) and C-1027 (1 2 ) stand out in  that 
th ey spontaneously cyc lo arom atize as soon as the chrom ophore is 
re leased  from  the stab iliz ing  apoprotein.
j ' '  Nu:I
R2
31
Myers-Saito r . 
Cyclization
OH
32
enyne-cumulene
OH
Scheme 5 Cycloaromatization pathways of neocarzinostatin and N1999A2 (31^33) and 
maduropeptin (34^36).
R 3
R
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1.2.4 C l in ic a l  u se  o f n a tu ra l e n e d iy n e s
In  spite o f the exceptional an titum or a ctiv itie s  o f the n a tu ra lly  o ccu rring  
enediynes, th e ir c lin ica l use so fa r is ra th e r lim ited . The la ck  o f sp ec ific ity
29and a general, ex trem ely h igh tox ic ity in  com bination  w ith  a poor 
stab ility  under physio log ica l cond itions p revents a w idespread  app lication  
in  the m ed ical field .
N onetheless, two d eriva tives o f n a tu ra lly  o ccu rring  ened iynes have  
found th e ir w ay to the drug m arket. The firs t has been N C S  cova len tly
30linked  to poly(styrene-co-m aleic acid ) (SM A ). Th is conjugate (S M A N C S ) 
shows an in creased  plasm a residence, a m ore favo rab le  b iod istribu tion  
and a reduced  apoprotein-induced im m unogenicity as com pared to the  
n atu ra l com pound. SM A N C S  has been approved  fo r the treatm en t o f
31advanced  hep ato ce llu la r carcinom a in  Ja p a n  since 1994.
A  m ore recen t exam ple is gem tuzum ab ozogam icin, consisting  of 
C A L ch em ica lly  bound via a lin ke r to a hum anized anti-CD33 m onoclonal
32antibody. The antibody sp ec ifica lly  ta rgets a g lycopro te in  an tigen
33p reva len t on leukem ic cells. FD A  approva l w as gran ted  in  2000, and the  
drug w as m arketed  as M ylo targ®  fo r the treatm en t o f acu te m yelo id  
leukem ia fo r patien ts above 60 years. In  Ju n e  2010, how ever, 
m anufactu rer P fize r announced to w ith d raw  M ylo ta rg  from  the U S  
m arket a fte r post-approval c lin ica l tria ls  ra ised  doubts about its safety
34and e ffic ien cy in  the targeted  app lication . N everthe less, the  
developm ent o f o ther d eriva tives o f n a tu ra lly  occu rring  enediynes,
27esp ecia lly  C A L and C-1027, is ongoing.
1.3 Terminal acetylenic amino acids
As ind icated  in  the genera l in troduction , ace ty len ic  am ino acids have  
been id en tified  as su itab le  bu ild ing  blocks fo r constructing  enediyne- 
contain ing  am ino acids. The fo llow ing  section  aim s to in troduce th a t class  
of com pounds.
1.3.1 In tro d u c t io n
In  recen t years, there  is an in creasin g  dem and fo r extending the am ino  
acid  re se rvo ir beyond the tw en ty  canon ica l p ro te inogen ic am ino acids. 
Non-natural am ino acids th at conta in  unsatu rated  carbon-carbon bonds 
in  the side cha in  com prise a class o f non-proteinogenic am ino acids th a t 
have m et a grow ing in te rest in  a ll fie lds of chem istry. E sp e c ia lly  in  
syn thetic chem istry, m ed icina l chem istry and peptide science, the  
add itional reactive  fu n ctio na lity  is h igh ly va lu ed .35 T erm ina l ace ty len ic  
am ino acids constitu te a subclass o f unsatu rated  am ino acids th a t contain
10
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a carbon-carbon trip le  bond a t the term inus of the a-substituent (F ig u re  
6 ).
Figure 6 Amino acids containing a terminal alkyne.
A lthough often co ined as "non-natural", severa l m em bers o f th is  
com pound class have been iso lated  from  n a tu ra l sources, iro n ica lly , in  
m ost cases long a fte r th ey have been m ade syn th e tica lly  ava ilab le . The  
sm allest o f the ace ty len ic  am ino acids, L-ethynylg lycine (3 7 ), fo r exam ple 
has been obtained from  broths o f S trep to m y c es  ca ten u la e  and d isp layed  
an tib io tic  a c tiv ity  against Gram -positive b a c te ria .36 Its  hom ologue L- 
p rop argylg lycine  (3 8 ) has been encountered  in  m ushroom s of the
37 38Am anita  genus, such as A. abrupta  and A. p seu d o p o rp h y ria . It  
possesses a broad spectrum  of b io log ical a ctiv itie s , am ongst others the  
inh ib ition  of cystath ione y-lyase ,39 and an tib io tic40 and an tifungal41 
properties. The h igher hom ologue L-hom opropargylglycine (3 9 ) has been  
extracted  from  the ed ib le m ushroom  C ortinarius cla rico lor  var. ten u ip es ,
42and it strong ly inh ib ited  the g row th  of B acillus subtilis  B-50.
A ce ty len ic  am ino acids have found w idespread  ap p lication  in  the  
fie lds o f syn thetic chem istry and peptide science by p rovid ing  an  
unsatu rated  handle th a t a llow s fo r a w hole range o f transform ations. In  
b iochem istry-related  studies, some em phasis cu rren tly  lies on Cu-
43cata lyzed  azide-alkyne cyloadd ition  ("c lic k ") reactions, w h ile  tran sitio n  
m etal-catalyzed reactions p reva il in  syn thetic o rgan ic ch em istry .35,44
The rem ainder o f th is in trod ucto ry ch ap ter p resents a se lection  of 
syn thetic app lications o f ace ty len ic  am ino acids. In  line  w ith  the contents  
of th is thesis, the focus o f the fo llow ing  exam ples lies on the form ation of 
carb acycles and arom atic system s invo lving  transfo rm ations o f the C= C  
trip le  bonds.45
1.3.2 C y c liz a t io n  in v o lv in g  th e  a c e t y le n ic  a - s u b s titu e n t
Kotha e t  al. reported  the use o f p rop argylg lycine  in  a m etathesis-based  
approach  tow ards h igh ly functionalized  p henyla lan ine d e riva tive s .46 
Prop arg y lg lyc in e  d eriva tive  40  served  am ong others as substrate in  a 
cross-enyne m etathesis reactio n  w ith  a lly l aceta te  using the 1 st 
generation  G rubbs ca ta lyst (4 1 ) to g ive the 1,3-diene 42 in  4 5 %  y ie ld  
(Schem e 6 ). Th is d iene subsequently underw en t a D iels-A lder reaction
37 38 39
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w ith  d im ethyl acetylened icarb oxylate  (D M AD , 43 ), fo llow ed  by DDQ  
oxidation to afford  the targeted  p henyla lan ine d eriva tive  44.
HN
Ac
¡^¡ÿNs^ OAc
CO2Me
40
PhH, rfx HN
Ac
OAc
MeO2C
,,CO2Me
43
CO2Me 
42 (45%)
1) PhMe, rfx
2) DDQ, PhH, rfx HNAc
OAc 
CO2Me
CO2Me
CO2Me 
44 (32%)
Scheme 6
The sam e group m ade use o f a s im ila r approach  in  o rd er to a rrive
47a t quinone-containing am ino acids (Schem e 7). En yne  cross-m etathesis 
betw een  p rop argylg lycine  d eriva tive  45 and ethylene gas, catalyzed  by 
41, afforded d iene 46. A t th is point, [4+ 2] cycloadd ition  betw een  46  and  
a series o f quinones fo llow ed  by m anganese dioxide-m ediated oxidation  
allow ed  the iso lation  of am ino acid-quinone hybrids 47.
45
h2c=ch2
41 (cat) 
'2Et CH2Cl2,rt
i.Me
46 (68%)
r
'Me
47a (81%) 47b (77%) 47c (93%)
Scheme 7
The group of G arc ia  p resented  a m ethod of p reparing  h igh ly  
substitu ted  phenyla lan ine d eriva tes em ploying a Rh (I)-cata lyzed  [2 + 2+2] 
cycloadd ition  betw een  p ro tected  p rop argylg lycines 48 and a va rie ty  o f
48d iynes 49. Reflux ing  the tw o reactan ts in  E tO H  in  the p resence of 10 
m o l%  o f W ilk in so n 's  ca ta lyst gave good to exce llen t y ie ld s o f arom atic  
products 50 (Schem e 8 ).
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HN
r
'CO2PG2 + \
R RhCl(PPh3)3 (10 mol%)
X
R
..^ NHPG1
CO2PG2PG1 R EtOH, rfx
48 49
R = H, alkyl
X = O, CH2, C(CO2Et)2,NSO2R
R
50 (64%-quant)
Scheme 8
1.3 .3  C y c liz a t io n  b e tw e e n  tw o  a - su b s titu e n ts
U ndheim  and co-workers developed routes to con fo rm ationally  
constra ined  analogues o f cystine  (51, Schem e 9). O f specia l in te rest w as  
the tr ic y c lic  bis-am ino acid  d eriva tive  53 w h ich  can  be considered  a rig id  
cystine  analogue .49 The key step tow ard  53 w as the construction  o f the  
tr ic y c lic  system , ach ieved  by sub jecting  the acetylene-tethered  
d ip ropargylg lycine  d eriva tive  52 to the 1st generation  G rubbs ca ta lyst 
(41 ). The resu lting  m etathesis cascade reaction  furn ished  53 in  5 8 %  
yie ld . A  s im ila r R C M  cascade could  be app lied  to d ienynes 54 in  o rder to 
a rrive  at b icyc lic  d ienes 55 th a t w ere  designed to be used in  D iels-A lder 
reactions to fu rn ish  tr ic y c lic  cystine  d eriva tives.
Scheme 9 Reagents and conditions: Grubbs catalyst 41 (cat), PhMe, 85 °C, 14 h.
Silyl-bearing  arom atic com pounds w here  show n to read ily  undergo  
e lectrop h ilic  ipso  substitu tion  reactions thereb y p rovid ing  access to a 
va rie ty  o f arom atic d eriva tives. Kotha and co-workers p resented  a sim ple  
stra tegy for the synthesis o f TM S-contain ing  indane-based am ino acids  
(Schem e 10).50 In  a [2+ 2+ 2] cycloadd ition  betw een  d ia lkyn yl am ino acids  
56 and b is (trim e th y ls ily l)a ce ty len e  (B T M SA , 57 ) prom oted by V o llh ard t's  
ca ta lyst (C p C o (C O )2), the silicon-substituted indanylg lycines 58 w ere  
obtained a lb e it in  low  yie lds. Ipso  substitu tion  of the T M S  groups a llow ed  
for fu rth e r functionalization .
51
cystine 52 53 (58%) 54 55 (85-86%)
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= > :
NHR
'CO2Et
56a R = Piv 
56b R = Ac
Scheme 10
_TMS
TMS 57 
CpCo(CO)2 (cat) 
neat, 140 °C
tms^ ^ nhr
TMS CO2Et
58a (26%) 
58b (12%)
A nother en try  into indanylg lycine  d eriva tives is show n in  Schem e
11 .51 In tram o lecu la r enyne ring-closing m etathesis (R C M ) o f a-allyl-a- 
p ropargylg lycine  60  cata lyzed  by 41 y ie ld ed  cyc lic  d iene 61 w h ich  w as  
subjected  to a va rie ty  o f ace ty len ic  d ienophiles in  [4+ 2] cycloadd ition  
reactions. O xidation o f the resu lting  b icyc lic  structu res by m eans of DDQ  
gave the ta rg e t com pounds 62.
R1 =R2 = CO2Me (88%)
R = H, CO2Me (67%)
R = H, Ts (82%)
Scheme 11 Reagents and conditions: (a) (i) allyl bromide, KOH, n-Bu4NBr, MeCN, 0 °C; 
(ii) 3 M HCl, Et2O, rt; (iii) Ac2O, DMAP, CH2Cl2; (b) 41 (cat), CH2Cl2, rt; (c) (i) dienophile; 
(ii) DDQ, PhH, rfx.
dienophiles:
MeO2C— —CO2Me —CO2Me —Ts
1.3.4 C y c liz a t io n  b e tw e e n  th e  a -sid e  c h a in  a n d  a  n it ro g e n ­
s u b s titu e n t
Tetrahydro isoqu ino line  (T ic ) is a constra ined  p henyla lan ine analogue and  
serves as an im portan t probe and bu ild ing  b lock in  the fie ld  o f peptide  
science. Approaches tow ard  T ic d eriva tives em ploying [2+ 2+ 2] 
cycloadd ition  reactions as the key step w ere  reported  by Kotha and co­
w o rkers52 (Schem e 12). A  rep resen ta tive  exam ple is the cyclo- 
trim erization  o f p ropargylg lycine-based d iyne 63 w ith  various  
d isubstitu ted  acetylenes using W ilk in so n 's  or V o llh a rd t's  ca ta lyst th ereb y  
provid ing  T ic d eriva tives  64 in  accep tab le  to good yie lds.
Scheme 12
N CO2Et 
Ts
63
RhCl(PPh3)3 (cat) 
EtOH, rfx 
or
CpCo(CO)2 (cat) 
PhMe / octane, rfx
R ^ ^ ^ r-''v-Y"CO2Et 
R ^ O - T ,
64 (19-65%)
R = CO2Me, CH2OH, Ph, TMS
R R
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Y e t ano ther en try  into constra ined  p henyla lan ine d eriva tives w as  
d isclosed by Kotha and K hedkar53 (Schem e 13): Ring-closing m etathesis  
o f N -hom oallylp ropargylg lycine 65 m ediated  by the 2nd generation  
Grubbs ca ta lyst (6 8 ) fu rn ished  diene 6 6 . A  [4+ 2] cycloadd ition  w ith  
D M AD  (4 3 ) and consecutive oxidative arom atization  using DDQ  d elivered  
functionalized  2,3,4,5-tetrahydro-1H-3-benzoazepine-2-carboxylic acid  67  
in  20%  y ie ld  over the last two steps.
CO2Me
N CO2Et Ts 2 TsN
65
CO2Et 
66 (54%) CO2Et 
67 (20%)
Scheme 13 Reagents and conditions: (a) 68 (cat), PhMe, 100 °C, 24 h; (b) DMAD (43), 
PhMe, rfx, 17 h; (c) DDQ, PhMe, rfx, 48 h.
Se ve ra l quinone-containing T ic d eriva tives have been accessed  via 
a com bination  of [2 + 2+2] and [4+ 2] cycloadd ition  reactions (Schem e  
14).54 N -Propargylp ropargylg lyc ine  63 served  as substrate fo r a [2 + 2+2] 
cyclo trim erization  w ith  2-butyne-1,4-diol u tiliz ing  W ilk in so n 's  cata lyst. 
The resu lting  d io l 69 w as converted  into the correspond ing d ibrom ide 70 
th rough the agency o f P B r3. Exposure o f the d ibrom ide to sodium  
hydroxym ethylsu lfinate (R o n g a lite® ) p rovided su ltine 71 w h ich  
functioned  as a m asked o-quinodim ethane (7 2 ) in  subsequent D iels-A lder 
reactions w ith  a series o f quinones. A rom atization  of the cycloadd ition  
products by the action  of M nO 2 accom plished the syntheses o f the ta rg e t 
com pounds 73.
Ts CO2Et
63
O
«
d O
^ ^ y /' y CO2Et
^ L ^ J^ N T s
. I-- 69 R = OH (53%)
b 70 R = Br (83%)
CO2Et 
NTs
O
D X T t
CO2Et 
NTs
71 (69%)
73 (71-82%)
Scheme 14 Reagents and conditions: (a) RhCl(PPh3)3 (cat), but-2-yne-1,4-diol, EtOH; (b) 
PBr3, CHCl3, rt; (c) sodium hydroxymethylsulfinate, TBAB, DMF, rt; (d) (i) PhMe, rfx; (ii) 
MnO2, dioxane, rfx.
a c
O
15
Chapter 1
Yam am oto and H ayash i in vestigated  rhodium -catalyzed  
in tram o lecu la r [4+ 2] and [5+ 2] cycloadd itions o f ethynylg lycine-based  
d ienyne 74 and cyclopropylenyne 76 (Schem e 5).55 The d iene-alkyne  
cycloadd ition  of 74 proceeded w e ll in  the p resence o f a ca ta ly tic  quan tity  
o f R h (a ca c )(C O )2 in  to luene w ith  m icrow ave heating. Tw o isom eric  
products (7 5 a  and 75b ) w ere  form ed in  a ratio  o f 36:64, resp ective ly . Fo r  
the [5+ 2] cycloadd ition  of substrate 76, a sw itch  o f the ca ta ly tic  system  
to R h C l(P P h 3)3/AgOTf proved to be essen tia l in  o rd er to obtain  accep tab le  
yie lds. U n d er these conditions, the tw o products 77a and 77b  w ere  
form ed in  a ratio  o f 63:37, resp ective ly , in  a com bined y ie ld  o f 46% .
BnN
EtO2C
74
nBu
Me BnNRh(acac)(CO)2 (cat)
PhMe, MW, 120 °C EtO2C nBu
75a
Me
64% (36:64)
BnN
EtO2C nBu
75b
Me
BnN
EtO2C
76
Scheme 15
nBu
RhCl(PPh3)3 (cat) 
AgOTf (cat)
PhMe, MW, 120 °C
BnN
Bn,Æ )  +
EtO2C nBu EtO2CnBu 
77a 46% (63:37)
nBu
77b
+
1.3 .5  O th e r  c y c liz a t io n s
The access ib ility  o f fused cyclobutenes is the sub ject o f a paper o f the  
group o f M a rtín .56 A  gem -disubstituted fuller-1,6-enyne (7 9 ) could  be 
p repared  from  [6 0 ]fu lle rene  and the azom ethine y lid e  o f p ropargylg lycine  
78. Subsequent reflux ing  o f in term ed iate  79 in  ch lorobenzene brought 
about a th e rm ally  allow ed, in tram o lecu la r [2 +2 ] cycloadd ition  g iv ing  rise  
to the stab le, fu llerene-fused cyclobutene 80 in  exce llen t yie ld .
CO2Et
H2N CO2Et 
78
HCHO, C6
PhCl, rfx PhCl, rfx
79 (40%) 80 (90%)
Scheme 16
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1.4 Purpose and outline of the thesis
The purpose o f the research  detailed  in  th is thesis has been the synthesis  
and ch aracte riza tion  o f cyc lic  enediyne-contain ing am ino acids based on 
te rm in a l ace ty len ic  am ino acids.
In  the ch ap ter a t hand, a concise h isto ric o verv iew  of n a tu ra lly  
occu rring  ened iyne an tib io tics is g iven, and the class o f te rm in a l 
acety len ic  am ino acids is shortly  in troduced.
C hap ter 2 describes the p reparation  of a series o f cyc lic  enediyne- 
conta in ing  am ino acids w ith  ring  sizes va ry in g  from  10  to 12  atom s 
starting  from  p rop argylg lycine  and hom opropargylg lycine.
C hap ter 3 d iscusses the ch aracte riza tion  and p roperties o f the  
com pounds synthesized in  C hap ter 2. T h e ir re a c tiv ity  tow ards Bergm an  
C yclization  under e levated  tem peratu res is explored and the d ifferences  
betw een  the com pounds a re  rationalized .
C hap ter 4 covers the synthesis o f cyc lic  ened iyn ic am ino acids from  
a-m ethylp ropargylg lycine. K in e tic  studies o f these ened iynes are  
conducted and th e ir behavior in  peptide coup ling reactions is 
investigated .
C hap ter 5 reports the synthesis o f acetylene-contain ing a- 
trifluo ro m eth yl am ino acids. E ffo rts  to obtain  cyc lic  trifluorom ethyl-  
conta in ing  ened iyne am ino acids are  described.
C hap ter 6 p resents the concep t o f ened iynes linked  to gold  
nanoparticles. T rigg erin g  of the Bergm an  C yclization  should be possib le  
via p lasm onic heating  o f the nanoparticles by e lectrom agnetic rad iation .
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Abstract*
The cu rren t chap ter describes the synthesis o f cyc lic  enediyne-contain ing  
am ino acids w ith  ring  sizes rang ing  from  10  to 12  atom s and featu ring  
d iffe ren t v in y lic  substituents.
In itia lly , tosyl-protected acyc lic  ened iyn ic m esylates w ere  cyclized  
via base-induced nucleoph ilic d isp lacem ent reactions. S ta rtin g  from  
p ropargylg lycine , 1 0 -mem bered and 1 2 -m em bered cycles w ere  accessib le  
in  th is m anner. U nexpected ly, com plete racem ization  occu rred  during  
rin g  closure. Fu rtherm ore, e lim ination  ra th e r than  cyclization  took p lace  
in  the route tow ard  the 11-m em bered ring . The sam e products as in  the  
d isp lacem ent stra tegy w ere  obtained by M itsunobu condensation  as a 
m eans of enacting  cycliza tion  of a cyc lic  ened iynyl alcohols. Fe w e r  
reactio n  steps and p a rtia l p reservation  of o p tica l p u rity  are  the  
advantages o f the la tte r route.
F in a lly , eleven-m em bered cyc lic  ened iyn ic am ino acids, assem bled  
from  hom opropargylg lycine, and a pyridine-fused ened iyne a re  presented.
Part of this chapter has been published as: J. Kaiser, B. C. J. van Esseveldt, M. J. A. 
Segers, F. L. van Delft, J. M. M. Smits, S. Butterworth, F. P. J. T. Rutjes Org. Biomol. 
Chem. 2009, 7, 695.1
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2.1 Introduction
E v e r  since the firs t s tru ctu ra l e lucidations o f n a tu ra l enediynes, i .e .
2 3 4neocarzinostatin , esperam icin  and ca licheam ic in , the chem ical 
com m unity has pursued the synthesis o f m odel system s that m im ic th e ir  
chem ica l and b io log ical functions. The m otivation  fo r th is endeavor is 
th reefo ld :
F irs t of a ll, one sought to understand  the p aram eters th a t contro l 
or in fluence the Bergm an  cycliza tion  (B C ), i .e . the p ivo ta l reactio n  th a t 
generates rad ica ls  from  these com pounds. One also w anted  to lea rn  
about the developm ent o f the ened iyne class o f n a tu ra l products, not in  
the least because o f th e ir aw e-inspiring stru ctu re  and un ique mode of 
action. Second ly, the pow erfu l an tib io tic  and an titum or a c tiv ity  o f the  
n atu ra l ened iynes has obviously im pressed both industry and the  
scien tific  com m unity, and it spurred  the search  fo r sim pler, m ore 
accessib le  ened iynes that featu re  the sam e c lin ica lly  d esirab le  attribu tes. 
F in a lly , th ere  is m uch room  for im provem ent, e sp ecia lly  concern ing  the  
g en era lly  poor se lec tiv ity  and targ e tin g  p roperties o f the n a tu ra l 
com pounds m aking them  unsu itab le  for m ed ica l treatm ents in  th e ir  
orig in a l form .
O ur invo lvem ent in  ened iynes started  w ith  the insigh t that the  
com bination  of an ened iyne "w a rh e a d " w ith  the ve rsa tility  o f an  am ino  
acid  w ould  resu lt in  in te restin g  com pounds. The fun ction a lities o f an  
am ino acid  could provide attachm ent points fo r a v a rie ty  o f m odules like  
DN A-targeting probes or trig g erin g  devices, possib ly enab ling  these  
enediynes to be d e livered  and activated  on spot. Fu rtherm ore , th ey could  
be incorporated  into peptides. In  th a t case, the cyc lic  ened iyn ic am ino  
acids could act as beta-turn m im ics; BC-induced conform ational changes  
in  the peptide as w e ll as rad ical-m ediated  p ro te in  degradation5 belong to 
the possib ilities. F in a lly , B C  o f the ened iyn ic am ino acids w ould  provide  
access to novel am ino acids.
A  few  exam ples o f enediyne-connected am ino acids have been  
reported  (F ig u re  1 ). The group of Jones devised  enediyne-am ino acid  
conjugates like  1  fo r purposes of p ro te in  b ind ing and photo-induced  
pro te in  degradation  via B C .5t1,6 B asak  et  al. p repared  severa l ened iynyl 
am ino acids, exem plified  by 2 , and dem onstrated  the ab ility  of 
in tram o lecu la r H-bonds to lo w er the activa tio n  energy o f the BC . 
A nother exam ple is the enediyne-bridged am ino acid  3 that has been  
presented  by Je r ic  et  al. as a too l to be used in  peptide conform ational
o
studies.
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NHBoc
HN__CO2Me
2 O Me
Figure 1 Literature examples of enediynyl amino acids.
N CO2H H 2
H NH2
NrSO Ph
2.2 Previous work in our group
The ve ry  firs t synthesis o f cyclic  enediyne-contain ing am ino acids has 
been in itia ted  by van  Esseve ld t as p art o f his PhD  research 9 (vide infra). 
The genera l stru ctu re  o f cyc lic  enediyne-contain ing am ino acids 4 
(Schem e 1) can  be re tro syn th e tica lly  d isassem bled as fo llow s: A  scission  
of the ring  betw een  n itrogen  and the m ethylene carbon  w ould  resu lt in  
the open-chain p recu rso r 5. Th is acyc lic  ened iyne should be accessib le  
from  the appropriate  ace ty len ic  am ino acids 6  and halo-enynes 7 via 
tran sitio n  m etal-catalyzed coup ling reactions. The halo-enynes, in  turn , 
could be rea lized  from  v in y lic  or arom atic v ic in a l d ihalides (8 ).
=> !'I.V.
Scheme 1 Retrosynthesis of cyclic enediyne-containing amino acids.
2
1
3
o2r 1
o2r 1
2
10S ta rtin g  from  N-tosyl-protected (R )-propargylg lycine (R)-9 and
haloenyno ls11 10 o r 11, the acyc lic  ened iynes 13 and 14 have been
12prepared  by m eans o f Sonogashira-type reactions by van  Esseve ld t 
(Schem e 2). T reatm en t w ith  m ethanesu lfonyl ch lo ride (M sC l) afforded  the  
correspond ing m esylates 15 and 16, setting  the stage for base-induced  
cycliza tion  reactions.
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Scheme 2 Preparation of the mesylated cyclization precursors.9 Reagents and conditions: 
(a) Haloenynol (10 or 11), PdCl2(PPh3)2 (cat), Cui (cat), Et2NH, Et2O, rt, 3 h; (b) MsCl, 
Et3N, CH2Cl2, 0 °C ^ rt, 4 h.
T reatm en t o f a d ilu te  so lution (6 m M ) o f 15 in  D M F  w ith  potassium  
carbonate (5 equ iv) resu lted  in  a c lean  conversion  to the cyc lic  enediyne  
(±)-17 (Schem e 3). Rem arkab ly, the product d isp layed  no op tica l a c tiv ity  
in  the p o larim eter as opposed to its p recursor. Indeed, crysta ls  grow n
13from  the product show ed both enantiom ers in  the un it cell.
Scheme 3 Cyclization via nucleophilic displacement.9
Along the sam e lines, the h igher hom ologue 16 has been subjected  
to the sam e cond itions (Schem e 4). H ow ever, no cyc lic  stru ctu re  w as  
form ed, and the resu lting  product appeared  to be the e lim ination  product
14(±)-18. Fu rtherm ore, th is d iened iyne, too, show ed no o p tica l activ ity .
(±)-18 (76%) 
racemic
Scheme 4 E limination of homopropargylic mesylate 16.
Supposedly, two facto rs con tribu te  to the racem ization  o f the cyc lic  
enediyne (±)-17. F irs tly , the sulfonam ide p ro tecting  group renders the a ­
H  su ffic ien tly  acid ic to be prone to ab straction  even  by a re la tiv e ly  m ild  
base. Second ly, the a-H is the m ost acid ic proton of the cyc lic  stru ctu re  in
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con trast to the open p recu rso r 15 in  w h ich  the sulfonam ide proton has 
the low est pK^. A ccord ing ly, the racem ic natu re  o f e lim ination  product 
(± )-18 can  best be explained by assum ing in itia l form ation of the 1 1 - 
m em bered ring  stru ctu re 15 ((R )-19 ), fo llow ed  by racem ization  and fin a lly  
strain-prom oted e lim in ative  ring  fission 16 to g ive the acyc lic  expanded  
conjugated  system  (Schem e 5).
Scheme 5 Proposed racemization-ß-elimination sequence.
2.3 Enediynes based on propargylglycine
2.3 .1  U se  o f th e  B o c  p ro te c t in g  g ro u p
It  w as rationalized  that, in  o rd er to attenuate  the a-H-acidity o f the cyc lic  
enediynes, the strong ly e lectron-w ithdraw ing sulfonam ide p ro tecting  
group could  be rep laced  by a carbam ate-based p ro tecting  group. The Boc  
group w as iden tified  as a su itab le  cand idate, m ostly because o f its 
stab ility  under the basic cond itions encountered  during  the genera l 
synthesis of the cycliza tion  precursors.
Thus, the Boc-protected m esylate 22 w as p repared  com m encing  
from  Boc-protected p rop argylg lycine  20 and app lying  the sam e protocol 
as used for accessing  the tosyl-protected analogues (Schem e 6 ).
Scheme 6 Assembly of a Boc-protected cyclization precursor. Reagents and conditions: 
(a) Haloenynol 10, PdCl2(PPh3)2 (cat), Cui (cat), Et2NH, Et2O, rt, 6 h; (b) MsCl, Et3N, 
CH2Cl2, 0 °C, 1 h.
H ig h ly  d ilu te  (5 m M ) solutions o f 22 w ere  subjected  to various  
conditions aim ing at cycliza tion  to form  cyc lic  ened iyne 23. The resu lts  
are  sum m arized in  Tab le 1 . E v id en tly , carbonate bases gave no 
conversion  at all, even  at e levated  tem peratu res (en tries 1-6). The use o f
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K H M D S w as m ore prom ising; add ition  of 2 equ iva len ts in  portions at 0 °C  
fo llow ed by w arm ing  to room  tem peratu re  a llow ed  the iso lation  o f the  
in tended product in  a y ie ld  o f 1 3 %  (en try  7). The rest o f the m ass balance  
had been converted  to “ base line  m ate ria l” . Low ering  the in itia l 
tem peratu re  to -78 °C  w ith  concu rren t in crease o f reactio n  tim e did not 
im prove the outcom e (en try  8 ). F in a lly , the h ighest y ie ld  w as ach ieved  by 
em ploying sodium  hydride in  T H F  over extrem ely long reactio n  tim es (89 
days), fu rn ish ing  23 in  a y ie ld  o f 1 7%  (en try  10).
Table 1 Cyclization conditions for Boc-protected substrate 22.
MsO
J
BocHN CO2Me 
22
J  c = 5 mM--------
conditions MeO2C','''*\
23
X 3
entry base equiv T (°C ) solvent time (h) isolated
yield
1 K 2CO3 1.2 rt TH F 24 a
2 K 2CO3 5.0 rt TH F 24 a
3 K 2CO3 1.2 50 TH F 5 a
4 K 2CO3 5.0 50 TH F 5 a
5 Cs2CO3 1.2 rt DM F 24 a
6 Cs2CO3 4.0 rt DM F 19 a
7 KHM D S 
(0.5 M  in tol)
2.0
(in
portions)
0 ^  rt TH F 4 13 %
8 KHM D S 
(0.5 M  in tol)
1.6
(in
portions)
-78 ^  0 TH F 12 10 %
9 NaH 2.0 0 ^  rt TH F 15 trace
10 NaH 2.7 rt TH F 89 days
XX
%71
a) no conversion; b) Estimated conversion: 90% (by TLC).
It  seem ed u n like ly  th a t th is approach  w ould  g ive access to cyc lic  
enediyne am ino acids w h ile  p reserving  the o p tica l p u rity  o f the starting  
m ateria l w hen  considering  that ra th e r strong bases (N aH , K H M D S ) had  
to be em ployed in  o rd er to b ring  about cycliza tion  o f the Bo c  substrate 2 2  
and th at the ach ieved  y ie ld s w ere  low.
2 .3 .2  T h e  M its u n o b u  a p p ro a c h
A fte r the fa ilu re  o f the Boc-protected substrate to e ffic ien tly  form  the  
desired  product, w e retu rned  our atten tion  to the sulfonam ide p ro tecting  
groups. A pparen tly, the in itia l base-induced nucleoph ilic d isp lacem ent
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approach  proved to be too harsh  causing  racem ization  and e lim ination  
problem s in  the cycliza tion  step (vide su p ra ). C learly , a m ethod as gentle  
as possib le w as requ ired  to b ring  about the desired  transform ation . One
17 18answ er to th is prob lem  could be the M itsunobu reaction . ' It  has been  
recognized as a m ild  and e ffic ien t w ay  to N -alkylate sulfonam ides and  
sulfonam ide-protected am ino acids, e sp ecia lly  w hen  app lied  for
19in tram o lecu lar bond form ation. Som e exam ples o f th is ap p lication  of
M itsunobu chem istry on enantiopure substrates are  show n in  Schem e 7,
20 21rang ing  from  sim ple N -alkylations (24  and 25 ) ' to the in tram o lecu la r
22 23form ation of sm all heterocycles (2 6 ) and m edium -sized rings (2 7 ) .
o2n
NO2 o O Me Br
N CO2Me + >
J U  H OH
r HOHN CO2 Bu " V
Et
O
Ns
HO^^I
HN^Mey
o = r N ' r YO H O 1
OH
OAc
NO2 o O Me
O2N
\' >r 
S-.'N CO2Me 
k /B r
24
,Ph
EtOlY " '" ^ C O 2^ Bu 
O Ns
25
H,N^,Me
r Y
Ar-S=O O 1 
il
O 26
Schem e 7 Examples of N-functionalizations of enantiopure, sulfonamide- 
protected amino acids making use of the Mitsunobu reaction.
Fo llow ing  th is concept, the p reviously described  tosyl-protected  
acyc lic  ened iyno ls (R)-13 and (R)-14 w ere  trea ted  w ith  d iethyl 
azodicarboxylate (D EA D ) and P P h 3 as h igh ly d ilu te  (~ 5  m M ) T H F  
solutions (Schem e 8 ). The reactions p roceeded  q u ick ly  but to our dism ay, 
the outcom e ve ry  m uch resem bled  th a t o f the m esylate d isp lacem ent 
approach: S ta rtin g  from  (R)-13 (> 9 8 %  ee), the ten-m em bered cyc lic  
ened iyne (R)-17 w as obtained in  7 5 %  y ie ld . U nexpected ly, ch ira l H P LC  
analysis revea led  a substan tia lly  d im in ished  enantiom eric excess (7 6 %  
ee) o f the product. In  the case o f hom opropargylic enyno l (R)-14  
e lim ination  and p a rtia l racem ization  took p lace again . The e e  o f the  
e lim ination  product (R)-18 w as determ ined  to be as low  as 4 2 % .
27
Chapter 2
(60%, 42% ee)
Scheme 8 Mitsunobu reactions on enediyne alcohols.
F in a lly , the th ird  m em ber of th is series, the racem ic hom ologue 
(± )-28, w as p repared  from  (±)-9 and 12. It  w as successfu lly  cyclized  
under id en tica l cond itions g iving  rise  to the correspond ing cyc lic  1 2 - 
m em bered enediyne (± )-29 in a y ie ld  of 88% . As expected, no e lim ination  
product w as observed  in th is case.
C rysta ls  su itab le for X-ray stru ctu ra l e lucidation  could be grow n  
from  acyc lic  ened iyne 28 as w e ll as from  cyc lic  enediyne 29, 
unam biguously proving the form ation of the cyc lic  structu re  (F ig u re  2). 
The crysta l structu re  of 17 has been published ea rlie r.
28 29
Figure 2 PLUTON24 drawings of the crystal structures of cyclization precursor 28 and 
12-membered cyclic enediyne 29.
It  has to be assum ed that the p a rtia l racem ization  of e lim ination  
product (.R)-18 proceeds as described  fo r the m esylate approach, nam ely  
via the cyc lic  enediyne 11-membered ring  (Schem e 5).
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The p ropensity o f ened iynes 17 and 18 to racem ize, even  under the  
m ild  cond itions app lied  here, c le a rly  em phasizes the acid ic natu re o f the  
a-proton o f the cyc lic  am ino acids. C onsidering  the resu lts so fa r le t us to 
b elieve  that the prob lem  of racem ization  o f sulfonam ide-protected cyc lic  
enediyne-contain ing am ino acids o f type 4 cannot be fu lly  circum ven ted  
and is in trin s ic  to these structu res. In  spite o f th is d raw back, w e fe lt th a t 
the app lied  strategy, i.e . in tram o lecu la r cycliza tion  o f an  ened iynyl 
alcoho l using M itsunobu chem istry, constitu tes a genera l and ve ry  d irect 
m ethod o f p reparing  the desired  com pounds, a lb e it in  racem ic form .
In  the m ean tim e, Re itz  and co-workers had published an  
a lte rn a tive  synthesis o f 1 0 -m em bered benzene-fused cyc lic  am ino acids of 
type 33 (Schem e 9 ).25 They, too, started  from  enantiopure, sulfonam ide- 
protected  p ropargylg lycine , but chose to assem ble the cyclization  
precurso rs 32 in  a s tric tly  lin ea r m anner. F irs t, 1,2-diiodobenzene w as 
coupled to p rop arg ylg lycines 30 using aqueous Sonogash ira  cond itions  
thus a rriv in g  a t enyn ic am ino acids 31. A  second Sonogash ira  coup ling  
fu rn ished  the lin ea r ened iyne alcoho ls 32 th a t in  tu rn  w ere  cyclized  using  
the M itsunobu reaction . Fo llow ing  th is sequence, they p repared  a range  
o f d iffe ren tly  p ro tected  cyc lic  enediynes. Rem arkab ly, the issue of 
racem ization  has not been addressed in  th e ir paper; e e  va lu es or specific  
ro tation  va lu es have not been reported.
R= Me, 4-MeCgH4, 4-MeOCgH4 ee values or
3,4-(MeO)2C6H3, 4-NO2C6H4 specific rotations not reported
Scheme 9 Synthesis of cyclic enediynes 33 as reported by Reitz and co-workers.25 
Reagents and conditions: (a) 1,2-Diiodobenzene, PdCl2(PPh3)2 (cat), Cui (cat), NH4OH, 
DME; (b) propargyl alcohol, PdCl2(PPh3)2 (cat), Cui (cat), NH4OH, DME; (c) DEAD, PPh3, 
THF.
2 .3 .3  N o n - b en z o fu sed  e n e d iy n e s
It  is know n from  lite ra tu re  th a t the substituents o f the v in y lic  portions o f 
ened iynes can  be of profound in fluence on the ra te  of the Bergm an  
cyc liza tio n .26,27
One sim ple but im portan t change in  that resp ect w ould  be to om it the  
fused benzene ring . The resu lting  non-benzofused coun terparts to the  
series produced so fa r should be accessib le  by app lying  the estab lished  
protoco l to v in y lic  substrates in  p lace o f phenylic ones.
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Thus, starting  from  racem ic p ropargylg lycine  (± )-9 and read ily
11 28ava ilab le  haloenyno ls ' 34-36, the acyc lic  ened iyne alcoho ls 37-39  
w ere  p repared  via Sonogash ira  coup ling reactions (Schem e 10). 
Sub jection  of the shortest cycliza tion  p recu rso r (3 7 ) to M itsunobu  
conditions led  to the sw ift consum ption of starting  m ateria l w ith  
concom itant appearance o f a sing le new  spot on T LC  w h ich , how ever, had  
d isappeared  a fte r work-up. No ened iyne could be iso lated  by flash  colum n  
chrom atography; instead  the tetrahydro isoqu ino line  d eriva tive  41 w as  
obtained, show ing a d iffe ren t re ten tion  facto r on T LC  than  the p reviously  
observed  spot.
(±)-9
n = 1 -3 
34, 35, 36
CO2Me 
HN-Ts
OH n
37, n = 1 (39%)
38, n = 2 (77%)
39, n = 3 (75%
CO2Me
Ts
40
during
work-up
œ .üW2N».■COMe Ts
41 (16%)
=n
b
2=n 3=n
CO2Me 
NHTs
42 (34%)
O2Me
-Ts
43 (61%)
Scheme 10 Synthesis of non-benzofused enediynes. Reagents and conditions: (a) 
Haloenynol (34, 35 or 36), PdCl2(PPh3)2 (cat), Cui (cat), n-BuNH2, Et2O, rt; (b) PPh3, 
DEAD, THF (high dilution), rt.
O bviously, the desired  ened iyne 40  had been form ed, but it 
underw ent Bergm an  cycliza tion  during  work-up. Th is m eans that 
tem peratu res rang ing  betw een  room  tem peratu re  and 30 °C  over a 
period  o f 30 m inutes w ere  su ffic ien tly  activa tin g  fo r the BC  to occur. In  
sta rk  con trast to th is behavior, its benzene-fused coun terpart 17 w as  
stab le in  the solid state for m onths and could be kept in  ch loroform
29solution for severa l days w ithou t deterio ration .
The h igher hom ologues reacted  as th e ir benzofused counterparts: 
the hom opropargylic alcoho l 38 led  to the e lim ination  product 42 in  3 4%  
y ie ld , w h ile  39 w as transform ed  into the 12-m em bered cycle  43 in  a 
reasonab le y ie ld  (6 1 % ). A  c rys ta l stru ctu re  o f the la tte r ened iyne has 
been obtained (F ig u re  3).
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2.4 Eleven-membered cyclic enediynes from homo- 
propargylglycine
In  o rd er to gain  access to the thus fa r e lusive 11-m em bered cyc lic
enediynes, it w as decided  to sta rt from  N-tosyl-protected (S)-
10hom opropargylg lycine m ethyl este r (4 4 ). In  th is approach, ß-elim ination  
of the cyclized  am ine cannot take p lace.
HN
Ts
XCO2M6
44
OH
TsHN CO2Me 
46 (66%)
CO2M6
Ts
47 (70%) 
[a]D =131.9
CO2M6
Ts
48 (80%) 
[a]D = 37.0
Scheme 11 Preparation of the 11-membered cycles starting from homopropargylglycine. 
Reagents and conditions: (a) Haloenynol (10 or 34), PdCl2(PPh3)2 (cat), CuI (cat), n- 
BuNH2, Et2O, rt; (b) PPh3, DEAD, THF (high dilution), rt.
b
b
Schem e 11 shows the syntheses o f both the o lefin ic and the  
benzene-fused species. The acyc lic  ened iynes 45 and 46 w ere  read ily  
assem bled by Sonogash ira  reactions. G ra tify in g ly , th e ir in tram o lecu la r 
condensation under M itsunobu conditions fu rn ished  the cyc lic  11-
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m em bered enediynes 47 and 48  in 7 0 %  and 8 0 %  y ie ld , resp ective ly . Bo th  
products showed optica l a c tiv ity  in the po larim eter; the e e  va lues, 
how ever, w ere  not estab lished  due to the lack  of racem ic m ateria l for 
com parison. Considering  the tendency of the propargylg lycine-based  
enediynes to racem ize, it is lik e ly  that the 1 1 -m em bered cycles, too, 
su ffer from  p artia l racem ization  during the cyclization  step.
A  crysta l structu re  of the benzene-fused ened iyne 48 has been  
estab lished, proving the form ation of an 11-membered ring  (F ig u re  4).
48
Figure 4 Depiction24 of the crystal structure of the 11-membered cyclic enediyne 48.
2.5 Pyridine-fused enediynes
2.5 .1  In tro d u c t io n
As m entioned p reviously, e lectron ic  effects can have a profound in fluence  
on the ra te  of BC  of ened iynes .26 There are a few  reports in  lite ra tu re  
describ ing  the substitu tion  of the v in y lic  portion of enediynes, but the  
effects of d ire c tly  decorating  th is double bond w ith  electron-donating or 
electron-w ithdraw ing groups are not stra igh tfo rw ard . Depending on the  
exact natu re of the substituent, the rate  of the BC  can be slow ed down by 
both electron-donating and e lectron-w ithdraw ing substituents, e .g .
30substitu tion  by ch lo ride  slows down BC  and p -m ethoxyphenyl does so,
27too.
A  m ore consisten t e ffect can be ach ieved  by m eans of fusion w ith  
ce rta in  (h e te ro )a ry l m oieties. Electron-poor arom atics have shown to 
in crease the rate  of BC  w hereas electron-rich  ones slow  down the 
reaction . Fo r instance, Sem m elhack and N ico laou  have p repared  a series  
of cyc lic  quinone/hydroquinone ened iynes and showed th at the quinones
31reacted  s ig n ifican tly  faste r than th e ir d ihydroquinone counterparts  
(F ig u re  5). This w as also the case w ith  structu res having the 
quinone/hydroquinone rem ote ly attached  to the enediyne, thus 
suggesting an e lectron ic effect tak ing  p lace ra th e r than effects due to the  
d ifference in  arom atic ity  alone. In  a study on acyc lic  arom atic-fused  
enediynes, K im  and Russel dem onstrated  th at the pyridine-fused
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ened iyne 54 had a considerab ly lo w er activa tio n  energy (E a) than  its a ll­
carbon  analogue 5 3 .32
O
49 50 51 52
t1/2>7d/120°C t1/2 = 88h / 40 °C t1/2 >1 d /120 °C t1/2 = 15h / 84°C
53 54
Ea = 25.1 kcal/mol Ea = 21.5 kcal/mol
Figure 5 Literature examples of enediynes having electron-withdrawing or electron- 
donating aromatics fused to their vinylic site.
O
The lite ra tu re  p recedence insp ired  us to in vestigate  the design o f a 
pyridine-fused enediyne-contain ing am ino acid  (5 5 ). Its  retrosyn thesis, 
show n in  Schem e 12, is qu ite s im ila r to th a t o f the benzene-fused  
enediynes, and it suggested sulfonam ide-protected p rop argylg lycine  and  
2,3-dihalo-substituted pyrid ine  as starting  m ateria ls.
so2r
(±)-30
Scheme 12 Retrosynthesis of pyridine-fused enediyne 55.
2 .5 .2  S o n o g a s h ira  c o u p lin g s  to  t r if la t e s
W e  w ere  som ew hat lim ited  by the lack  o f com m ercia lly  ava ilab le  2,3- 
d iha lopyrid ines w ith  the exception o f the d ich loro  species. Se ve ra l 
attem pts w ere  m ade to couple p ropargyla lcoho l to 2 ,3-dichloro pyrid ine  
(5 8 ) under Sonogash ira  conditions. U n fo rtunate ly, no p roduct could be 
iso lated  a fte r 24 h a t rt nor a fte r 5 d a t 50 °C , p robab ly due to the a ry l 
ch lo ride  not being reactive  enough (Schem e 13). The re a c tiv ity  of
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halogens tow ards Pd-catalyzed coup lings is g en era lly  know n to be I > B r  
> Cl. In  the ligh t o f the low  re a c tiv ity  o f the ch lo ride, w e tu rned  to 
trifla tes. These "pseudo ha lides" have been em ployed in  aryl-alkyne
34couplings and g en era lly  show  a re a c tiv ity  com parable to th a t of 
brom ides.
64 (96%)
Scheme 13 Sonogashira couplings to the 2-position of pyridine derivatives. Reagents and 
conditions: (a) Tf2O (1.2 equiv), Et3N (2.2 equiv), CH2Cl2, 0 °C, 4 h; (b) PdCl2(PPh3)2 (5 
mol%), Cui (10 mol%), Et2NH (5 equiv), Et2O, rt, o/n.
Thus, com m ercia lly  ava ilab le  2-iodo-3-hydroxypyridine (6 0 ) w as  
converted  to its trifla te  (6 1 ) by the action  o f tr iflic  anhydride and  
trie thylam ine . Coup ling of the trifla te  to p ropargyl alcoho l under standard  
Sonogash ira  cond itions proceeded read ily  at room  tem peratu re  as judged  
by T LC . The iso lation  of p roduct 63, how ever, tu rned  out to be 
cum bersom e due to its h igh po larity . P ro tection  o f the p rop argylic alcoho l 
w ith  a T B D M S  group p rio r to the reactio n  circum ven ted  th at problem , 
and the 2-substituted coup ling product 64 w as obtained in  excellen t y ie ld  
(9 6 % ). No 3-substituted p yrid ine  had been observed  at th is stage. The  
next step w as the coup ling o f p ropargylg lycine  (±)-9 to the new ly  
obtained trifla te  64. W e  an tic ip ated  th is step to be m ore d ifficu lt than  the  
firs t one due to the facts th a t trifla te s  are  less reactive  than  iodides and  
th at Pd-catalyzed coup lings to the 3-position of pyrid ines are  gen era lly  
m ore cha lleng ing  than  those to the 2-position .35 M u ltip le  cond itions for 
th is coup ling reaction  have been trie d ; they are  sum m arized in  Tab le  2.
34
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Table 2 Sonogashira-type couplings of propargylglycine (±)-9 to pyridinyl triflate 64.
c f ^ Y O T f -►  f
s . ^ C O 2 M e
N H Ts
I  ^  A .
TsH N  C O 2M e N 
(±)-9 64
^ O T B D M S
N
II
65
^ O T B D M S
entry amine catalyst system loading
(m ol%)
solvent T (°C ) time result
1 E t2NH PdCl2(PPh3)2 / CuI 5/10 E t2O rt o/n - a)
2 E t3N Pd(PPh3)4 / CuI 5/10 DM F 50 
then rt
4 h 
o/n
_ b)
3 E t3N PdCl2(PPh3)2 / CuI 5/10 Et3N 50 
then rt
2 h 
o/n
- b)
4 E t2NH PdCl2(PPh 3)2 / CuI 5/10 DM F 100 20 min - b)
5 E t2NH PdCl2(PPh3)2 / CuI 5/10 DM F 60 
then rt
30 min 
2 d
- b)
6 E t3N Pd2dba3 / D PPE  / CuI 5/20/10 M eCN rt 2 d
- a)
7 E t2NH PdCl2(PPh3)2 / CuI 5/10 DM F c)001 1 h _ b)
8 Et3N PdCl2(PPh3)2 / LiC l 5/250 DM F c)001 1 h - b)
9 Et3N PdCl2(PPh3)2 / LiC l 5/250 DM F 75 10 h 15%
then rt o/n
a) No conversion; b) starting material and multiple unidentified products; c) microwave 
heating.
The on ly set o f cond itions that gave any y ie ld  at a ll w as the use o f 
ca ta ly tic  Pd C l2(P P h 3)2 together w ith  L iC l as co-catalyst and trie th ylam ine  
in  D M F  at 75 °C  fo r an  in itia l period  of 10 h fo llow ed  by stirrin g  overn igh t 
at room  tem peratu re  (en try  9). U n fo rtunate ly, th is reaction  tu rned  out to 
be irrep rod u cib le  at la rg e r scales.
CÜ2Me 
NHTs
OR
CÜ2Me
Ts
65, R = TBDMS
66, R = H (68%) J
67 (10%)
Scheme 14 Final steps of the synthesis of pyridine-fused enediyne 67. Reagents and 
conditions: (a) TBAF, THF, 0 °C; (b) PPh3, DEAD, THF, rt, o/n.
b
N everthe less, it w as decided  to go on w ith  the little  m ateria l w e  
had obtained. A  fluoride-m ediated dep rotection  of s ily l e th er 65 furn ished  
6 6  in  a m oderate y ie ld  (Schem e 14). A t th is stage, less than  10 mg of 
m ateria l w as le ft fo r attem pting  the in tram o lecu la r M itsunobu ring
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closure. The la tte r reactio n  p roceeded  as expected as judged  by T LC  but 
the am ount o f iso lated  product w as ra th e r sm all (< 1  mg, 1 0 % ). 
C h aracterization  by m eans o f H -N M R  and LC -M S strong ly suggested the  
form ation of the desired  cyc lic  ened iyne (6 7 ); how ever, fu rth e r s tru ctu ra l 
proof w as th w arted  by the lim ited  q uan tity o f ava ilab le  m ateria l.
2 .5 .3  C o u p lin g s  to  n o n a fla te s
The low  e ffic ien cy  o f the route so fa r prom pted us to try  im proving the  
yie lds, e sp ecia lly  concern ing  the Pd-catalyzed coup ling to the 3-position 
of pyrid ine-derivative 64. A ry l and v in y l nonaflates (nonafluoro- 
butanesu lfonyl, nonaflyl, N f) have been app lied  in  tran sitio n  metal- 
cata lyzed  couplings as an e ffic ien t and m ore reactive  a lte rn a tive  to 
tr ifla te s .36 The nonaflates d isp lay an in creased  re a c tiv ity  in  some 
reactions as com pared to trifla tes  and at the sam e tim e appear to be 
m ore stab le tow ard  flash  chrom atography. M oreover, they can  be cheap ly  
prepared  from  alkoxides and nonafly l fluoride.
^  62^^ ••^ ...OTBDMS 
-OH /s^-ON^ , ^ ï^ O N fa  c c .N I N I N '^^OTBDMS 60 68 (92%) 69 (88%)
Scheme 15 Preparation of aryl nonaflate 69. Reagents and conditions: (a) NfF, 
CH2Cl2/Et3N, 20 min; (b) PdCl2(PPh3)2 (cat), CuI (cat), Et2NH, Et2O, rt, 4 h.
W e  an ticip ated  th a t the substitu tion  o f a nonaflate fo r the trifla te  in  
the 3-position w ould  m ake th is c ru c ia l coup ling step h igher yie ld ing . 
Thus, 2-iodo-3-hydroxypyridine (6 0 ) w as a llow ed  to react w ith  2 
equ iva len ts o f nonafly l fluoride in  d ich lorom ethane/triethylam ine (5:1, 
v/v) (Schem e 15). The product o f th is reaction  (6 8 ) w as coupled to 
TBD M S-pro tected  p ropargyla lcoho l (6 2 ) under standard  Sonogash ira  
conditions to a rrive  at nonaflate 6 9 , read y to be coupled to 
p rop argylg lycine  (±)-9. U n fo rtunate ly, ju s t as in  the trifla te  case, the  
coupling o f the nonaflate p roved not to be stra igh tfo rw ard . Tab le  3 
sum m arizes the cond itions tried .
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Table 3 Sonogashira-type couplings of propargylglycine (±)-9 and pyridinyl nonaflate 69.
XHNi
Ts
^ ^ v^ -O N f 
CO2Me
(±)-9 69
cC
65
,*^ NNN-*CO2Me
NHTs
.^OTBDM S,-OTBDMS
entry amine catalyst system loading solvent T time result
m ol%
1 BuN H 2 Pd (PPh3)4/CuI 5/10 E t2O rt 3 d a
2 E t2NH PdCl2(PPh3)2/CuI 5/10 E t2O rt o/n 8%
3 E t2NH PdCl2(PPh3)2/CuI 5/10 DM F rt o/n a
4 E t3N PdCl2(PPh3)2/LiCl 5/250 DM F rt o/n traceb
5 piperi- (n3-C3H5)2Pd2Cl2/ 2.5/10 M eCN rt 2 d traceb
dine P (tBu )3
6 E t2NH PdCl2(PPh3)2/ 5/ DM F 50 oC 4 h c
CuI/LiCl/I2 10/20/1 ^  rt o/n
a) Starting material and multiple unidentified products; b) ~50% conversion, product 
visible on TLC; c) no conversion.
O n ly one set o f reaction  cond itions could be found th a t gave any  
y ie ld  at all. The "standard " Sonogash ira  conditions, i.e . the com bination  
o f d iethylam ine, Pd C l2(P P h 3)2, and cuprous iodide as co-catalyst furn ished  
8%  o f the product (en try  2). The reaction  could be reproduced  on sm all 
scales (25-300 mg o f starting  m ateria l), but fa iled  at a la rg e r scale (10 g) 
ju s t as the reaction  on the trifla te  did. In te restin g ly , the copper-free 
conditions th a t successfu lly coupled the trifla te  substrate (64, see Tab le
2) w ere  not fru itfu l in  case o f the nonaflate (en try  4).
In  sum m ary, it can  be said  th a t w e have experienced  the  
Sonogash ira  coup ling to the 3-position o f pyrid ines as a ra th e r cap ric ious  
reactio n  that is characterized  by low  yie ld s and suffers from  bad  
rep roducib ility .
2.6 Conclusion
In  th is chap ter, routes to cyc lic  enediyne-contain ing am ino acids have  
been described  starting  from  read ily  ava ilab le  ace ty len ic  am ino acids. 
O lefin ic and benzene-fused ened iynes have been p repared  w ith  ring  sizes 
rang ing  from  10  to 12  atom s.
The synthesis stra tegy invo lved  the construction  of acyc lic  
enediynes via Sonogashira-type coup lings and subsequent cyclization  of 
these p recurso rs e ith e r by nucleoph ilic d isp lacem ent reactions or by 
M itsunobu reactions. The la tte r approach  saves one step, nam ely the  
conversion  o f the hydroxyl into a good leavin g  group. Fo r the cyclization  
reactions to p roceed  e ffic ien tly , the N-term inus of the am ino acid  needs
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to bear a sulfonam ide p ro tecting  group in  o rd er to su ffic ien tly  activate  
the N H  tow ards deprotonation.
D uring  cyclization  into the targeted  cyc lic  enediynes, in  severa l 
instances an  unexpected (p a rtia l) racem ization  took p lace, even  under the  
m ild and v irtu a lly  n eu tra l M itsunobu conditions. Fu rtherm ore, 
d ehydrative  ß-elim ination p roh ib ited  the cycliza tion  o f substrates  
featu ring  a hom opropargylic hydroxide and thus p revented  the  
p reparation  o f 11-m em bered cycles from  p ropargylg lycine . Upon  
chang ing the starting  m ateria l to hom opropargylg lycine, isom eric cyc lic  
enediynes w ere  successfu lly  synthesized.
F in a lly , w e explored the access ib ility  o f pyridine-fused cyclic  
enediynes via the Sonogash ira-M itsunobu sequence. W h ile  g en era lly  
possible, th is approach  w as seriously ham pered by the low  yie ld ing  Pd- 
catalyzed  coup lings to the 3-position o f 2-substituted pyrid ines.
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2.8 Experimental section
2 .8 .1  G e n e r a l in fo rm a t io n
So lven ts w ere  d istilled  from  appropriate  d rying  agents p rio r to use and  
stored  under n itrogen. En an tiop u re  propargyl- and hom opropargylg lycine  
w ere  purchased  from  C h ira lix  B .V . A ll o ther chem icals w ere  purchased  
from  Sigm a-A ldrich or A cros and used as rece ived . Pro tected  
p rop argylg lycine  and hom opropargylg lycine w ere  p repared  accord ing  to 
the protocols d eta iled  in  ref. 10. A ll reactions w ere  ca rried  out under an  
in e rt atm osphere o f d ry n itrogen  o r argon, un less stated  o therw ise. 
Reactions w ere  fo llow ed  and R f va lues w ere  obtained using th in  la ye r  
chrom atography (T LC ) on s ilica  gel-coated p lates (M e rck  60 F 254) w ith  
the ind icated  so lvent m ixture. M icrow ave  reactions w ere  ca rried  out in  a 
C E M  D isco very  m icrow ave. IR  spectra  w ere  recorded  on an A T I M attson  
G enesis Se rie s  F T IR  spectrom eter, o r a B ru k e r Tensor 27 F T IR  
spectrom eter. N M R  spectra  w ere  recorded  on a B ru k e r D PX  200 (200 
M H z), a B ru k e r D M X  300 (300 M H z), and a V a rian  Inova 400 (400 M H z). 
C hem ical sh ifts are  g iven  in  ppm  w ith  respect to te tram eth yls ilan e  (T M S ) 
as in te rn a l standard . Coupling constants are  reported  as J-values in  Hz. 
F lash  chrom atography w as ca rried  out using A cros s ilica  gel (0.035-0.070
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mm, 6 nm  pore d iam eter). O p tica l ro tations w ere  determ ined  w ith  a 
Pe rk in  E lm e r 241 po larim eter; concen trations (c ) are  g iven  in  g/100 m L. 
The e e  va lues w ere  obtained by ch ira l H P L C  on a Sh im adzu LC-2010C  
apparatus equipped w ith  a D a ice ll AD-H colum n (e luen t: hexane/2- 
propanol). H igh  reso lu tion  m ass spectra  w ere  recorded  on a M AT900 (E I, 
C I and E S I).
2 .8 .2  P r e p a r a t iv e  P ro c e d u re s
3-(2-Iodophenyl)prop-2-yn-1-ol (10)
OH 1,2-Diiodobenzene (1.010 g, 3.062 mmol) was dissolved in Et2O 
(10 mL). Pd(PPh3)4 (140 mg, 0.121 mmol) and CuI (53 mg, 0.280 
mmol) were added to the stirred solution, followed by n-BuNH2 
(1.5 mL, 15.2 mmol). Once a clear, homogeneous solution had 
been formed, prop-2-yn-1-ol (0.175 mL, 3.006 mmol) was added via syringe, and 
stirring was continued for 6 h. One aliquot of a saturated aqueous NH4Cl was 
poured into the reaction flask, the phases were separated, and the aqueous layer 
was extracted with EtOAc (3x 5 mL). The combined organic layers were washed 
with brine, dried over MgSO4, and concentrated in vacuo. The crude product was 
purified by flash chromatography (EtOAc/heptane, 2:7) yielding 10 as a yellowish 
oil that solidified on cooling (401 mg, 1.554 mmol, 52%).
The characterization data were consistent with those in ref. 11a.
4-(2-Iodophenyl)but-3-yn-1-ol (11)
The title compound was prepared following the same procedure 
as described for 10 starting from 1,2-diiodobenzene (669 mg, 
l i^ l  oh 2.027 mmol) in Et2O (10 mL), PdCl2(PPh3)2 (70 mg, 0.010 mmol),
CuI (40 mg, 0.210 mmol), Et2NH (1.05 mL, 10 mmol), and but-3- 
yn-1-ol (0.190 mL, 2.510 mmol). Flash chromatography 
(EtOAc/heptane, 1:10 ^  1:3) furnished 11 as a light brown oil that solidified on 
cooling (318 mg, 1.169 mmol, 58%).
The characterization data were consistent with those in ref. 11b.
5-(2-Iodophenyl)pent-4-yn-1-ol (12)
The title compound was prepared following the same procedure 
as described for 10  by letting react a solution of 1 ,2- 
OH diiodobenzene (2.34 g, 7.09 mmol) in Et2O (20 mL) with 
Pd(PPh3)4 (218 mg, 0.188 mmol), CuI (61 mg, 0.320 mmol), n- 
BuNH2 (3.8 mL, 38.4 mmol), and pent-4-yn-1-ol (0.66 mL, 7.09 
mmol) over a period of 12 h. Work-up and purification by flash chromatography 
(EtOAc/heptane, 1:10 ^  2:3) gave 12 as a yellow oil that solidified on cooling 
(1.081 g, 3.78 mmol, 53%).
The characterization data were consistent with those in ref. 11a.
(•R)-5-(2-(3-Hydroxyprop-1-ynyl)phenyl)-2-(toluene-4-sulfonylamino)pent-4-ynoic acid  
methyl ester (13)
A stirred solution of 4-(2-iodophenyl)prop-3-yn-1-ol (10) (335 
^ ^ \ o C° 2Me mg, 1.298 mmol) in Et2O (15 mL) was treated with 
nhts PdCl2(PPh3)2 (40 mg, 0.057 mmol), CuI (22 mg, 0.116 mmol), 
and Et2NH (0.57 mL, 5.5 mmol). Stirring was continued until 
^ \ ^ o h  a clear, homogeneous solution had been formed and 
protected propargylglycine (R)-9 (309 mg, 1.098 mmol) was 
added. After 4 h at ambient temperature, the reaction mixture was poured into an 
aliquot of saturated aqueous NH4Cl, the phases were separated and the aqueous 
layer was extracted with EtOAc (3x 8 mL). The combined organic layers were 
washed with brine, dried over MgSO4, and all volatiles were removed in vacuo.
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Purification by flash chromatography (EtOAc/heptane, 2:3) provided 13 as a 
yellowish oil (401 mg, 0.975 mmol, 89%).
Rf 0.48 (EtOAc/heptane, 1:1); e e  = 98.5%; additional characterization data were 
consistent with those published in ref. 9 and ref. 25.
(.R)-4-Tosyl-1,2,7,8-tetradehydro-3,4,5,6-tetrahydro-4-benzazecine-5-carboxylic acid  
methyl ester (17)
Triphenylphosphine (262 mg, 0.999 mmol) was dissolved in a 
dilute solution (c = 5 mM) of alcohol (R)-13 (207 mg, 0.503 
mmol) in THF (100 mL). DEAD (40% in toluene; 0.150 mL, 
0.953 mmol) was added, and the reaction mixture was 
stirred for 20 min at ambient temperature followed by removal of all volatiles in 
vacuo at room temperature. Flash chromatography (EtOAc/heptane, 1:10 ^  1:3) 
afforded (R)-17 as a white solid (156 mg, 0.396 mmol, 79%).
Rf 0.19 (EtOAc/heptane, 1:4); ee = 73%; vmax (ATR) 3058, 3028, 2954, 2245, 
2224, 1740, 1597, 1342, 1156, 1087, 728; <5h (300 MHz, CDG3) 7.80 (2 H, d, J =
8.0 Hz), 7.26-7.19 (4 H, m), 7.10 (2 H, d, J =  8.0 Hz), 4.75 (1 H, d, J =  19.3 Hz), 
4.30 (1 H, dd, J =  10.1, 3.1 Hz), 4.19 (1 H, d, J =  19.3 Hz), 3.83 (3 H, s), 3.39-3.12 
(2 H, m), 2.22 (3 H, s); Öq (75 MHz, CDG3) 169.9, 143.4, 137.7, 129.3, 128.7,
128.0, 128.0, 127.6, 127.4, 127.1, 95.2, 92.7, 87.1, 83.9, 64.1, 52.9, 42.2, 21.5, 
21.2; HRMS (EI) calcd. for C22H19NO4S (M+) 393.10348, found 393.10334; 
characterization data were consistent with those published in ref. 9 and ref. 25.
CO2Me
NHTs
OH
(.R)-5-(2-(4-Hydroxybut-1-ynyl)phenyl)-2-(toluene-4-sulfonylammo)pent-4-ynoic acid  
methyl ester (14)
The title compound was synthesized following the same 
procedure as described for 13 by allowing to react 4-(2- 
iodophenyl)but-3-yn-1-ol (11) in Et2O (15 mL) with 
PdCl2(PPh3)2 (18 mg, 0.025 mmol), CuI (10 mg, 0.052 mmol), 
Et2NH (0.26 mL, 2.5 mmol) and propargylglycine (R)-9 over a 
period of 12 h. Work-up and purification by flash 
chromatography (EtOAc/heptane, 2:3) afforded 14 as a light yellow oil (151 mg, 
0.355 mmol, 71%).
Rf 0.15 (EtOAc/heptane, 2:3); e e  > 99%; vmax (neat) 3495, 3266, 2955, 1736, 
1584, 1473, 1438; öh (300 MHz, CDCl3) 7.74 (2 H, d, J = 8.4 Hz), 7.38-7.35 (1 H, 
m), 7.29-7.14 (5 H, m), 6.12 (1 H, d, J = 8.7 Hz), 4.20-4.14 (1 H, m), 3.89-3.82 (2 
H, m), 3.61 (3 H, s), 2.98 (2 H, dd, J = 5.0, 3.4 Hz), 2.86 (2 H, dt, J = 5.8, 2.7 Hz),
2.55 (1 H, t, J = 6.3 Hz), 2.34 (3 H, s); öc (75 MHz, CDCl3) 169.9, 143.3, 136.8,
131.8, 131.6, 129.4, 127.7, 127.3, 126.9, 125.8, 125.0, 91.1, 86.5, 83.0, 81.3,
60.9, 54.3, 52.9, 25.2, 24.0, 21.7; HRMS (EI) calcd. for C23H23NO5S (M+) 425.1297, 
found 425.1311. Characterization data consistent with ref. 9.
0>CO2Me
NHTs
(fi)-5-(2-But-3-en-1-ynyl-phenyl)-2-(toluene-4-sulfonylamino)-pent-4-ynoic acid  
methyl ester (18)
A stirred, dilute solution of alcohol (R)-14 (115 mg, 0.270 
mmol) in THF (75 mL; c = 4 mM) was treated with PPh3 (71 
mg, 0.271 mmol). As soon as it had been dissolved, DEAD 
(40% in toluene; 0.043 mL, 0.273 mmol) was added via 
syringe and stirring was continued for 1 h. The volatiles were 
removed in vacuo, and the crude product was subjected to 
flash chromatography (EtOAc/heptane, 1:10 ^  1:3) yielding (R)-18 as a slightly 
yellowish oil (66 mg, 0.162 mmol, 60%).
Rf 0.14 (EtOAc/heptane, 1:4); ee = 42%; vmax (neat) 3270, 2949, 2915, 1740, 
1593, 1480, 1442; Öh (300 MHz, CDCh) 7.75 (2 H, d, J = 8.4 Hz), 7.44-7.41 (1 H, 
m), 7.35-7.19 (5 H, m), 6.13 (1 H, dd, J =  17.5, 11.2 Hz), 5.80 (1 H, dd, J =  17.6,
2.1 Hz), 5.60 (1 H, dd, J =  11.1, 2.1 Hz), 5.56 (1 H, d, J =  9.1 Hz), 4.22 (1 H, ddd, J 
= 9.1, 5.4, 4.6 Hz), 3.62 (3H, s), 2.99 (1 H, dd, 17, 4.6 Hz) , 2.89 (1 H, dd, 17 Hz,
5.4 Hz), 2.38 (3 H, s); Öq (75 MHz, CDCh) 169.9, 143.6, 136.9, 132.1, 131.9, 129.6,
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127.9 (2 C), 127.6, 127.1, 125.6, 124.9, 117.2, 92.0, 88.7, 86.9, 83.0, 54.5, 53.1,
25.5, 21.8; HRMS (EI) calcd. for C23H21NO4S (M+) 407.1191, found 407.1197.
Methyl 2-(ferf-butoxycarbonylamino)-5-(2-(3-hydroxyprop-1-ynyl)phenyl)pent-4- 
ynoate (21)
,CO2Me The title compound was prepared according to the procedure 
described for the synthesis of 13. Thus, aryl iodide 10 (613 
NHBoc mg, 2.38 mmol) was dissolved in Et2O (25 mL) along with 
PdCl2(PPh3)2 (71 mg, 0.10 mmol), CuI (40 mg, 0.21 mmol) 
and Et2NH (1.0 mL, 9.7 mmol). Upon addition of Boc- 
protected propargylglycine 20 (637 mg, 2.80 mmol), the reaction mixture was 
stirred for 2 h. Work-up followed by flash chromatography (EtOAc/heptane, 1:2) 
produced 21 as a slightly yellowish oil that solidified on standing (717 mg, 2.01 
mmol, 84%).
Rf 0.36 (EtOAc/heptane, 1:1); vmax (ATR) 3466, 2930, 1743, 1160; Öh (300 MHz, 
CDG3) 7.43-7.36 (2 H, m), 7.26-7.21 (2 H, m), 5.66 (1 H, br d, J = 8.9 Hz), 4.66­
4.62 (1 H, m), 4.57 (2 H, t, J = 6.6 Hz), 3.79 (3 H, s), 3.33 (1 H, t, J = 6.6 Hz), 3.10­
2.94 (2 H, m), 1.46 (9 H, s); Öq (75 MHz, CDCh) 171.49, 154.9, 132.2, 131.8,
131.5, 127.8, 127.7, 125.1, 91.7, 87.6, 83.7, 82.4, 80.5, 52.9, 52.1, 51.4, 28.4, 
24.1; HRMS (ESI) calcd. for C20H24NO5 358.1610 (M+ + H), found 358.1601.
Methyl 2-(ferf-butoxycarbonylammo)-5-(2-(3-(methylsulfonyloxy)prop-1-ynyl)- 
phenyl)pent-4-ynoate (22)
,CO2Me A cooled (0 °C ) solution of the alcohol 21 (675 mg, 1.89 
mmol) in CH2Cl2 (25 mL) was treated with MsCl (295 |iL, 3.81 
NHBoc mmol). Triethylamine (560 |iL, 4.02 mmol) was added slowly 
OMs over a period of 5 min, and stirring was continued at 0 °C  for 
'  s 1 h. The reaction mixture was poured into water (50 mL), the 
phases were separated, and the aqueous layer was extracted with CH2Cl2 (3x 10 
mL). The combined organic layers were washed with brine and dried over MgSO4. 
After removal of all volatiles and flash chromatography of the crude product, the 
title compound was obtained as amber-colored viscous oil (766 mg, 1.76 mmol, 
93%).
Rf 0.42 (EtOAc/heptane, 1:1); vmax (ATR) 3012, 2950, 1747, 1133; öh (300 MHz, 
CDCl3) 7.46-7.40 (2 H, m), 7.34-7.24 (2 H, m), 5.47 (1 H, d, J = 8.3 Hz), 5.21 (2 H, 
br s), 4.61-4.55 (1 H, m), 3.79 (3 H, s), 3.19 (3 H, s), 3.09-2.94 (2 H, m), 1.46 (9 H, 
s); öc (75 MHz, CDCl3) 170.7, 154.7, 132.0, 132.0, 128.8, 127.7, 125.7, 123.4,
88.6, 87.7, 84.4, 81.6, 80.3, 58.6, 52.7, 52.1, 39.1, 28.4, 24.0; HRMS (ESI) calcd. 
for C21H25NO7S 435.1352 (M+), found 435.1344.
4-(ferf-Butyl) 5-methyl 1,2,7,8-tetradehydro-3,4,5,6-tetrahydro-4-benzazecine-4,5- 
dicarboxylate (23)
CO2Me A dilute solution of mesylate 22 (154 mg, 0.354 mmol) in ]T X 2"'~ dry THF (70 mL; c = 5 mM) was cooled to 0 °C  and KHMDS 
■’' Boc (0.5 M in toluene; 0.70 mL, 0.35 mmol) was added dropwise 
via syringe whilst stirring. After 2 h at 0 °C, another portion 
of KHMDS (0.5 M in toluene; 0.70 mL, 0.35 mmol) was transferred into the 
reaction vessel and the setup was allowed to come to room temperature over a 
period of 2 h. The reaction mixture was partitioned between saturated aqueous 
NH4Cl (50 mL) and EtOAc (50 mL), and the phases were separated. The aqueous 
layer was extracted using EtOAc (3x 10 mL), and the combined organic phases 
were washed with brine (10 mL) followed by drying over MgSO4. Removal of the 
volatiles at room temperature and flash chromatography (EtOAc/heptane; 1:10 ^  
2:3) yielded the pure product as a white solid (16 mg, 0.047 mmol, 13%).
Rf 0.42 (EtOAc/heptane, 1:2); vmax (ATR) 3023, 2321, 1701, 1109, 761; Öh (300 
MHz, CDG3; T = 298 K) rotamers in a 1 :2  ratio 7.36-7.29 (2 H, m), 7.27-7.20 (2 H, 
m), 5.12 (1/3x 1 H, d, J = 18.4 Hz), 4.87 (2/3x 1 H, d, J = 18.6 Hz), 4.17 (2/3x 1
H, dd, J = 6.2, 7.6 Hz), 4.05 (1/3x 1 H, dd, J = 2.7, 11.0 Hz), 3.92 (1/3x 1 H, d, J =
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18.6 Hz), 3.84 (2/3x 1 H, d, J = 18.4 Hz), 3.75 (2/3x 3 H, s), 3.74 (1/3x 3 H, s), 
3.45 (1/3x 1 H, dd, J = 11.0, 18.4 Hz), 3.22-3.12 (5/3 H, m), 1.46 (1/3x 9 H, s),
1.43 (2/3x 9 H, s); Öq (75 MHz, CDCh; T = 298 K) rotamers 170.0, 153.4, 129.0,
128.6, 128.1, 128.0, 127.8, 127.7, 127.5, 127.5, 127.3, 127.2, 96.9, 96.0, 94.5,
94 .4, 86.4, 86.0, 83.4, 82.9, 81.7, 81.5, 63.4, 62.8, 52.5, 41.3, 40.5, 28.4, 21.9, 
20.7; HRMS (ESI) calcd. for C20H21NO4 (M+) 339.1471, found 339.1462.
CO2Me
OH
5-(2-(5-Hydroxypent-1-ynyl)phenyl)-2-(toluene-4-sulfonylamino)pent-4-ynoic acid  
methyl ester (28)
The title compound was synthesized analogously to the 
preparation of 13. Thus, 5-(2-iodophenyl)pent-4-yn-1-ol (12) 
(377 mg, 1.318 mmol) was stirred with Pd(PPh3)4 (81 mg, 
0.070 mmol), CuI (30 mg, 0.158 mmol), and Et2NH (0.8 mL,
7.7 mmol) in Et2O (25 mL) before propargylglycine (±)-9 (405 
mg, 1.440 mmol) was added, and stirring was continued over night. Work-up and 
purification by flash chromatography (EtOAc/heptane, 1:1) afforded 18 as an off- 
white solid (578 mg, 1.315 mmol, 99%). Crystals suitable for X-ray analysis could 
be grown from a CHCl3 solution top-layered with heptane; for crystal structure 
data, see end of the Experimental Section.
Rf 0.32 (EtOAc/heptane, 1:1); vmax (KBr) 3486, 3118, 2942, 2228, 1752; Öh (300 
MHz, CDCl3) 7.75 (2 H, d, J = 8.3 Hz), 7.40-7.37 (1 H, m), 7.30-7.16 (5 H, m), 6.11 
(1 H, d, J =  8.9 Hz), 4.18 (1 H, td, J =  9.0, 5.2 Hz), 3.89 (1 H, q, J =  5.8 Hz), 3.64 (3 
H, s), 2.98 (1 H, dd, J =  17.0, 5.3 Hz), 2.90 (1 H, dd, J =  17.0, 5.1 Hz), 2.67 (1 H, 
dt, J =  6 .6, 0.8 Hz), 2.34 (3 H, s), 2.30 (1 H, t, J =  5.6 Hz), 1.96-1.87 (2 H, m); Öq 
(75 MHz, CDG3) 170.4, 143.6, 137.0, 132.1, 132.0, 128.0, 127.3, 127.2, 126.2,
124.9, 93.8, 86.5, 83.0, 80.1, 61.9, 54.3, 52.8, 31.1, 24.9, 21.5, 16.3; HRMS (CI) 
calcd. for C24H25NO5S (M+) 439.1453, found 439.1441. For X-ray data see Table 4.
CO2Me
Ts
5-Tosyl-1,2,9,10-tetradehydro-3,4,5,6,7,8-hexahydro-5-benzazacyclododecine-4- 
carboxylic acid methyl ester (29)
Triphenylphosphine (87 mg, 1.094 mmol) was dissolved in a 
solution of enediynic alcohol 28 (401 mg, 0.912 mmol) in 
THF (110 mL; c = 8 mM). DEAD was added (40% in toluene; 
0.500 mL, 1.091 mmol), and the reaction mixture was stirred 
for 30 min. The volatiles were removed in vacuo and the 
crude product was subjected to flash chromatography (EtOAc/heptane, 1:3) to 
yield the title compound as a colorless viscous oil that solidified on standing (339 
mg, 0.804 mmol, 88% ). Crystals suitable for X-ray analysis could be grown by 
slow evaporation of a CDCl3 solution; for crystal structure data, see end of the 
Experimental Section.
Rf 0.58 (EtOAc/heptane, 1:1); vmax (KBr) 3442, 3069, 2951, 2920; 2230, 1752, 
1598, 1484, 1348; öh (400 MHz, CDCl3) 7.68 (2 H, d, J =  8.4 Hz), 7.33-7.25 (4 H, 
m), 7.21-7.13 (2 H, m), 4.88 (1 H, dd, J =  6.5, 2.4 Hz), 4.10 (1 H, ddd, J =  15.3,
12.6 Hz, 4.1 Hz), 3.73 (1 H, ddd, J =  15.0, 12.3, 4.9 Hz), 3.50 (3 H, s), 3.36 (1 H, 
dd, J =  17.7, 6.5 Hz), 2.83 (1 H, dd, J =  17.7, 2.4 Hz), 2.56-2.42 (2 H, m), 2.40 (3 
H, s), 2.38-2.30 (1 H, m), 2.08-1.97 (1 H, m); öc (100 MHz, CDCl3) 169.1, 143.4,
136.2, 131.1, 129.5, 127.9, 127.2, 126.8, 126.7, 94.5, 88.2, 82.8, 81.4, 57.8, 52.1,
45.8, 30.9, 23.9, 21.4, 17.0; HRMS (CI) calcd. for C24H23NO4S (M+) 421.1348, 
found 421.1329. For X-ray data see Table 4.
OH
(Z)-5-Chloropent-4-en-2-yn-1-ol (34)
A stirred solution of (Z)-1,2-dichloroethene (1.10 mL, 14.57 mmol) in 
Et2O (15 mL) was treated with Pd(PPh3)4 (386 mg, 0.335 mmol), CuI 
(206 mg, 1.082 mmol), and Et2NH (7.20 mL, 69.60 mmol). Once a 
'ci clear, homogeneous solution had been formed, prop-2-yn-1-ol (0.77
mL, 14.57 mmol) was added and stirring was continued for 3 h at ambient 
temperature. The reaction mixture was poured into two aliquots of saturated 
aqueous NH4Cl and the phases were separated. The aqueous layer was extracted
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with EtOAc (3x 10 mL), the combined organic phases were washed with 1M 
KHSO4 (1x 20 mL) and brine (1x 20 mL) followed by drying over MgSO4. Removal 
of the volatiles and purification of the crude product by bulb-to-bulb distillation 
(110 °C, 5.0 mbar) furnished 34 as a clear, colorless liquid (463 mg, 3.97 mmol, 
27%).
The characterization data were consistent with those in ref. 11d and ref. 28.
(Z)-6-Chlorohex-5-en-3-yn-1-ol (35)
The title compound was prepared using the same methodology as 
described for 34 by letting react (Z)-1,2-dichloroethene (0.395 mL, 
OH 5.232 mmol) in Et2O (10 mL) with PdCl2(PPh3)2 (130 mg, 0.112 mmol), 
CuI (77 mg, 0.404 mmol), Et2NH (2.00 mL, 19.33 mmol), and but-3-yn- 
1-ol (0.300 mL, 3.963 mmol) over a period of 4 h. Work-up followed by bulb-to- 
bulb distillation (60 °C, 0.13 mbar) gave 35 as a clear, colorless liquid (284 mg, 
2.175 mmol, 55%).
The characterization data were consistent with those in ref. 28.
(Z)-7-Chlorohept-6-en-4-yn-1-ol (36)
The title compound was synthesized following the method described 
for 34. Thus, (Z)-1,2-dichloroethene (0.500 mL, 6.622 mmol) in Et2O 
OH (10 mL) was allowed to react with Pd(PPh3)4 (217 mg, 0.188 mol), 
CuI (108 mg, 0.563 mmol), Et2NH (3.00 mL, 29.00 mmol), and pent- 
4-yn-1-ol (0.560 mL, 6.018 mmol) over a period of 7 h. Work-up and 
purification by bulb-to-bulb distillation (70 °C, 0.07 mbar) afforded 36 as a clear, 
colorless liquid (785 mg, 5.429 mmol, 90%).
The characterization data were consistent with those in ref. 11c.
(Z)-10-Hydroxy-2-(toluene-4-sulfonylamino)dec-6-ene-4,8-diynoic acid methyl ester 
(37)
CO2Me The title compound was synthesized by a similar procedure as 
'  2 described for 13. Thus, (Z)-5-chloro-pent-4-en-2-yn-1-ol (34) 
NHTs (144 mg, 1.236 mmol) in Et2O (15 mL) was allowed to react with 
n-BuNH2 (0.6 mL, 6.1 mmol), CuI (23 mg, 0.121 mmol), 
' OH PdCl2(PPh3)2 (42 mg, 0.060 mmol) and propargylglycine (±)-9 
(396 mg, 1.408 mmol) over a period of 5 h. Work-up and purification by flash 
chromatography (EtOAc/heptane, 2:3) yielded 37 as a yellowish solid (175 mg, 
0.484 mmol, 39%).
Rf 0.30 (EtOAc/heptane, 1:1); vmax (ATR) 3494, 3274, 2950, 1740, 1329; öh (300 
MHz, CDCl3) 7.77 (2 H, d, J = 8.3 Hz), 7.29 (2 H, d, J = 8.3 Hz), 5.93 (1 H, d, J = 7.8 
Hz), 5.85 (1 H, td, J =  10.8, 1.9 Hz), 5.74 (1 H, td, J =  10.8, 1.9 Hz), 5.51 (2 H, d, J 
= 6.5 Hz), 4.17 (1 H, td, J = 4.5, 9.0 Hz), 3.64 (3 H, s), 3.03 (1 H, t, J = 6.5 Hz), 
2.96-2.81 (2 H, m), 2.42 (3 H, s); öc (75 MHz, CDCl3) 170.2, 143.8, 136.9, 129.7,
127.1, 119.9, 119.3, 95.8, 90.4, 82.5, 82.0, 53.9, 53.1, 51.4, 25.3, 21.5; HRMS (EI) 
calcd. for C18H19NO5S (M+) 361.0984, found 361.0991.
(Z)-11-Hydroxy-2-(toluene-4-sulfonylamino)undec-6-ene-4,8-diynoic acid methyl 
ester (38)
The title compound was prepared following a similar procedure 
' CO2Me as described for 13 by letting react (Z)-6-chlorohex-5-en-3-yn-1- 
NHTs ol (35) (134 mg, 1.026 mmol) in Et2O (15 mL) with n-BuNH2 (0.51 
mL, 5.2 mmol), PdCl2(PPh3)2 (38 mg, 0.054 mmol), CuI (0.104 
mmol), and propargylglycine (±)-9 (311 mg, 1.106 mmol) over a 
OH period of 4 h. Work-up and flash chromatography 
(EtOAc/heptane, 1:10 ^  1:1) afforded the title compound as a yellow oil (298 mg, 
0.794 mmol, 77%).
Rf 0.20 (EtOAc/heptane, 1:1); vmax (KBr) 3444, 3265, 2953, 2215, 1753, 1160; Öh 
(300 MHz, CDCl3) 7.76 (1 H, d, J =  8.3 Hz), 7.28 (1 H, d, J =  8.3 Hz), 6.18 (1 H, br 
s), 5.79 (1 H, td, J =  10.8, 2.1 Hz), 5.68 (1 H, td, J =  10.8, 1.8 Hz), 4.15 (1 H, t, J =
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4.7 Hz), 3.80 (1 H, t, J =  6.2 Hz), 3.60 (1 H, s), 2.94-2.78 (2 H, m), 2.71 (2 H, dt, J 
= 6.2, 1.5 Hz), 2.40 (1 H, s); Öq (75 MHz, CDCh) 169.9, 143.5, 136.8, 129.5, 126.9,
120.1, 118.3, 95.3, 90.1, 81.5, 79.5, 60.6, 54.0, 52.6, 24.8, 23.7, 21.3; HRMS (CI) 
calcd. for C19H22NO5S (M++H) 376.1219, found 376.1206.
(Z)-12-Hydroxy-2-(toluene-4-sulfonylamino)dodec-6-ene-4,8-diynoic acid methyl 
e s te r (39)
The title compound was assembled similar to the preparation of 
xO2Me 13. Thus, (Z)-7- chlorohept-6-en-4-yn-1-ol (36) (88 mg, 0.609 
mmol) in Et2O (15 mL) was coupled to (±)-9 employing 
PdCl2(PPh3)2 (20 mg, 0.028 mmol), CuI (12 mg, 0.063 mmol), and 
-oh n-BuNH2 (0.30 mL, 3.04 mmol). After stirring over night, work-up 
and flash chromatography (EtOAc/heptane, 1:10 ^  1:1) yielded 39 as a yellowish 
oil (179 mg, 0.460 mmol, 75%).
Rf 0.31 (EtOAc/heptane, 1:1); vmax (ATR) 3525, 3274, 3049, 2950, 2876, 2215, 
1744, 1161; öh (300 MHz, CDCh) 7.76 (2 H, d, J =  8.3 Hz), 7.28 (2 H, d, J =  8.3 Hz),
6.21 (1 H, d, J =  9.0 Hz), 5.78 (1 H, td, J =  10.8, 2.2 Hz), 5.65 (1 H, td, J =  10.8, 2.1 
Hz), 4.13 (1 H, td, J =  9.1, 5.2 Hz), 3.81 (2 H, t, J =  6.1 Hz), 3.60 (3 H, s), 2.95-2.78 
(2 H, m), 2.70 (1 H, br s), 2.56 (2 H, dt, J =  6.7, 2.2 Hz), 2.40 (3 H, s), 1.88-1.79 (2 
H, m); öq (75 MHz, CDCh) 170.1, 143.5, 136.8, 129.5, 126.9, 120.3, 117.9, 97.9,
89.9, 81.4, 78.5, 61.3, 54.0, 52.6, 30.8, 24.8, 21.3, 16.2; HRMS (CI) calcd. for 
C20H23NO5S (M+) 390.1375, found 390.1378.
2-Tosyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid methyl ester (41)
Enediynic alcohol 37 (112 mg, 0.310 mmol) and PPh3 (121 mg, 0.461 mmol) were 
-co2Me dissolved in THF (75 mL; c = 4 mM). Whilst stirring, DEAD (0.075 
mL, 0.476 mmol) was added via syringe and stirring was 
'Ts continued for 2 h at ambient temperature. All volatiles were 
removed in vacuo (T > 30 °C ) and the crude product was purified by flash 
chromatography (EtOAc/heptane, 1:3 ^  1:1) providing 41 as a clear colorless 
viscous oil (17 mg, 0.049 mmol, 16%).
Rf 0.78 (EtOAc/heptane, 1:1); vmax (ATR) 3032, 2950, 2915, 1740, 1459, 1160; Öh 
(300 MHz, CDCl3) 7.72 (2 H, d, J =  8.3 Hz), 7.28 (2 H, d, J =  8.3 Hz), 7.19-7.02 (4
H, m), 5.01 (1 H, t, J =  4.5 Hz), 4.70 (1 H, d, J =  15.5 Hz), 4.49 (1 H, d, J =  15.5 
Hz), 3.45 (3 H, s), 3.18 (2 H, d, J =  4.5 Hz), 2.41 (3 H, s); Öq (75 MHz, CDCh) 170.7,
143.5, 136.0, 131.4, 130.7, 129.5, 128.7, 127.3, 126.8 (2 C), 126.1, 53.8, 52.2,
44.4, 31.9, 21.5; HRMS (EI) calcd. for C18H19NO4S (M+) 345.1035, found 345.0985.
(Z)-2-(Toluene-4-sulfonylamino)undeca-6,10-diene-4,8-diynoic acid methyl ester (42)
Enediynic alcohol 38 (134 mg, 0.357 mmol) was dissolved in 
-C° 2Me THF (70 mL; c = 5 mM). PPh3 (142 mg, 0.541 mmol) was added 
NHTs to the stirred solution and once it had dissolved, DEAD (40% in 
toluene; 0.250 mL, 0.545 mmol) was transferred into the 
reaction vessel via syringe. Stirring was continued for 1 h at 
ambient temperature followed by removal of all volatiles in 
vacuo. Flash chromatography (EtOAc/heptane, 1:10 ^  1:3) of the crude product 
furnished 42 as a yellowish oil (44 mg, 0.123 mmol, 34%).
Rf 0.56 (EtOAc/heptane, 1:1); vmax (KBr) 3470, 3278, 2955, 2208, 1744; öh (300 
MHz, CDCl3) 7.74 (2 H, d, J =  8.4 Hz), 7.28 (2 H, d, J =  8.4 Hz), 6.04 (1 H, ddd, J =
17.5, 11.1, 2.3 Hz), 5.91 (1 H, dd, J =  10.8, 2.2 Hz), 5.77-5.69 (2 H, m), 5.56 (1 H, 
dd, J =  11.1, 2.1 Hz), 5.47 (1 H, d, J =  9.2 Hz), 4.15 (1 H, ddd, J =  9.2, 5.4, 4.3 Hz), 
3.61 (3 H, s), 2.92 (1 H, ddd, J =  17.6, 4.3, 2.2 Hz), 2.83 (1 H, ddd, J =  17.6, 5.41,
2.2 Hz), 2.41 (3 H, s); öc (75 MHz, CDCl3) 170.0, 143.7, 136.9, 129.7, 128.0, 127.1,
119.8, 118.8, 117.1, 95.7, 90.9, 87.2, 81.6, 54.1, 52.8, 25.3, 21.5; HRMS (CI) 
calcd. for C19H20NO4S (M++H) 358.1113, found 358.1103.
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min at room
(Z)-1-Tosyl-azacyclododec-6-ene-4,8-diyne-2-carboxylic acid methyl ester (43)
Triphenylphosphine (164 mg, 0.624 mmol) was dissolved in a 
stirred, dilute solution (c = 5 mM) of enediynic alcohol 39 (161 
mg, 0.413 mmol) in THF (90 mL). DEAD (40% in toluene; 0.280 
mL, 0.612 mmol) was added and stirring was continued for 30 
temperature. Removal of the volatiles followed by flash 
chromatography (EtOAc/heptane, 1:10 ^  1:4) afforded 43 as white, waxy solid (90 
mg, 0.252 mmol, 61%). Crystals suitable for structural analysis could be grown 
from a CHCl3 solution top-layered with MeOH; for crystal structure data, see end 
of the Experimental Section.
Rf 0.60 (EtOAc/heptane, 1:1); Vmax (ATR) 3023, 2949, 2193, 1748, 1333; Öh (300 
MHz, CDCl3) 7.67 (2 H, d, J =  8.4 Hz), 7.30 (2 H, d, J =  8.4 Hz), 5.72 (2 H, d, J =  1.5 
Hz), 4.84 (1 H, dd, J =  6.4, 2.4 Hz), 4.05-3.94 (1 H, m), 3.84-3.73 (1 H, m), 3.56 (3 
H, s), 3.25 (1 H, tdd, J = 17.6, 6.4, 1.6 Hz), 2.73 (1 H, dd, J =  17.6, 2.4 Hz), 2.51­
2.21 (3 H, m), 2.43 (3 H, s), 2.07-1.93 (1 H, m); Öq (75 MHz, CDCh) 169.1, 143.5,
136.2, 129.5, 127.2, 121.9, 120.6, 98.4, 91.8, 82.1, 81.2, 57.6, 52.2, 45.6, 30.7,
23.8, 21.4, 17.3; HRMS (EI) calcd. for C20H21NO4S (M+) 371.1191, found 371.1181. 
For X-ray data see Table 5.
(Z)-(S)-11-Hydroxy-2-(toluene-4-sulfonylamino)undec-7-ene-5,9-diynoic acid methyl 
ester (45)
The title compound was prepared using a similar procedure as 
described for 13: Protected (S)-homopropargylglycine 44 (247 
mg, 0.836 mmol) was coupled to (Z)-5-chloropent-4-en-2-yn-1-ol 
(34) (100 mg, 0.858 mmol) by the action of Pd(PPh3)4 950 mg, 
0.043 mmol), CuI (18 mg, 0.095 mmol), and n-BuNH2 (0.50 mL,
5.1 mmol) in Et2O (40 mL) over a period of 5 h. Work-up and 
flash chromatography (EtOAc/heptane, 1:2 ^  1:1) gave access to 45 as a 
yellowish solid (265 mg, 0.706 mmol, 84%).
Rf 0.23 (EtOAc/heptane, 1:1); [a ]22D = +50.0° (c 0.11, CH2Cl2); Vmax (ATR) 3511, 
3270, 2949, 1744, 1433, 1338; Öh (300 MHz, CDCh) 7.76 (2 H, d, J =  8.4 Hz), 7.29 
(2 H, d, J =  8.4 Hz), 5.82 (1 H, td, J =  10.9, 1.8 Hz), 5.76 (1 H, td, J =  10.9, 2.0 Hz),
5.34 (1 H, d, J =  9.2 Hz), 4.46 (1 H, dd, J =  6.5, 1.8 Hz), 4.19-4.11 (1 H, m), 3.59 (3 
H, s), 2.58 (1 H, t, J =  6.5 Hz), 2.49 (2 H, dt, J =  6 .6, 2.0 Hz), 2.42 (3 H, s), 2.08­
1.97 (1 H, m), 1.94-1.82 (1 H, m); Öq (75 MHz, CDCh) 172.0, 143.8, 136.5, 129.7,
127.3, 120.0, 118.7, 95.9, 95.2, 82.6, 79.5, 54.9, 52.8, 51.5, 31.8, 21.6, 15.9; 
HRMS (ESI) calcd. for C19H21NNaO5S (M+ + Na) 398.1038, found 398.1045.
CO2Me
NHTs
(S)-6-(2-(3-Hydroxy-prop-1-ynyl)phenyl)-2-(toluene-4-sulfonylamino)-hex-5-ynoic 
acid methyl ester (46)
CO2Me
NHTs
The title compound was synthesized following a similar 
procedure as used for 13. Thus, 3-(2-iodophenyl)prop-2-yn- 
1-ol (10) (130 mg, 0.504 mmol) in Et2O (25 mL) was allowed 
to react with PdCl2(PPh3)2 (18 mg, 0.026 mol), CuI (10 mg, 
0.053 mmol), n-BuNH2 (0.26 mL, 2.63 mmol) and protected 
(S)-homopropargylglycine 44 (146 mg, 0.494 mmol) over a 
period of 5.5 h. Work-up followed by flash chromatography (EtOAc/heptane, 1:10 
^  1:1) furnished 46 as a yellow solid (139 mg, 0.327 mmol, 66% ).
Rf 0.20 (EtOAc/heptane, 1:1); [a ]22D = +26.9° (c 1.0, CH2Cl2); vmax (ATR) 3499, 
3261, 2950, 1735, 1432, 1337; öh (300 MHz, CDCl3) 7.74 (2 H, d, J =  8.4 Hz), 7.45­
7.39 (1 H, m), 7.36-7.30 (1 H, m), 7.26-7.20 (2 H, m), 7.16 (2 H, d, J =  8.4 Hz), 
5.80 (1 H, d, J =  9.1 Hz), 4.55 (2 H, d, J =  6.0 Hz), 4.19 (1 H, dt, J =  8.6, 5.0 Hz),
3.56 (3 H, s), 3.11 (1 H, t, J =  6.0 Hz), 2.54 (2 H, t, J =  6.6 Hz), 2.30 (3 H, s), 2.13­
2.02 (1 H, m), 1.99-1.87 (1 H, m); öc (75 MHz, CDCl3) 172.1, 143.6, 136.4, 132.1,
131.7, 129.5, 127.9, 127.5, 127.2, 125.8, 125.1, 91.8, 91.6, 83.9, 80.6, 54.9, 52.7,
51.3, 31.6, 21.4, 15.7; HRMS (ESI) calcd. for C23H23NNaO5S (M++Na) 448.1195, 
found 448.1194.
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(Z)-(S)-1-Tosyl-azacycloundec-7-en-5,9-diyne-2-carboxylic acid methyl ester (47)
O In a stirred solution of enediynic alcohol 45 (103 mg, 0.274 CO2Me mmol) in THF (55 mL; c = 5 mM) was dissolved PPh3 (86 mg, 0.380 mmol) followed by the addition of DEAD (40% in toluene; 
'  ls 0.150 mL, 0.327 mmol). Stirring was continued for 15 min at 
ambient temperature, then all volatiles were removed in vacuo at room 
temperature. Purification of the crude product by flash chromatography 
(EtOAc/heptane, 1:4) afforded the title compound as an off-white solid (69 mg, 
0.193 mmol, 70%).
Rf 0.62 (EtOAc/heptane, 1:1); [a ]22D = +131.9° (c 0.72, C^Cfe); Vmax (ATR) 3023, 
2950, 2915, 2842, 2198, 1731, 1433, 1333; öh (300 MHz, CDCfe) 7.69 (2 H, d, J =
8.4 Hz), 7.31 (2 H, d, J =  8.4 Hz), 5.83 (1 H, d, J =  10.4 Hz), 5.79 (1 H, d, J =  10.4 
Hz), 5.25 (1 H, dd, J =  8.9, 2.5 Hz), 4.49 (1 H, d, J =  17.9 Hz), 4.38 (1 H, d, J =  17.9 
Hz), 3.64 (3 H, s), 2.79-2.69 (1 H, m), 2.63-2.55 (2 H, m), 2.42 (3 H, s), 2.12-2.01 
(1 H, m); öq (75 MHz, CDCfe) 171.7, 143.6, 137.8, 129.7, 127.0, 122.6, 120.1, 99.4, 
91.0, 86.7, 81.8, 57.1, 52.2, 41.9, 33.0, 21.5, 19.1; HRMS (ESI) calcd. for 
C19H19NNaO4S (M+ + Na) 380.0933, found 380.0960.
(S)-4-Tosyl-1,2,8,9-tetradehydro-4,5,6,7-tetrahydro-3H-4-benzazacycloundecine-5- 
carboxylic acid methyl ester (48)
Enediynic alcohol 46 (126 mg, 0.296 mmol) was dissolved 
■CO2Me in THF (60 mL; c = 5 mM). Whilst stirring, PPh3 (93 mg, 
,n\ 0.355 mmol) and DEAD (40% in toluene; 0.165 mL, 0.360
Ts mmol) were added, and stirring was continued for 15 min, 
then all volatiles were removed in vacuo. The crude product was subjected to 
flash chromatography (EtOAc/heptane, 1:10 ^  1:4) to yield 48 as a white solid (96 
mg, 0.236 mmol, 80%). Crystals suitable for X-ray structural analysis could be 
grown from a CHCl3 solution top-layered with MeOH; for crystal structure data, see 
end of the Experimental Section.
Rf 0.70 (EtOAc/heptane, 1:1); [a ]22D = +37.0° (c 0.30, C ^ C h ); vmax (ATR) 3062, 
2950, 2915, 2846, 2228, 1735, 1445, 1329; öh (300 MHz, CDCfe) 7.72 (2 H, d, J =
8.4 Hz), 7.34-7.18 (6 H, m), 5.23 (1 H, dd, J =  8.2, 3.5 Hz), 4.58 (1 H, d, J =  17.5 
Hz), 4.44 (1 H, d, J =  17.5 Hz), 3.65 (3 H, s), 2.76-2.66 (1 H, m), 2.64-2.59 (2 H, 
m), 2.40 (3 H, s), 2.21-2.11 (1 H, m); Öq (50 MHz, CDCfe) 171.6, 143.6, 137.7,
129.7, 129.4, 129.3, 128.2, 127.5, 127.1, 126.9, 126.0, 95.1, 87.5, 86.9,+82.0,
57.6, 52.2, 41.7, 32.0, 21.4, 18.5; HRMS (ESI) calcd. for C23H21NNaO4S (M++Na) 
430.1089, found 430.1092. For X-ray data see table 5.
2-Iodopyridin-3-yl trifluoromethanesulfonate (61)
a OTf A stirred and cooled (0 °C ) solution of 2-iodopyridin-3-ol (60) (4.0 g, 18 mmol) and triethylamine (5.2 mL, 40 mmol, 2.2 equiv) in dry n ‘I dichloromethane (100 mL) was treated dropwise with 
trifluoromethanesulfonic anhydride (3.4 mL, 22 mmol, 1.2 equiv). The color of the 
reaction mixture changed from yellowish to dark red whereupon the cooling bath 
was removed and stirring was continued for 4 h. Cold water (100 mL) was added 
to quench the reaction and the phases were separated. The aqueous layer was 
extracted with EtOAc (3x 20 mL), and the combined aqueous layers were washed 
with brine followed by drying over MgSO4. After removal of all volatiles, the 
resulting crude product was purified by flash chromatography (EtOAc/heptane, 
1:3), affording 5.66 g of the title compound as off-white crystals (16.0 mmol, 
89%).
Rf 0.65 (EtOAc/heptane, 1:1); Vmax (ATR) 1403, 1212, 715, 519; öh (300 MHz, 
CDCl3) 8.41 (1 H, dd, J = 4.6, 1.6 Hz), 7.58 (1 H, dd, J = 8.3, 1.6 Hz), 7.36 (1 H, dd, 
J = 8.3, 4.6 Hz); öc (75 MHz, CDCl3) 149.3, 147.8, 128.4, 123.4, 118.1 (q, J = 321 
Hz), 113.0; HRMS (EI) caldcd. for C6H4F3INSO3 (M++H) 353.8909, found 353.8876.
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(64)
^OTf
N
2-(3-(teri-Butyldimethylsilyloxy)prop-1-ynyl)pyridin-3-yl trifluoromethanesulfonate
A stirred solution of aryl iodide 61 (440 mg, 1.25 mmol) in 
Et2O (15 mL) was treated with PdCl2(PPh3)2 (46 mg, 0.065 
mmol), CuI (25 mg, 0.13 mmol), and Et2NH (0.6 mL, 6.3 
" mmol). To the resulting clear solution was added tert-butyldi-
methyl(prop-2-ynyloxy)silane (62) (213 mg, 1.25 mmol), and stirring was 
continued for 4 h. The reaction mixture was poured into two aliquots of saturated 
aqueous NH4Cl and the phases were separated. The aqueous layer was extracted 
with EtOAc (2x 10 mL), the combined organic phases were washed with brine (1x 
10 mL) followed by drying over MgSO4. Removal of the volatiles in vacuo and 
purification of the crude product by flash chromatography (EtOAc/heptane, 1:3) 
furnished the product as yellowish oil (460 mg, 1.16 mmol, 93%).
Rf 0.95 (EtOAc/heptane, 1:1); Vmax (ATR) 3071, 2920, 2854, 1216, 836; öh (300 
MHz, CDCl3) 8.56 (1 H, dd, J =  4.7, 1.2 Hz), 7.62 (1 H, dd, J =  8.4, 1.1 Hz), 7.34 (1 
H, dd, J =  8.4, 4.7 Hz), 4.58, (2 H, s), 0.90 (9 H, s), 0.14 (6 H, s); Öq (75 MHz, 
CDCl3) 148.8, 147.2, 136.7, 128.8, 123.4, 118.1 (q, J = 3+9 Hz), 95.5, 51.4, 25.3,
17.8, -5.8; HRMS (ESI) calcd. for C ^ H ^ N N a O ^ S i (M++Na) 418.0732, found 
418.0741.
Methyl 5-(2-(3-(ferf-Butyldimethylsilanyloxy)prop-1-ynyl)pyridin-3-yl)-2-(toluene-4- 
sulfonylamino)pent-4-ynoate (65)
,co2Me A mixture of aryl triflate 64 (110 mg, 0.27 mmol), 
PdCl2(PPh3)2 (9 mg, 0.013 mmol), LiCl (29 mg, 0.65 mmol) 
NHTs and Et3N (0.07 mL, 0.50 mmol) in DMF (8 mL) was stirred 
otbdms until a clear solution had been formed. Protected 
propargylglycine (±)-9 (85 mg, 0.29 mmol) was added, and 
the reaction mixture was heated to 55 °C  for 1 h. Thereafter, the setup was kept 
at room temperature over night followed by heating to 75 °C  until TLC indicated 
full conversion (~10 h). The reaction mixture was poured into saturated aqueous 
NH4Cl (50 mL), EtOAc (30 mL) was added, and the phases were separated. The 
aqueous layer was extracted with EtOAc (3x 10 mL), and the combined organic 
layers were washed with brine. Drying over MgSO4, evaporation of the solvents 
and purification of the crude product by flash chromatography (EtOAc/heptane, 
1:1) afforded the title compound as a light brown, waxy solid (21 mg, 0.040 mmol, 
15%).
Rf 0.39 (EtOAc/heptane, 1:1); Vmax (ATR) 3260, 1748, 1199, 836; Öh (300 MHz, 
CDCl3) 8.48 (1 H, dd, J =  4.8, 1.7 Hz), 7.75 (2 H, d, J =  8.3 Hz), 7.62 (1 H, dd, J =
7.9, 1.7 Hz), 7.25 (2 H, d, J =  8.3 Hz), 7.15 (1 H, dd, J =  7.9, 4.8 Hz), 5.56 (1 H, d, J 
= 8.8 Hz), 4.64 (2 H, s), 4.20 (1 H, td, J =  8 .8, 5.1 Hz), 3.63 (3 H, s), 2.95 (2 H, d, J 
=  5.1 Hz), 2.38 (3 H, s), 0.93 (9 H, s), 0.17 (6 H, s); Öq (75 MHz, CDCh) 170.1,
149.1, 144.9, 144.1, 139.8, 130.0 (2 C), 127.6 (2 C), 122.4, 92.1, 90.2, 80.9, 54.6,
53.3, 52.5, 30.0, 23.0, 14.5, -4.7; HRMS (ESI) calcd. for C27H34N2NaO5SSi (M++Na) 
549.1855, found 549.1903.
Methyl 5-(2-(3-Hydroxyprop-1-ynyl)pyridin-3-yl)-2-(toluene-4-sulfonylamino)-pent-4- 
ynoate (66)
,CO2Me Silyl ether 65 (15 mg, 0.028 mmol) was dissolved in THF (3 
mL) and cooled to 0 °C. A solution of TBAF (1 M in THF; 0.10 
NHTs mL, 0.10 mmol) was added dropwise whilst stirring. Once the 
reaction had gone to completion (TLC), the reaction mixture 
was poured into saturated aqueous NH4Cl (10 mL), and 
EtOAc (15 mL) was added. The phases were separated and the aqueous layer was 
extracted with EtOAc (3x 5 mL), followed by washing of the combined organic 
phases with brine. After drying over MgSO4 and removal of the volatiles, the 
resulting crude product was purified using flash chromatography (EtOAc/heptane, 
3:1). A yellowish solid was obtained (8 mg, 0.019 mmol, 68% ).
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Rf 0.06 (EtOAc/heptane, 1:1); vmax (ATR) 3000-3260, 1744, 1579, 1160; öh (300 
MHz, CDCl3) 8.10 (1 H, dd, J = 4.7, 1.2 Hz), 7.75 (2 H, d, J = 8.4 Hz), 7.30 (2 H, d, J 
= 8.4 Hz), 7.23 (1 H, dd, J = 8.2, 1.2 Hz), 7.10 (1 H, dd, J = 8.2, 4.7 Hz), 5.58 (1 H, 
br s), 4.25 (2 H, s), 4.09-4.16 (1 H, m), 3.62 (3 H, s), 2.77-2.92 (2 H, m), 2.40, (3 H, 
s); öq (75 MHz, CDCfe) 169.2, 147.7, 143.5, 142.8, 138.0, 135.9, 128.7, 126.2,
121.2, 90.7 (2 C), 88.9 (2 C), 53.0, 52.1, 50.4, 24.5, 20.5; HRMS (ESI) calcd. for 
C21H20N2NaO5S (M++Na) 435.0991, found 435.0998.
Methyl 9-(toluene-4-sulfonyl)-5,6,11,12-tetradehydro-7,8,9,10-tetrahydropyrido[2,3- 
e]azecine-8-carboxylate (67)
O Me Acyclic enediyne 66  (8 mg, 0.019 mmol) and PPh3 (10 mg, 
|T f  ~ 2 0.038 mmol) were dissolved in dry THF (4 mL). Whilst 
‘’' Ts stirring, DEAD (40% in toluene, 18 |iL, 0.039 mmol) was 
injected into the solution and stirring was continued over 
night. All volatiles were removed in vacuo at room temperature and the crude 
product was subjected to flash chromatography (EtOAc/heptane, 1:1) to give 0.9 
mg of a colorless solid (0.002 mmol, 10% ).
Rf 0.21 (EtOAc/heptane, 1:1); öh (300 MHz, CDCh) 8.41 (1 H, dd, J =  4.8, 1.5 Hz), 
7.79 (2 H, d, J =  8.4 Hz), 7.51 (1 H, dd, J = 7.9, 1.5 Hz), 7.16-7.11 (3 H, m), 4.78 (1 
H, d, J = 19.5 Hz), 4.33-4.23 (2 H, m), 3.84 (3 H, s), 3.41-3.20 (2 H, m), 2.24 (3 H, 
s). LC-MS calcd. for C21H19N2O4S (M++H) 395.1, found 395.1.
2-Iodopyridin-3-yl 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate (68)
.ÿs j^DNf 2-Iodopyridin-3-ol (60) (2.00 g, 9.05 mmol) was dissolved in a cooled (0 
C  J L  °C ) mixture of CH2Cl2 / Et3N (5:1, vol:vol; 60 mL) followed by the 
"V  i addition of perfluorobutanesulfonyl fluoride (5.40 g, 17.88 mmol). After 
20 min, the reaction was quenched with 3 g of silica. The slurry was filtered over a 
short bed of silica and rinsed several times with small quantities of CH2Cl2. 
Concentration of the filtrate in vacuo and flash chromatography (EtOAc/heptane, 
1:8) of the crude product yielded the title compound as white crystals (4.19 g, 
8.33 mmol, 92%).
Rf 0.77 (EtOAc/heptane, 1:1); vmax (ATR) 1398, 1139, 1030; Öh (300 MHz, CDCh) 
8.41 (1 H, dd, J =  4.6, 1.5 Hz), 7.58 (1 H, dd, J =  8.2, 1.5 Hz), 7.36 (1 H, dd, J =
8.2, 4.6 Hz); Öq (75 MHz, CDCh) 149.8, 148.5, 128.9, 123.9, 119.7-118.0 (m), 
115.5-114.3 (m), 113.7, 111.7-108.1 (m); HRMS (CI) calcd. for C9H4NO3F9SI 
(M++H) 503.8813, found 503.8806.
2-(3-(teri-Butyldimethylsilyloxy)prop-1-ynyl)pyridin-3-yl 1,1 ,2 ,2 ,3 ,3 ,4,4,4-nona- 
fluorobutane-1-sulfonate (69)
„ONf The title compound was synthesized following a similar
|[ procedure as described for 64. Thus, a solution in Et2O (15
mL) of aryl iodide 68 (300 mg, 0.60 mmol), PdCl2(PPh3)2 (20 
OTBDMS mg, 0.028 mmol, 5 m ol%), CuI (11 mg, 0.058 mmol, 10 
mol%) and Et2NH (0.30 mL, 2.9 mmol, 5.0 equiv) was allowed to react with tert- 
butyldimethyl(prop-2-ynyloxy)silane 62 (102 mg, 0.60 mmol) over a period of 4 h 
at room temperature. Work-up and purification by flash chromatography 
(EtOAc/heptane, 1:2) furnished the pure product as yellowish oil (288 mg, 0.53 
mmol, 88% ).
Rf 0.71 (1%  MeOH in CHCl3); vmax (ATR) 2236, 1428, 1234, 1208, 1087, 728; öh 
(300 MHz, CDCl3) 8.58 (1 H, dd, J =  4.7, 1.3 Hz), 7.64 (1 H, dd, J =  8.5, 1.3 Hz),
7.35 (1 H, dd, J =  8.5, 4.7 Hz), 4.60 (2 H, s), 0.91 (9 H, s), 0.15 (6 H, s); öc (75 
MHz, CDCl3) 149.2, 147.9, 137.4, 129.0, 123.9, 119.3-118.2 (m), 115.5-113.4 (m),
111.7-108.1 (m), 96.2, 78.0, 51.9, 25.7, 18.2, -5.4; HRMS (CI) calcd. for 
C18H21F9NO4SSi (M+ + H) 546.0817, found 546.0780.
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Table 4 Crystal data and structure refinement data for compounds 28 and 29.
compound number 28 29
CCDC No. — 698983
crystal color translucent light yellow translucent light yellow
crystal shape regular fragment rather regular large fragment
crystal size 0.28 x 0.22 x 0.18 mm 0.63 x 0.46 x 0.33 mm
empirical formula C24 H25 N O5 S C24 H23 N O4 S
FW 439.51 421.49
Temperature 208(2)K 208(2) K
radiation / À MoKa (graphite mon.) / 0.71073 Â
crystal system / space group Monoclinic / P21/c Triclinic / P -1
unit cell dimensions a 11.4813(14) Â 8.4021(5) Â
b 7.5601(5) Â 11.9570(9) Â
c 25.344(2) Â 12.0405(8) Â
a 9 O O 69.128(6)°
ß 102.305(8)° 70.351(5)°
Y 9 O O 84.942(5)°
volume 2149.4(4) Â3 1063.76(12) Â3
Z / calc. density 4 / 1.358 Mg/m3 2 / 1.316 Mg/m3
absorption coefficient 0.187 mm-1 0.183 mm-1
diffractometer / scan Nonius KappaCCD with area detector 9 and w scan
F(000) 928 444
0 range 2.17 to 25.00° 2.58 to 27.50°
index ranges -13<=h< = 13 -10<=h< = 10
8=<k=<8- -15<=k< = 15
-30<=l<=30 -15<=l< = 15
reflections collected / 
unique 31321 / 3774 27752 / 4862
Rint 0.0231 0.0199
reflections observed 3290 [I>2ct (I)] 4028 [I>2ct (I)]
absorption correction SADABS multiscan correction (Sheldrick, 1996)
refinement method Full-matrix least-squares on F2
computing SHELXL-97 (Sheldrick, 1997)
data / restraints / 
parameters 3774/0/283 4862/0 / 273
goodness-of-fit on F2 1.112 1.083
SHELXL-97 weight 
parameter 0.037200, 1.426600 0.0407, 0.4145
final R indices [I>2ct (I)] R1 = 0.0398, wR2 = 0.0914
R1 = 0.0364, 
wR2 = 0.0888
R indices (all data) R1 = 0.0479, wR2 = 0.0953
R1 = 0.0486, 
wR2 = 0.0967
largest diff. peak and hole 0.316 and -0.382 e-A-3 0.238 and -0.390 e-A-3
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Table 5 Crystal data and structure refinement data for compounds 43 and 48.
compound number 43 48
CCDC No. 698982 698984
crystal color translucent colorless translucent colorless
crystal shape regular needle rather regular fragment
crystal size 0.22 x 0.05 x 0.03 mm 0.18 x 0.11 x 0.04 mm
empirical formula C20 H21 N O4 S C23 H21 N O4 S
FW 371.44 407.47
Temperature 208(2) K 208(2) K
radiation / À MoKa (graphite mon.) / 0.71073 Â
crystal system / space group Orthorhombic / Pbca Monoclinic / P2i
unit cell dimensions a 8.6566(7) Â 8.1942(12) Â
b 12.0779(8) Â 9.7320(7) Â
c 35.500(3) Â 13.0079(13) Â
a 9 O O 9 O O
ß 9 O O 104.996(9)°
Y 9 O O 9 O O
volume 3711.7(5) Â3 1002.00(19) Â3
Z / calc. density 8 / 1.329 Mg/m3 2 / 1.351 Mg/m3
absorption coefficient 0.199 mm-1 0.191 mm-1
diffractometer / scan Nonius KappaCCD with area detector 9 and w scan
F(000) 1568 428
0 range 2.29 to 22.00° 2.57 to 25.00°
index ranges -9<=h<=9 -9<=h< = 9
-12<=k< = 12 -1 1 <=k<=11
-37<=l<=37 -15<=l< = 15
reflections collected / 
unique 30562 / 2279 13482 / 3516
Rint 0.1411 0.0488
reflections observed 1648 [I>2ct (I)] 2608 [I>2ct (I)]
absorption correction SADABS multiscan correction (Sheldrick, 1996)
refinement method Full-matrix least-squares on F2
computing SHELXL-97 (Sheldrick, 1997)
data / restraints / 
parameters 2279 / 0/ 250 3516 / 1 / 264
goodness-of-fit on F2 1.224 1.080
SHELXL-97 weight 
parameter 0.0404, 5.6577 0.0202, 0.4542
final R indices [I>2ct (I)] R1 = 0.0763, wR2 = 0.1329
R1 = 0.0523, 
wR2 = 0.0752
R indices (all data) R1 = 0.1146, wR2 = 0.1452
R1 = 0.0867, 
wR2 = 0.0833
absolute structure 
parameter - 0.07(10)
largest diff. peak and hole 0.225 and -0.246 e-A-3 0.224 and -0.264 e-A-3
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Abstract*
The propensity of the cyc lic  enediyne-containing am ino acids presented in 
C hap ter 2 to undergo the Bergm an  Cyclization  at e levated  tem peratures 
w as assessed. Half-lives and rate  constants have been determ ined w here  
possible. In  p articu la r the chem istry of the 10-membered benzofused 
enediyne w as fu rther evaluated. Using  th is compound, d ipeptides have 
been prepared, and the ir reactiv ity  in the Bergm an  Cyclization  has been 
evaluated.
Parts of this work have been published as: J. Kaiser, B. C. J. van Esseveldt, M. J. A. 
Segers, F. L. van Delft, J. M. M. Smits, S. Butterworth, F. P. J. T. Rutjes, Org. Biomol. 
Chem. 2009, 7, 695.1
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3.1 Introduction
The Bergm an  Cyclization  (B C )  is the sym metry-allowed, therm al 
rearrangem ent of an (Z)-3-ene-1,5-diyne (herea fte r re ferred  to as 
"ened iyne") m oiety into a benzenoid CT,CT-1,4-diradical (som etim es called  
p-benzyne). Subsequent hydrogen rad ica l abstraction  by the arom atic 
d irad ica l in term ediate produces the corresponding benzene derivative  
(Schem e 1). The cyclization into the d irad ica l is h igh ly endergonic and 
genera lly  necessitates e levated  tem peratu res.4
1 2 3 4
Scheme 1 The Bergman Cyclization
Fo r the B C  to occur, the d ista l acetylen ic carbons (c-d, see: 
Schem e 1) have to come in close proxim ity of each other. Covalent 
b inding is established if  the threshold  of 1.79 Â  is crossed.5 A  stabilizing 
n-n* in teraction  betw een  the c-d carbons allow s form ation of the new  ct- 
bond w ith  concom itant c leavage of the in-plane acety len ic bonds.6 W o rth  
noticing is that the developing d irad ica l is orthogonal to the cyc lic  n- 
system. A  num ber of param eters are re levan t w ith  respect to the rate  of 
the Bergm an  Cyclization  of enediynes, w h ich  basica lly  can be d ivided into 
geom etrica l and e lectron ic contributions.
3.1.1 G e o m e t r ic a l  fa c to r s  in f lu e n c in g  th e  B e r g m a n  C y c l iz a t io n
In  the ea rly  days of enediyne research , it w as a lready recognized that the 
reac tiv ity  is la rge ly  dependent on the ir structure. W h ile  B C  of acyclic  
enediynes genera lly  requ ires h igh activation  tem peratures (>150 °C ), BC  
of enediynes confined in suffic iently sm all cycles can  proceed
o
spontaneously at physio logical tem perature. R ing  size is of utmost 
im portance as has been dem onstrated by Sem m elhack e t a l.9 w ith  the 
series of enediynes shown in F igu re  1. The 10-membered cycle  6 had a 
half-life of 24 h at 84 °C , w h ile  the 11-membered analogue 7 did not react 
at tem peratures up to 200 °C . T he ir 9-membered counterpart 5 on the 
other hand could not be isolated a fter synthesis, p robably due to 
spontaneous decom position.
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5 6 7
not isolated t1/2 = 24h(80 °C) not reactive (< 200 °C)
Figure 1 Cyclic enediynes of different ring sizes show different reactivities.
N atu re 's  enediynes a ll are  incorporated  into rings of 9 or 10 atoms, 
in  com bination w ith  ingenious locking and triggering  devices (see: 
C hap ter 1.2.3) to p revent the natu ra l enediynes from  prem ature 
cyclization. A t the onset of enediyne research , N ico laou e t a l. proposed 
that an ened iyne 's reactiv ity  tow ards Bergm an  Cyclization  could be 
judged  from  the d istance of its acetylene term in i (c-d d istance). They
proposed an em p irica lly  established c r it ica l va lue  of 3.20-3.31 Â  for
10w hich  cyclization  should occur at physio logical tem peratures. La te r  on, 
th is range w as extended to 2.9-3.4 Â  on the basis of theoretica l 
ca lcu lations.11 A lthough the genera lity  of th is concept has been proven 
w rong since it does not hold for a ll enediyne structu res,7a the c-d
distance can still g ive a rough estim ation of reactiv ity  w hen  com paring
12structu ra lly  re lated  enediynes. Yet, it should only be used for a ve ry  
genera l qualitative  assessm ent of reactiv ity . M ore recen t studies attribute 
a g rea te r role to the stra in  d ifference betw een the ground state and the
13transition  state of the reaction.
3 .1 .2  E le c t r o n ic  fa c to r s  in f lu e n c in g  th e  B e r g m a n  C y c l iz a t io n
The e lectron ic influences on the BC  are probably the least understood. 
There  is theo retica l evidence that the in-plane four-electron repulsion of 
the occupied acetylene n-orbitals in the transition  state is the m ain
14b arr ie r to overcom e for the B C  to proceed. As a result, electron- 
w ithd raw ing  groups (E W G ) or electron-releasing groups (E R G ) that 
in te ract w ith  these orb ita ls should a lte r the rate  of arom atization. Indeed, 
Schm itte l e t a l. showed that on rep lacing  the electron-releasing methoxy 
substituents in  compound 8 (F igu re  2) by nitro groups, the activation  
energy of the B C  w as decreased .15 Fu rth e r experim ental proof w as 
provided by the group of Anthony, reporting an unusually  h igh reactiv ity  
of the b is(b rom oethynyl)arenes 9 tow ards B C .16 Za lesk i and co-workers 
disclosed an enediyne nickel-porphyrin featuring brom ide substituents at 
the te rm ina l acetylene carbons (1 0 ).17 Im pressively, it cycloarom atized at 
am bient tem peratures, w hereas its parent structure requ ired  
tem peratures of 190-280 °C  to do so.
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R = OMe, H, NO2
Br
Br
10
X = H: reactive atT> 190 °C 
X = Br: reactive at rt
Figure 2 Substitution of the acetylene termini with electron-releasing or electron- 
withdrawing substituents.
R
X
X9
R
The effect of substituents on the v iny lic  portion of enediynes is not
as clear-cut. M a ie r  e t a l. reported  an increase in  stab ility  of esperam icin
model compound 11 (F igu re  3) upon exchange of a v iny lic  proton w ith
18the electron-releasing p-MeOC6H 4 substituent. On the other hand, 
stepw ise ch loride substitution of 9-membered (12 ) and 10-membered
19(13 ) cyclic  enediynes strongly d e ce le ra te d  BC  as shown by Jones e t a l. 
In trigu ing  is the case of the 9-membered cycle  12, the chloro-derivative 
o f w h ich  d isp layed a half-life of 8 h at 0 °C , w h ile  the corresponding C-H 
enediyne w as too labile to be isolated. The stabiliz ing effect of the 
ch loride atom  has been rationalized  by e lectron  repulsion betw een  the 
ch loride lone-pair and the developing d irad ica l in the transition  state.
TBSO
‘O  X O
11
R = H, p-MeOC6H4
12
X = H: not isolated 
X = Cl: t1/2 = 8h(0°C)
Figure 3 Vinylic substitution of enediynes.
13
X = H, H: reactive at rt 
X = H, Cl: t1/2 = 5h(60 °C)
X = Cl, Cl: t1/2 = 24h(170°C)
D FT  ca lcu lations by the same group suggested that a-w ithdraw ing
viny lic  substituents adverse ly  in teracted  w ith  the transition  state, w h ile
a-donating groups low ered  the cyclization  barrie r; n-EW G /ERG s w ere
20found to have little  effect. A  special case of v iny lic  substitution is 
benzannulation. In  the ea rly  1990s, it transp ired  that benzannulation can 
d rastica lly  enhance the therm al stab ility  of cyclic  enediynes. N ico laou e t
a l., for instance, p repared  three  dynem icin  model compounds (14, F igu re
214) and noted that arene annulation  s ign ificantly  im peded BC . The non- 
benzo-fused structure cyclized spontaneously at am bient tem perature, 
w hereas the benzannulated and the naphtho-fused compounds d isplayed 
half-lives of 0.67 h at 30 °C  and 45.6 h at 37 °C , respectively. A  range of 
nitrogen-containing cyclic  endiynes (15 ) has been published by Basak  and
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co-workers, and w ith in  this series, the benzo-fused compounds requ ired
22sign ificantly h igher tem peratures and longer reaction  tim es to cyclize. 
Bha ttacharyya  e t a l. observed the same trend  w ith in  the enediyne-
23dithio late structures 16.
H
14 15 16
Figure 4 Examples of benzo-fused and non-benzo-fused enediynes based on the same 
parent structures.
The reduced reactiv ity  of benzo-fused enediynes to undergo B C  as
com pared to the ir paren t structures has been attributed  to the
21dim inishing gain  in  resonance stabilization energy and the decreasing 
reactiv ity  of the 1,4-benzenoid d irad ica l w ith  progressing num ber of 
annulated  arenes (benzene-1,4-diyl > naphthalene-1,4-diyl > anthracene-
241,4-diyl). A t the same time, the retro-reaction, i.e . ring opening of the 
benzenoid d irad ica l to the enediyne, becom es faster.25 These factors have 
also been associated w ith  the observation that for some cyclic, 
benzannulated enediynes the quenching of the d irad ica l becom es the 
rate-determ ining step, and the reaction  rate  therefore can be dependent 
on the concentration  of the rad ica l trap .26
3.2 Structural description of the cyclic enediyne- 
containing amino acids
In  C hap ter 2, the developm ent of a genera l route to cyc lic  enediyne- 
contain ing am ino acids and the synthesis of a va r ie ty  of specim en of this 
compound class has been described. In  the chap ter a t hand, these 
compounds are characterized  in more detail, especia lly  w ith  respect to 
the ir propensity to undergo Bergm an  Cyclization  at various tem peratures. 
F igu re  5 shows the cyclic  enediyne-containing am ino acids that are 
evaluated.
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ring size
10 11 12
CÜ2Me
17
not isolated
Ts
CO2Me
Ts
CO2Me
Ts
19 21
CO2Me
Ts
CO2Me 
N—Ts
CO2Me
N~Ts
18 20 
Figure 5 Cyclic enediyne-containing amino acids under study.
22
Representations of the crysta l structures of enediynes 20-22 can 
be found in Chapter 2.3 and 2.4 w h ile  that of 18 has been published
27
earlier; the la tte r is depicted in F igu re  6 for clarity.
18
28Figure 6 PLUTON drawing of the crystal structure of 18 as disclosed in ref. 27a.
G eom etrica l param eters of in terest w ith  respect to the cu rren t 
study are the d ihedral angle of the v iny lic  part of the enediyne as w e ll as 
the bond angles of the v iny lic  carbons. The Cx-Csp-Csp angles of the 
acetylenes provide an estim ation of how  strained  the enediyne m oiety is. 
R e levan t data extracted from  crysta l structures are sum m arized in 
Tab le 1.
The 10-membered cycle 18 (en try  1) had the least distorted v iny lic  
d ihedral angle of 0 .7 °, m eaning that the v iny lic  part in this enediyne w as 
nearly  flat. This cam e as no surprise because the re la tive ly  sm all ring size 
did not leave room  for m uch distortion in that respect. A t the same time, 
the v iny lic  angles w ere  the sm allest encountered  among our enediynes, 
nam ely 116.5° and 116.8°, respectively . Again  the sm all ring size w as 
undoubtedly the cause for this considerable deviation from  120° for 
unperturbed sp  carbons. A  feature w orth  noting is that the arom atic part 
of the tosyl group in 18 w as folded back in an endo  fashion over the 
enediyne ring (see F igu re  6). In  all o ther structures of this series, the
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tosyl group w as sticking out of the p lane of the enediyne in angles 
va ry ing  from  compound to compound.
Table 1 Dihedral angle around the ene part of enediynes and bond angles around the 
acetylenes. Data are taken from crystal structures.
ßl
i: Í
ß2
r S 2
ix3
N
entry com­
pound
ene 
dihedral 
angle (°)
ß1 (°) ß2 (°) Cx-Csp-Csp angles (°) 
a1 a2 a3 a4
1 18 0.7 116.5 116.8 171.8 166.0 166.0 177.0
2 20 5.9 118.2 119.6 174.8 175.5 174.4 172.6
3 2 1 3.3 121.9 121.6 167.4a (i) 
156.4a (ii)
172.1 177.2 178.5
4 22 2.5 118.5 120.0 173.3 171.8 175.4 179.1
a) Two different conformations in crystal structure
The e leven-membered ring 20 (en try  2) featured  the biggest 
deviation from  p lanarity  around its en e  part in  our list o f enediynes w ith  a 
d ihedra l angle of 5.9 °. W ith  118.2° and 119.6°, the angles of the vinylic  
carbons w ere  ra the r close to 120°, ind icating  that there w as not m uch 
stra in  on the bonds in th is region. The same w as true for the 12- 
m em bered benzofused 22 (en try  4), possessing quite s im ilar v iny lic  
angles of 118.5° and 120.0°. Its  torsional angle of 2 .5 ° around the 
enediyne's v in y l group w as ra the r small.
The 12-membered olefinic enediyne 21 (en try  3), the only 
e lucidated  structure of a non-benzofused enediyne of th is series, featured  
a torsional v iny lic  angle of 3.3 °. N o tew orthy in  th is structure is the fact 
that the bonds around the v in y l m oiety w ere  actua lly  bent outwards as 
ind icated  by va lues exceeding 120° (v iz . 121.9° and 121.6°).
The linearity  of the acetylenes contained in the enediynes can be 
judged  by the Cx-Csp-Csp angles (Table 1). Ju s t as in  the case of the 
v iny lic  sp  angles, the sm allest ring (com pound 18, en try  1) exhibited the 
b iggest deviation  from  the nom inal 180°, i.e . va lues betw een 166.0° and 
177.0°. The sm allest angles (166 .0 °) w ere  encountered  tow ards the side 
of the fused benzene ring.
On going to enediynes w ith  la rge r rings, the angles cam e much 
closer to linearity  w ith  the m arked exception of the olefin ic 12-membered 
cycle  21 (en try  3). There, a quite significant deviation  from  180° w as 
observed at the attachm ent point of the propylene unit. One of the two
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conform ations in  the crysta l structure made a 167.4° bend at one of the 
acetylenes. The other conform er even showed a va lue of 156.4° around 
this bond. Apparently , the accom m odation of th ree m ethylene units put 
the bonds at th is position under considerable strain.
A  genera l pattern  em erged w hen  looking at the acetylene angles 
connecting to the outside of the enediyne unit (i.e . C sp  -Csp-Csp): the 
greatest deviations from  linearity  are encountered  w here  the longest 
m ethylene bridge w as attached. Th is w as the side tow ards the N- 
term inus in the 10- and 12-membered enediynes, w hereas in  the 11- 
m em bered 20, it w as the side tow ards the C-terminus.
Table 2 Transannular (c-d) distances of enediynes 18 and 20-22.
ad y
entry compound c-d distancea (Â)
1 18 3.23
IS
J 2 O 3.76
3 21 3.88
4 22 3.77
a) Obtained by X-ray structural 
elucidation
The c-d d istances of the enediyne-containing amino acids as 
obtained from  the ir crysta l structures are listed in Tab le  2. Expected ly, 
the gap betw een  the term ina l acetylene carbons g rew  w ith  increasing 
ring  size. W h a t stood out w as the leap in  c-d d istance betw een  the 10- 
m em bered ring 18 (3.23 Â, en try  1) and the rest of the series (>3.76 Â, 
entries 2-4). Also notew orthy w as the s ign ificantly  la rg e r c-d separation 
in the olefin ic 12-membered 21 (3.88 Â, en try  3) w hen  com pared to its 
benzene-fused counterpart 22 (3.77 Â, en try  4).
3.3 Kinetics and half-life determinations
In  most studies concern ing the reactiv ity  of enediynes, the half-lives are 
reported  under e levated  tem peratures, often in the presence of a rad ica l 
trap. A  va rie ty  of techniques can be em ployed to fo llow  the Bergm an  
Cyclization, e ither by analysis of the consum ption of starting m ateria l or 
by the appearance of new  products. H -N M R  is a usefu l and 
stra ightforw ard  tool for these kinds of observations. Sam ples can be 
sealed under an inert atm osphere and the ratio  of its contents can  be
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conven iently m onitored over time. Ideally, the reaction  can be fo llowed in  
situ  by m aking use of N M R  probe heating.
F o r  our m easurem ents on enediynes 18-22, w e  chose deuterated  
D M SO  as solvent, m ain ly for its high boiling point (189 °C  for DMSO-hß) 
and its good solvation pow er of the compounds in question. The most 
com m only encountered  organic rad ica l trap  in BC  experim ents is 1,4- 
cyclohexadiene (C H D ). It  read ily  donates two hydrogen atoms and 
em erges from  this reaction  as easily  detectab le benzene. In  o rder to 
quantify the progression of the B C  reactions, an in terna l standard was 
needed. E ith e r  aceton itrile , cyclohexane, d im ethyl oxalate or m esitylene 
w ere  chosen, depending on the free regions in the H -N M R  spectra of the 
enediyne substrates.
Thus, enediynes 18-22 w ere  dissolved in deuterated  D M SO  (c = 
0.1 M ), 1,4-cyclohexadiene (2 equiv) and an in terna l standard  w ere  
added, and these sam ples w ere  sealed under an argon atm osphere in 
N M R  glass tubes p rio r to being subjected to e levated  tem peratures. 
M easurem ents at tem peratures of up to 353 K  (80 °C )  w ere  conducted 
inside a heated  N M R  probe. A  typ ica l set of N M R  traces resu lting from  
such an in-magnet experim ent is shown in F igu re  7.
ppm (t2) 7.0 6.0 5.0 4.0 3.0 2.
Figure 7 1H-NMR traces of a sample of 18 followed over the course of 14 h at 80 °C 
(solvent: DMSO-d6; internal standard: cyclohexane; the initial sample contained 2 equiv of 
CHD as radical trap).
Fo r tem peratures h igher than 80 °C , the sealed sam ples w ere  
im m ersed in an oil bath of the ind icated  tem peratu re ; a t d ifferent points 
in time, the sam ples w ere  sw iftly  cooled to room  tem perature  and H- 
N M R  spectra w ere  recorded im m ediately. The am ount of enediyne over 
tim e w as determ ined re la tive  to the in terna l standard.
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0)C
"U<D
0)c
"U<u
time (m in) time (m in)
time (m in) time (m in)
time (min) time (m in)
time (min) time (m in)
Figure 8 Plots of the fraction of enediyne vs. time (left column) and plots of the natural 
logarithm of the normalized amount of enediyne vs. time (right column). Exponential and 
linear trend lines are shown together with their equations.29 [A] Decay of enediyne 18 at 
T = 52° C; [B] decay of 18 at T = 80° C; [C] decay of enediyne 19 at T = 90° C; [D] decay 
of enediyne 20 at T = 120° C.
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D ata of those experim ents w here  tem perature-induced cyclizations 
took p lace (i.e . enediynes 18-20) are d isp layed in F igu re  8. In  the left 
column, the am ount of enediyne re la tive  to the in terna l standard is 
plotted against time, and a cu rve  fit ind icated  exponential decay in  a ll 
cases. M apped  out in the right colum n is the natu ra l logarithm  of the 
norm alized am ounts of enediyne (X /X0) against time, resu lting in stra ight 
lines for a ll experim ents. This linear re lationsh ip  is ind icative for first­
order or pseudo-first-order reactions as expressed by Equation  1 w h ich
30can be derived  from  the first-order rate  law.
In = -kt Equation 1
o J
Apparently, the therm al decay of enediynes 18-20 under the given 
conditions indeed fo llowed first-order or pseudo-first-order kinetics. The 
negative va lue  of the slope of the linear fit (F igu re  8, r igh t colum n) gives 
the rate  constants (k). Fu rtherm ore, the half-lives of first-order reactions 
fo llow  d irectly  by solving Equation  2, i.e . finding the tim e at w h ich  ha lf of 
the starting m ateria l has been consum ed:
In i 0.5[X]o 1
tl / 2
o J In 2 Equation 2
- k k
Tab le 3 gives an overv iew  of a ll cyclization  experim ents w ith  ha lf­
lives and rate  constants if availab le.
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Table 3 Half-life determination of oyolio enediynes.
r )n  
c = 0.1 M
-'CO2Me
'T s
A
CHD (2 equiv.)
DMSO-d6 
internal standard C O ,
K l^C O 2M e
T^nN'Ts
sealed NMR tube
entry compound n, p T (°C ) half-life k (min-1)
1 17 1 , 1 rt-30 < 30 min a -
2 18 1 , 1 52 13.7 h 8.408-10"4
3 80 59 min 1.176-10"2
4 19 1 , 2 80 trace b -
5 90 26.4 h 4.382-10"4
6 20 c 1 , 2 80 stable d -
7 90 trace b -
8 120 176 h 6.570-10"5
9 21 3, 1 80 stable d -
10 90 stable d -
1 1 120 trace b -
12 22 3, 1 80 stable d -
13 90 stable d -
14 120 stable d -
a) Uncontrolled oyolization during reaction work-up; b) a small amount of the 
aromatization product was observed by 1H-NMR after 24 h at the indicated 
temperature; c) cenediyne = 0.05 M; d) no sign of product was observed by 1H-NMR after 
24 h at the indicated temperature.
The 10-membered olefin ic enediyne 17 (en try  1) underw ent 
spontaneous cycloarom atization  (see: C hap ter 2.3.3); it is included for 
com pleteness. Its benzofused analogue 18 is the only structure w ith  a 
confirm ed c-d d istance w ith in  the “ reactive  w ind ow ” of 2.9-3.4 Â. It 
d isplayed a half-life of 13.7 h at 52 °C  (en try  2) and a reaction  rate  of k =
A 1 R 1 *318.408-10" m in (1.401-10' s ' )  under the conditions applied. Increasing  
the tem perature  to 80 °C  resulted, ra th e r expectedly, in a m uch shorter 
half-life of 59 m in (en try  3) associated w ith  a reaction  rate  la rg e r by one 
order of m agnitude (k  = 1.176-10-2 m in-1 = 1.960-10-4 s-1). S ign ifican tly  
h igher tem peratures and reaction  tim es w ere  requ ired  to induce B C  of 
the 11-membered rings (entries 4-8), w h ich  fo llowed our expectations. 
Indeed, only a trace  am ount of an arom atized product w as detected  ( H- 
N M R ) a fter having subjected 19 to tem peratures of 80 °C  for 24 h. 
Increasing  the tem perature  to 90 °C  (en try  5) caused the BC  to proceed 
w ith  a half-life of 26.4 h (k = 4.382-10-4 m in-1 = 7.303-10-6 s-1). E ven  
h igher tem peratures w ere  needed for benzo-fused 20 to arom atize
64
Characterization and Reactivity of Cyclic Enediyne-Containing Amino Acids
effic iently : a fte r 24 h at 90 °C  only sm all am ounts of the corresponding 
product could be detected. F in a lly  a half-life of 176 h w as obtained at 120 
°C  (k  = 6.570-10-5 m in-1 = 1.095-10-6 s-1; en try  8).
Bo th  12-membered species 21 and 22 w ith  c-d d istances of 3.77 Â  
and 3.88 Â, respectively, proved to be therm ally  stable at a tem perature 
of 90 °C  as anticipated. Upon subjecting sam ples to a tem perature  of 120 
°C , a m inute am ount of a new  product could be detected  after 24 h in  the 
case of 21, w h ile  22 rem ained com pletely unchanged (entries 9-14).
These half-life determ ination experim ents showed that, in line w ith  
previous studies, a ll benzannulated enediynes reacted  s ign ificantly  s low er 
than  the ir unsubstituted counterparts. M oreover, it becam e evident that 
ring stra in  p layed a m ajor role: an increase in  ring size w en t along w ith  a 
d istinct decrease of the rate  of cycloarom atization.
The d ifference in  cyclization behavior betw een  the closely re lated  
11-membered cycle  20 and the 12-membered cycle  22, both showing 
alm ost equal c-d d istances in the solid state (3.76 Â  and 3.77 Â, 
respectively ; see Tab le 2), dem onstrated once more that the c-d value 
fails to provide an accurate  estim ate of reactiv ity . The underly ing  reason 
most like ly  is the d ifference in  ring size, but the proxim ity of the electron- 
w ithd raw ing  sulfonam ide to the enediyne m otif could also p lay a role (i.e . 
separated  by a m ethylene un it in  20 and by a propylene unit in  22).
3.4 Peptide couplings involving cyclic enediyne- 
containing amino acids
O f the enediynes presented in the previous section, the 10-membered 
benzannulated system  18 has the highest potential u tility: it is stable at 
room tem perature, but can be activated  at m odestly e levated  
tem peratures. It  w as thus decided to fu rther e laborate on the chem istry 
of derivatives of th is enediyn ic am ino acid, v iz . rem oval of p rotecting 
groups and simple peptide couplings.
Figure 9 Definition of the abbreviation "Edy".
F o r  convenience, the three-letter abbreviation  "Ed y " w ill be assigned to 
the core structure of 18 throughout the rem ainder of th is w ork  
(F igu re  9).
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3.4.1 F u n c t io n a l iz a t io n  a t th e  C - T e rm in u s
A fte r hydrolysis of the m ethyl ester of Ts-Edy-OMe (18), peptide bond 
form ation to the C-terminus of the thus obtained free acid  23 w as 
explored (Schem e 2). Genera lly , peptide bond fom ation of N-alkylated 
am ino acids is considered a ra the r challenging reaction. The steric 
h indrance exerted by the secondary am ino group strongly im pedes
32reaction  at the N-term inus, but also at the C-terminus. Fo r th is reason,
33 34phosphonium-based BOP-Cl and the uron ium  reagent H A T U  w ere  
chosen, both recognized as being pow erfu l coupling reagents35 for 
dem anding substrates.
18 23 (87%) 24 (48%; via b)
(58%; via c) 
d.r. = 1:1
Scheme 2 Preparation of enediyne-containing dipeptide 24. Reagents and conditions: (a) 
LiOH, THF/MeOH/H2O, 0 °C, 3 h; (b) HCl-H-Ala-OMe, BOP-Cl, Et3N, CH2Cl2, 0 °C, 29 h;
(c) HCl-H-Ala-OMe, HATU, DiPEA, CH2Cl2, 0 °C, 2 h.
Thus, the free carboxylic acid  23 w as a llow ed to react w ith  the H C l 
salt of a lan ine m ethyl ester in  the presence of an organic base, em ploying 
e ither BO P-C l or H A T U  as coupling agents. In  case of BOP-Cl, the 
reaction  proceeded sluggishly, and additional quantities of the reagent 
had to be added over tim e to drive the reaction  to com pletion over a 
period of 29 h w ith  a y ie ld  of 4 8 % . H A T U  on the other hand accom plished 
the transform ation sm oothly w ith in  2 h and led to a h igher y ie ld  (5 8 % ). 
Bo th  reactions provided the product Ts-Edy-Ala-OMe (24 ) as an 
inseparab le  1:1 m ixture of d iastereoisom ers. T reatm ent of a D M F  
solution of the d ipeptide w ith  K 2C O 3 over severa l hours at 0 °C  or 
am bient tem perature  did not change the d iasteriom eric ratio.
3 .4 .2  F u n c t io n a l iz a t io n  a t th e  ^ - T e rm in u s
3 .4 .2 .1  N i t r o b e n z e n e s u l f o n y l- p r o t e c t e d  e n e d i y n e
In  o rder to N-functionalize the enediyn ic am ino acids, it is essentia l that 
the p rotective groups can be se lective ly  rem oved, p re ferab ly  in  a m ild 
way. W h ile  the m ethyl ester of the enediynes presented so far did not 
pose any problem s in that respect, the tosyl group did. U sually , N-tosyl 
deprotection  is realized  by d issolving m etal reduction  (sodium  in
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am m onia or decalin), w h ich  is un like ly  to leave the enediyne unscathed. A  
m ore suitable a lte rnative  is the ortho-nitrobenzenesulfonyl p rotecting 
group (N s ).36 Be ing  a strongly e lectron-w ithdraw ing sulfonamide, it 
low ers the N H -acid ity of the starting amino acid  suffic iently to a llow  for 
the M itsunobu strategy as outlined in C hap ter 2.3. M ost im portantly, the 
N s protecting group can be cleaved  off under m ild conditions by the
37action of thiolates.
25 27 (59%) 28 (67%) 29 (2%)
Scheme 3 Synthesis of the Ns-protected enediyne 28 and the observed byproduct 29. 
Reagents and conditions: (a) Aryl iodide 26, Pd(PPh3)4 (cat), CuI (cat), n-BuNH2, Et2O, rt, 
4 h; (b) PPh3, DIAD, THF, rt, 10 min.
Schem e 3 shows the path to Ns-protected enediynes: A
38Sonogashira-type coupling of Ns-protected p ropargylg lycine 25 w ith  
a ry l iodide 26 furnished acyclic  enediyne 27, w h ich  in tu rn  w as 
successfu lly ring-closed under M itsunobu conditions. The desired  product 
Ns-Edy-OMe (28 ) w as form ed in 6 7 %  y ie ld  along w ith  a sm all fraction  of 
the tetrahydrobenzo[g]isoquinoline 29. Its  form ation requ ires Bergm an  
Cyclization  of enediyne 28 and a ttack  of the a-carbon on the Ns- 
protecting group w ith  concom itant elim ination of SO2, not necessarily  in 
that order. A  sim ilar m igration  of a p-nitrophenyl group occurring  in p- 
Ns-protected amino acids under m ild ly basic conditions has been 
w itnessed by K inderm an .39
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Crystals su itable for X-ray structu ra l analysis could be obtained 
from both the enediyne 28 and the byproduct 29 (F igu re  10). In  structure 
28, the arom atic part of the N s group resides on top of the enediyne ring 
in an alm ost perfectly  perpend icu lar fashion. Furtherm ore, it features a 
ra the r large torsional angle around the v iny lic  part of the enediyne (4 .8 °), 
m uch la rg e r than in its Ts-protected counterpart 18 (0 .7 °) and 
com parable to the benzo-fused 11-ring 20 (Table 4; com pare w ith  Tab le  
1). The v iny lic  bonds and the acetylenes are som ewhat stra ined  as could 
be expected from a 10-membered enediyne. F ina lly , its c-d d istance of 
3.34 Â  is la rg e r than that of the Ts-protected counterpart 18 by 0.11 Â.
Table 4 Structural parameters of enediyne 28 obtained from X-ray data.
ß1 ^
N
compound c-d
distance
vinylic
dihedral
angle
(o)
ß1 (O) ß2 (O) Cx-Csp-Csp angles ( °)  
a1 a2 a3 a4
28 3.34 Â 4.8 116.6 117.5 169.4 167.4 167.2 172.7
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3 .4 .2 .2  P e p t i d e  b o n d  fo rm a t io n  a t  the  N - te rm in u s
Rem oval of the Ns protecting group from  28 w as ach ieved  by m eans of 
thiophenol and K 2CO 3 in M e C N  to give H-Edy-OMe (30 ) in  a y ie ld  of 6 6 %  
(Schem e 4).
Ns CO2Me
28
Scheme 4 Removal of the Ns protecting group
30 (66%)
Peptide bond form ation at the N-term inus of N-alkylated amino 
acids is genera lly  m ore challenging than at the C-terminus. Consequently, 
w e  chose g lycine as the least dem anding am ino acid  to be coupled to 30. 
A  va r ie ty  of coupling reagents35 w as evaluated, such as BOP-Cl, 
P y B rO P ,40 H A T U  and the com bination DCC/DM AP. Table 5 lists the 
efforts of coupling 30 to Boc-Gly-OH.
Table 5 Coupling conditions for the N-functionalization of enediyne 30.
Y^"~CO2Me
30
Boc-Gly-OH 
CH2Cl2, rt y
conditons
V...CO2 Me
/N^^N H Boc 
31 O
entry reagent base Boc-Gly-OH time isolated
(equiv) (equiv) (equiv) yield
1 DCC/DMAP (1.1/1.1) D iPEA  (3.0) 3.0 5 d a
2 BOP-Cl (3x 1.3) Et3N (1.5) 1.3 3 d a
3 PyBrO P (3x 2.0) D iPEA  (3.0) 2.0 24 h a
4 HATU (3.0) lutidine (2.0) 1.6 50 h 20%
5 HATU (4x 1.1) D iPEA  (2.2) 2.0 50 h 74%
a) no conversion
Evidently , only H A T U  accom plished peptide couplings to the N- 
term inus of the enediyne (entries 4 and 5) to give the d ipeptide Boc-Gly- 
Edy-OM e (31). In  all o ther cases no consum ption of starting m ateria l w as 
observed, even a fter prolonged reaction  tim es and the addition of 
m ultip le equivalents of coupling agent.
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3.5 Bergman Cyclizations of the nosyl variant, the free 
amine and the dipeptides
3.5.1 K in e t ic s  a n d  h a lf- li fe  d e te rm in a t io n s
time (min) time (min)
time (min) time (min)
time (min) time (min)
time (min) time (min)
Figure 11 Plots of the fraction of enediyne vs. time (left column) and plots of the natural 
logarithm of the normalized amount of enediyne vs. time (right column). Exponential and 
linear trend lines are shown together with their equations. 9 [A] Decay of enediyne 28 
(Ns-Edy-OMe) at T = 52° C; [B] decay of enediyne 30 (H-Edy-OMe) at T = 80° C; [C] 
decay of dipeptide 24 (Ts-Edy-Ala-OMe) at T = 52° C; [D] decay of dipeptide 31 (Boc-Gly- 
Edy-OMe) at T = 80° C.
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K inetic  experim ents w ere  conducted w ith  Ns-Edy-OMe (28), the free 
am ine H-Edy-OMe (30 ) and w ith  dipeptides Ts-Edy-Ala-OMe (24 ) and 
Boc-Gly-Edy-OMe (31). Half-life va lues and rate  constants w ere  
determ ined as described  in Section  3.3. Thus, sam ples of enediynes w ere  
prepared  w ith  concentrations of ~0.1 M  in DMSO-d6 contain ing two 
equivalents of 1,4-CHD and m esitylene as in terna l standard. They w ere  
sealed in  N M R  tubes before being subjected to e levated  tem peratures. 
Plots of the am ount of enediyne vs. tim e are g iven in F igu re  11.
The logarithm  of the am ount of enediyne p lotted against tim e 
displayed a lin ea r re lationship  in a ll cases (F igu re  11, right column), 
im plying (pseudo) first-order k inetics for a ll enediynes under the given 
circum stances. Rate  constants (k) and half-lives fo llow ing from  this set of 
experim ents are g iven in Tab le 6.
Table 6 Kinetic data for enediynes 24, 28, 30 and 31.
^ SSS R2
c = 0.1 M
A
CHD(2equiv) ___
DMSO-d6 X \  
mes itylene ( int. standard)
sealed NMR tube
O
| W r2
O k ^ . R l
entry enediyne R 1 R 2 T (°C ) half-life (h) k (min-1)
1 28 Ns OMe 52 8.28 1.395-10-3
2 30 H OMe 52 trace a -
3 80 13.4 8.642-10-4
4 24 b Ts Ala-OMe 52 3.69 3.130-10-3
5 31 Boc-Gly OMe 52 stable c -
6 80 25.9 4.457-10-4
a) A small amount of the aromatization product was observed by ‘H-NMR after 24 h at the 
indicated temperature; b) cenediyne = 0.05 M; c) no sign of product was observed by 1H-NMR 
after 24 h at the indicated temperature.
The nosyl-protected m ethyl ester (28 ) arom atized w ith  a half-life of 
8.28 h at 52 °C  (en try  1); the rate  constant associated w ith  this va lue is
1.395-10-3 m in-1 (2.325-10-5 s-1).41 The corresponding free am ine (30 ) did 
not react e ffic ien tly  at the same tem peratu re  (en try  2). A  m ere trace  of 
the arom atization product w as found in the H -N M R  spectrum  after 24 h 
at 52 °C . Exposure to a tem perature  of 80 °C  allow ed  the B C  to proceed 
w ith  a reaction  rate  of k = 8.642-10-4 m in-1 (1.440-10-5 s-1) and a half-life 
of 13.4 h (en try  3). The two d ipeptides d isp layed ra th e r d ifferent 
reactiv ities. D ipeptide Ts-Edy-Ala-OMe (24 ) (en try  4) exhibited an 
extraord inarily  short half-life of 3.69 h at 52 °C  (k = 3.130-10-3 m in-1 = 
5.217-10-5 s-1). In  sharp contrast, the d ipeptide Boc-Gly-Edy-OMe (31, 
entries 5-6) appeared  to be stable at 52 °C . O nly a fter ra ising the
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tem peratu re  to 80 °C  could therm al decay be observed. The half-life of 
25.9 h (k = 4.457-10-4 m in-1 = 7.428-10-6 s-1) at that tem perature 
established 31 as the most stable of a ll 10-membered enediynes enclosed 
in th is study.
3 .5 .2  C o m p a r is o n  o f  k in e t ic  d a ta
It  follows from  the k inetic data that Ns-Edy-OMe (28 ) undergoes 
Bergm an  Cyclization  at a m uch faster rate  (t1/2 = 8.28 h at 52 °C )  than  its 
Ts-protected counterpart 18 which, under the same conditions, had a 
half-life of 13.7 h (Table 3, en try  2). Com parison of 18 and 28 exem plifies 
once more that the c-d d istance m ere ly  a llow s a rough estim ation of 
propensity tow ards BC . The Ts-variant features a c-d va lue  of 3.23 Â  
(Table 2, en try  1) w h ile  the term ina l acety len ic carbons of the Ns- 
compound are separated  by 3.34 Â  (Table 4). I f  the c-d d istance would  be 
taken  as a m easure for the rate  of the B C  exclusively, one would  expect 
the Ts-protected enediyne to cyclize faster than the Ns-compound. The 
reversed  order of reactiv ity  is additional evidence that other factors p lay 
a more im portant role. Such  factors could be the stronger electron- 
w ithd raw ing  characte r of the Ns group, but also the special arrangem ent 
of the Ts-compound 18 w here  the arom atic part of the Ts-group is 
stacked on top of the enediyne ring (F igu re  6).
Ev idently , substitution at the n itrogen exerts a large influence on 
the cyclization behavior of the enediyn ic amino acids. Su lfonam ides Ts- 
Edy-OM e (18), Ns-Edy-OMe (28 ) and Ts-Edy-Ala-OMe (24 ) a ll react at a 
faster rate  than the non-sulfonamide enediynes. The free am ine 30 
arom atized more than  one order of m agnitude s low er (t1/2 = 13.4 h at 80 
°C )  than the Ts-protected equ iva lent (t1/2 =  59 m in at 80 °C ). In  th is case, 
the hybrid ization of the n itrogen could also p lay a role. Presum ably, it is 
sp  -hybridized for the free am ine, w h ile  crysta l structu ra l data of a ll 
sulfonam ides c lea rly  show a p lanar sp  -hybridized nitrogen. It  is 
reasonab le to assum e the enediyne ring to be d istorted in d ifferent w ays 
depending on the hybrid ization state of the n itrogen atom. H ow ever, it is 
also evident that the N-hybridization is only one of severa l factors. A fte r 
all, in the d ipeptide Boc-Gly-Edy-OMe (31 ) the enediyn ic n itrogen is part 
of a carboxam ide and as such sp  -hybridized. Yet, it has a ra the r long 
half-life ( t1/2 = 25.9 h at 80 °C ).
It  seems that sulfonam ide protecting groups prom ote the Bergm an  
Cyclization of enediyne-containing amino acids w ith  respect to the free 
am ines w h ile  carboxam ides slow  down the rate  of the reaction  in this 
respect. Such  rate  enhancem ents of sulfonam ide-protected enediyn ic aza- 
cyles as com pared to the ir carboxam ide counterparts has been reported  
previously by Basak  and co-workers (see F igu re  12):22b Fo r instance,
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sulfonam ide 32 showed a half-life of 49 h at 70 °C , w h ile  am ide 33 
arom atized m ore than 2.5 tim es s low er at the same tem perature.
O2
S,
no2 no2
32
t1/2 = 49h (70°C)
33
t1/2 = 136h(70 °C)
Figure 12 Higher BC rate of sulfonamides compared to carboxamides as published by 
Basak et al.22b
N otew orthy in  the series of Edy-derivatives is the short half-life of 
d ipeptide Ts-Edy-Ala-OMe (24 ) of 3.69 h at 52 °C , especia lly  in 
com parison w ith  Ts-Edy-OMe (18 ) w h ich  d isp layed a half-life of 13.7 h 
under the same conditions (v id e  su p ra ). Obviously, the cycloarom atization 
benefits from  the substitution of the m ethyl ester in  18 for the Ala-OMe 
peptide m oiety in 24. The experim ental data do not a llow  pinpointing a 
single factor for th is behavior. Conceivab le  are firstly  e lectron ic effects, 
secondly conform ational changes of the enediyne ring and th ird ly  fast 
in tram o lecu lar trapp ing  of the d irad ica l in term ediate by the peptide
42chain, p reventing  the retro-Bergm an reaction.
3.6 The Bergman Cyclization as synthetic tool
In  addition to its p ivotal role in enediyne-based antib io tics and 
antineop lastic agents, the Be rg m an  Cyclization  can also be considered a 
synthetic tool in the p reparation  of novel compounds or as a new  w ay  of
43m aking ava ilab le  known targets. The therm al cycloarom atization  of 11- 
m em bered cyclic  enediynes 19 and 20 w as put to use in  th is role to 
provide the hitherto  unknown tetrahydroazepines 34 and 35 (Schem e 6).
CHD (100 equiv)
19
EtCN 
97 °C 
6days
Ts'
CO2Me
34 (31%) 35 (60%)
Scheme 6 Preparative cycloaromatization of 11-membered enediynes 19 and 20.
To this end, the enediynes w ere  heated  in the presence of 1,4- 
cyclohexadiene in p roprion itrile . A fte r six days at reflux tem perature  (97 
°C ), enediyne 19 had been consum ed com pletely and the 
tetrahydrobenzazepine 34 w as isolated in a y ie ld  of 31% . S im ilarly , the
O
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benzene-fused derivative  20 w as converted  into the tetrahydro- 
naphthazepine 35 in a y ie ld  of 6 0 %  after being subjected to a 
tem peratu re  of 150 °C  for nine days in  a sealed tube. Bo th  34 and 35 can 
be considered s te rica lly  constrained phenyla lan ine derivatives. Thus, the 
Bergm an  Cyclization  provides a new  w ay  of accessing these kind of 
benzazepines o ther than e .g . nucleophilic d isp lacem ent reactions, the 
Pictet-Spengler cyclization  or sigm atropic rearrangem ent reactions .44
3.7 Conclusion
The tendency to undergo Bergm an  Cyclization  has been assessed for the 
olefin ic and benzo-fused cyc lic  enediyne-containing amino acids w h ich  
have been described in C hap ter 2. D ecay of a ll enediynes d isplayed 
(pseudo-)first-order behavior. Two trends em erged from  the k inetic data: 
in  the first place, the propensity of an enediyne to undergo B C  is large ly  
governed by ring size and secondly, benzannulation has a strongly 
dece lerating  effect on the reaction  rate. Bo th  observations are in  line 
w ith  lite ratu re  reports on other types of enediynes.
O f the explored enediynes, the benzene-fused 10-membered 
specim en w as identified  as the compound w ith  the h ighest potential 
u tility. Th is consideration w as based on its stab ility  at room  tem perature  
in  com bination w ith  its reactiv ity  at m odestly e levated  tem peratures. 
Rem oval of protecting groups provided access to the corresponding free 
am ines and acid  derivatives and allow ed  incorporation  into dipeptides. 
Com parison of the deriva tives ' half-lives im plied a rate acce lera tion  upon 
sulfonam ide form ation at the am ine and a dece leration  upon carboxam ide 
form ation. O f specia l in terest w as the reactiv ity  of the Ts-protected 
d ipeptide Ts-Edy-Ala-OMe w h ich  d isp layed an exceptionally high 
reactiv ity  and the shortest half-life (3.69 h at 52 °C )  of a ll enediynes 
described in this Chapter.
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3.9 Experimental section
3.9.1 G e n e r a l  in fo rm a t io n
F o r  genera l in form ation about methods, m ateria ls and instrum entation  
see experim ental section of Chapter 2.
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3.9 .2  P r e p a r a t iv e  p ro c e d u re s
4-Tosyl-1,2,7,8-tetradehydro-3,4,5,6-tetrahydro-4-benzazecine-5-carboxylic acid (23)
In a stoppered flask, methyl ester 18 (221 mg, 0.561 mmol) was 
dissolved in THF (6 mL) followed by the addition of MeOH (2 mL). The 
homogeneous solution was cooled to 0 °C and treated with an 
aqueous solution of LiOH (1.0 M; 2.0 ml, 2.0 mmol). After 10 min, the 
reaction mixture became cloudy whereupon water (1 mL), THF (2 mL) 
n—  ^ and MeOH (2 mL) were added. Stirring was continued at 0 °C until TLC 
Ts CO2H indicated full conversion (~3 h). The pH of the still cold solution was 
adjusted to 1 using 1.0 M HCl, resulting in a white precipitate that was filtered off 
and rinsed with ice-cold water (2x 0.5 mL) and ice-cold MeOH (2x 0.5 mL). After 
drying, the product was obtained as a white powder (185 mg, 0.488 mmol) in a 
yield of 87%.
Rf 0.21 (EtOAc/heptane/MeOH, 10:10:3); vmax (ATR) 3304 (br), 2976, 2928,1718 
(s), 1502, 1368, 1225 (s), 1109 (s); <5h (300 MHz, DMSO-Gf6) 13.05 (1 H, s), 7.75 (2 
H, d, J  = 8.2 Hz), 7.35-7.23 (4 H, m), 7.18 (2 H, d, J  = 8.2 Hz), 4.64 (1 H, dd, J  = 
10.8, 3.5 Hz), 4.57 (1 H, d, J  = 19.3 Hz), 4.30 (1 H, d, J  = 19.3 Hz), 3.18 (1 H, dd, J  
= 18.4, 10.8 Hz), 3.06 (1 H, dd, J  = 18.4, 3.5 Hz), 2.16 (3 H, s); <5c (75 MHz, DMSO­
de) 170.6, 142.9, 137.3, 129.1, 128.3, 128.1, 127.8, 127.7, 127.3, 127.2, 127.0,
96.5, 94.7, 86.0, 83.1, 63.5, 41.36, 21.0, 20.7; HRMS (ESI) calcd. for C^H^NNaOS 
(M++Na) 402.0776, found 402.0762.
(25)-Methyl 2-(4-tosyl-1,2,7,8-tetradehydro-3,4,5,6-tetrahydro-4-benzazecine-5- 
carboxamido)propanoate (24)
L-Alanine methyl ester hydrochloride (87 mg, 0.623 mmol) was 
suspended in a solution of enediynic acid 23 (79 mg, 0.208 
mmol) and dry CH2Cl2 (6 mL). The reaction mixture was cooled 
to 0 °C followed by the addition of DiPEA (0.200 mL, 1.210 
mmol), resulting in a clear solution that was treated with HATU 
(222 mg, 0.584 mmol). Stirring was continued at 0 °C for 2 h, 
and the reaction was worked up by the addition of saturated 
aqueous NH4Cl (20 mL). The phases were separated, and the 
aqueous layer was extracted with CH2Cl2 (2x 5 mL). The combined organic 
phases were washed consecutively with 0.5 M KHSO4 (10 mL), a saturated 
solution of NaHCO3 (10 mL) and brine (10 mL), followed by drying over MgSO4. All 
volatiles were removed and the crude product was subjected to flash 
chromatography (EtOAc/heptane, 45:55). Careful concentration of the 
chromatographic eluate in vacuo at room temperature caused the product to 
precipitate as an off-white powder that could be filtered off (56 mg, 0.121 mmol, 
58%). The product was obtained as an inseparable 1:1 mixture of 
diastereoisomers.
Rf 0.43 (EtOAc/heptane, 1:1); vmax (ATR) 3352, 3015, 2941, 1930 (w), 1735, 1675, 
1152, 750; <5H (300 MHz, CDCl3) 7.80 (2 H, d, J  = 7.8 Hz), 7.23 (1 H, d, J  = 5.7 Hz), 
7.23-7.08 (4 H, m), 7.03 (0.5x 2 H, d, J  = 7.8 Hz), 7.00 (0.5x 2 H, d, J  = 7.8 Hz),
4.82 (1 H, d, J  = 17.8 Hz), 4.68-4.52 (1 H, m), 4.29 (1 H, d, J  = 9.5 Hz), 4.19 (1 H, 
d, J  = 18.9 Hz), 3.78 (0.5x 3 H, s), 3.75 (0.5x 3 H, s), 3.49-3.26 (2 H, m), 2.10 (3 
H, s), 1.50 (0.5x 3 H, d, J  = 7.2 Hz), 1.45 (0.5x 3 H, d, J  = 7.2 Hz); <5C (75 MHz, 
CDCl3) 173.1, 172.7, 168.4, 143.9, 143.8, 136.3, 136.1, 129.6, 129.2, 128.8,
128.0, 127.8, 127.5, 127.4, 95.7, 95.6, 88.3, 87.5, 66.8, 52.6, 52.5, 48.7, 48.6,
42.6, 21.2, 20.5, 18.2, 17.9; HRMS (ESI) calcd. for C25H25N2O5S (M+ + H) 465.1484, 
found 465.1471.
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5-(2-(3-Hydroxyprop-1-ynyl)phenyl)-2-(2-nitrobenzenesulfonylamino)pent-4-ynoic 
acid methyl ester (27)
A stirred solution of 4-(2-iodophenyl)prop-3-yn-1-ol (26) (2.23 g,
8.64 mmol) in Et2O (60 mL) was treated with Pd(PPh3)4 (408 mg, 
0.354 mmol), CuI (162 mg, 0.852 mmol), and n-BuNH2 (6.0 mL, 61 
mmol). Stirring was continued until a clear, homogeneous solution 
had been formed and Ns-protected propargylglycine38 25 (2.72 g, 
8.71 mmol) was added. After 4 h at ambient temperature, the 
Ns reaction mixture was poured into an aliquot of saturated aqueous
NH4Cl, the phases were separated and the aqueous layer was extracted with 
EtOAc (3x 15 mL). The combined organic layers were washed with brine, dried 
over MgSO4, and all volatiles were removed in vacuo. Purification by flash 
chromatography (EtOAc/heptane, 1:10 ^  1:1) provided the product as a light 
brown oil (2.257 g, 5.101 mmol, 59%).
Rf 0.31 (EtOAc/heptane, 3:2); vmax (ATR) 3503 br, 3321, 3088, 3001, 2945, 
1969,1739, 1532, 1355, 1169, 754; <5h (200 MHz, CDCh) 8.14-8.10 (1 H, m), 7.88­
7.84 (1 H, m), 7.71-7.67 (2 H, m), 7.44-7.21 (4 H, m), 4.54-4.50 (3 H, m), 3.64 (3 
H, s), 3.19-2.97 (2 H, m); <5c (75 MHz, CDCh) 170.2, 147.5, 134.4, 133.6, 132.8, 
132.1, 132.0, 130.4, 128.1, 128.0, 125.4, 125.4, 124.9, 91.9, 86.2, 83.5, 83.2,
55.2, 53.1, 51.5, 25.1; HRMS (ESI) calcd. for C21 H18N2NaO7S (M++Na) 465.0732, 
found 465.0743.
4-(2-Nitrophenylsulfonyl)-1,2,7,8-tetradehydro-3,4,5,6-tetrahydro-4-benzazecine-5-
carboxylic acid methyl ester (28)
and
3-(2-Nitrophenyl)-1,2,3,4-tetrahydrobenzo[g]isoquinoline-3-carboxylic acid methyl
A vigorously stirred solution of acyclic enediyne 27 
(2.240 g, 5.063 mmol) in dry THF (400 mL, c = 12.6 
/  \  mM) was treated with PPh3 (1.594 g, 6.077 mmol).
Once a homogeneous solution had been formed, DIAD 
(  \  (1.20 mL, 6.05 mmol) was added via syringe and
hin— -^CO2Me stirring was continued for 10 min. All volatiles were 
removed in vacuo  at ambient temperature, and the 
° 2,N \—/ resulting crude product was subjected to flash 
chromatography (EtOAc/heptane, 1:2 ^  2:3). The first fraction consisted of 
benzoisoquinoline 29 which precipitated from the column eluate upon 
concentration as shiny, yellow flakes (34 mg, 0.094 mmol, 2%). Crystals suitable 
for X-ray analysis were obtained by slow evaporation of a CDCl3 solution.
Enediyne 28 was obtained by careful concentration of the corresponding 
chromatographic fractions at ambient temperature, causing the product to 
precipitate. Filtration and washing of the residue with heptane (3x 5 mL) and ice- 
cold MeOH (3x 1 mL) afforded 28 as an off-white powder (1.448 g, 3.412 mmol, 
67%). Crystals suitable for X-ray structural determination were obtained by top- 
layering an acetone solution with heptane.
Characterization data of enediyne 28 :45
Rf 0.44 (EtOAc/heptane, 1:1); vmax (ATR) 3097, 3019, 2950, 2215, 1740, 1537, 
1351, 1165, 746; <5H (300 MHz, CDCl3) 8.38 (1 H, dd, J  = 8.0, 1.2 Hz), 7.67 (1 H, 
dd, J  = 7.9, 1.3 Hz), 7.57 (1 H, dt, J  = 7.9, 1.3 Hz), 7.44 (1 H, dt, J  = 7.7, 1.3 Hz), 
7.37-7.26 (4 H, m), 4.79 (1 H, d, J  = 19.2 Hz), 4.46 (1 H, dd, J  = 11.1, 2.4 Hz), 4.32 
(1 H, d, J  = 19.2 Hz), 3.81 (3 H, s), 3.36 (1 H, dd, J  = 18.8, 2.4 Hz), 3.11 (1 H, dd, J  
= 18.8, 11.1 Hz); <5C (75 MHz, CDCl3) 169.3, 148.3, 134.0, 133.6, 132.0, 129.6,
128.4, 128.2, 128.1, 127.9, 127.3, 124.5, 95.5, 92.0, 87.7, 84.7, 64.9, 53.1, 42.9, 
21.7; HRMS (ESI) calcd. for C21H17N2O6S (M+ + H) 425.0807, found 425.0811. 
Characterization data of benzoisoquinoline 29:
Rf 0.56 (EtOAc/heptane, 1:1); <5H (300 MHz, CDCl3) 7.79-7.76 (1 H, m), 7.72-7.66 (3 
H, m), 7.58-7.53 (1 H, m), 7.45-7.39 (3 H, m), 7.37-7.34 (2 H, m), 4.19 (1 H, d, J  = 
16.8 Hz), 3.79 (3 H, s), 3.72 (2 H, d, J  = 16.3 Hz), 3.58 (1 H, d, J  = 16.8 Hz), 2.72
ester (29)
Ns CO 2Me
76
Characterization and Reactivity of Cyclic Enediyne-Containing Amino Acids
(1 H, br s); <5c (75 MHz, CDCI3) 173.8, 149.7, 133.9, 133.0, 132.4, 131.7, 130.7,
130.0, 128.6, 127.3, 127.1, 126.6, 125.6, 125.5, 124.7, 123.7, 62.6, 52.8, 44.1, 
37.5; HRMS (ESI) calcd. for C21H19N2O4 (M++H) 363.1345, found 363.1340.
Table 7 Crystal data and structure refinements for 28 and 29.
compound number 28 • acetone 29
CCDC No. — —
crystal color translucent colorless translucent colorless
crystal shape rough platelet rough thick plate
crystal size 0.29 x 0.20 x 0.02 mm 0.26 x 0.23 x 0.11 mm
empirical formula C24 H22 N2 O7 S C21 H18 N2 O4
FW 482.50 362.37
Temperature 208(2)K 208(2) K
radiation / À MoKa (graphite mon.) / 0.71073 Â
crystal system / space group Monoclinic / P21/n Monoclinic / C2/c
unit cell dimensions a 11.9984(13)Â 32.7121(16) Â
b 15.8082(9) Â 8.2174(7) Â
c 12.6584(6) Â 13.2736(6) Â
a 9 O O 9 O O
ß 117.541(7)° 95.733(4)°
Y 9 O O 9 O O
volume 2128.9(3) Â3 3550.2(4) Â3
Z / calc. density 4 / 1.505 Mg/m3 8 / 1.356 Mg/m3
absorption coefficient 0.205 mm-1 0.095 mm-1
diffractometer / scan Nonius KappaCCD with area detector 9 and w scan
F(000) 1008 1520
0 range 2.23 to 27.51 ° 2.50 to 25.00 °
index ranges -15<=h< = 15 -38<=h<=38
-20<=k< = 20 9=<II<9-
-16<=l< = 16 -15<=l< = 15
reflections collected / 
unique 59657 / 4903 30377 / 3095
Rint 0.0602 0.0420
reflections observed 3999 [I>2ct (I)] 2512 [I>2ct (I)]
absorption correction SADABS multiscan correction (Sheldrick, 1996)
refinement method Full-matrix least-squares on F2
computing SHELXL-97 (Sheldrick, 1997)
data / restraints / 
parameters 4903 / 0 / 272 3095 / 0 / 248
goodness-of-fit on F2 1.165 1.192
SHELXL-97 weight 
parameter 0.031000, 2.266400 0.0284, 6.0349
final R  indices [I>2ct (I)] R1 = 0.0696, wR2 = 0.1148
R1 = 0.0559, 
wR2 = 0.1062
R  indices (all data) R1 = 0.0951, wR2 = 0.1232
R1 = 0.0745, 
wR2 = 0.1124
largest diff. peak and hole 0.351 and -0.379 e-A-3 0.242 and -0.206 e-A-3
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Table 8 Selected structural data of enediyne 28.
selected bond lengths (Â)
S(1)-N(1) 1.618(2) C(5)-C(10) 1.408(4)
N(1)-C(14) 1.468(3) C(10)-C(11) 1.437(4)
N(1)-C(2) 1.476(3) C(11)-C(12) 1.193(4)
C(2)-C(3) 1.466(3) C(12)-C(13) 1.463(4)
C(3)-C(4) 1.187(3) C(13)-C(14) 1.536(3)
C(4)-C(5) 1.433(3) C(14)-C(15) 1.527(3)
selected bond angles (°)
C(14)-N(1)-C(2) 117.70(19) C(5)-C(10)-C(11) 117.5(2)
C(14)-N(1)-S(1) 120.37(16) C(12)-C(11)-C(10) 167.2(3)
C(2)-N(1)-S(1) 119.01(16) C(11)-C(12)-C(13) 172.7(3)
C(3)-C(2)-N(1) 109.53(19) C(12)-C(13)-C(14) 110.2(2)
C(4)-C(3)-C(2) 169.4(3) N(1)-C(14)-C(15) 112.7(2)
C(3)-C(4)-C(5) 167.4(3) N(1)-C(14)-C(13) 114.97(19)
C(10)-C(5)-C(4) 116.6(2) C(15)-C(14)-C(13) 111.4(2)
I,2,7,8-Tetradehydro-3,4,5,6-tetrahydro-4-benzazecine-5-carboxylic acid methyl 
e s te r (30)
Potassium carbonate (372 mg, 2.69 mmol, 2.8 equiv) was suspended 
in a cooled (0 °C) solution of Ns-protected enediyne 28 (403 mg, 
0.950 mmol) in dry MeCN (10 mL), directly followed by the dropwise 
/// addition of PhSH (0.195 mL, 1.91 mmol, 2 equiv). The reaction
mixture was stirred for 5 h at 0 °C, then 14 h at 6 °C and finally 3 h at 
ambient temperature. After removal of the volatiles, the crude 
H CO2Me product was loaded on silica and purified by flash chromatography 
(EtOAc/heptane, 1:1 ^  3:2). The title compound was obtained as a light brown 
solid (150 mg, 0.627 mmol, 66%).
Rf 0.57 (EtOAc/heptane, 1:1); vmax (ATR) 3342 (br), 3059, 2954, 2913, 2223, 1739, 
1259, 766; <5h (300 MHz, CDCh) 7.35-7.19 (4 H, m), 3.88-3.82 (2 H, m), 3.76 (3 H, 
s), 3.58 (1 H, d, J  = 18.2 Hz), 2.95 (1 H, d, J  = 17.5 Hz), 2.60 (1 H, dd, J  = 17.5,
I I .4  Hz), 2.32 (1 H, br s); <5c (75 MHz, CDCh) 173.5, 128.6, 128.6, 128.3, 127.8,
127.7, 127.6, 97.8, 96.0, 85.7, 83.6, 62.6, 52.6, 40.7, 25.8; HRMS (ESI) calcd. for 
C15H14NO2 (M+ + H) 240.1025, found 240.1030.
4-(2-(feri-Butoxycarbonylam m o)acetyl)-1,2,7,8-tetradehydro-3,4,5,6-tetrahydro-4- 
benzazecine-5-carboxylic acid methyl ester (31)
M To a stirred solution of enediyne 30 (80 mg, 0.334 mmol) 
2 e in CH2Cl2 (6 mL) were added consecutively Boc-Gly-OH 
-N^ ''^NHBoc (118 mg, 0.674 mmol), DiPEA (0.12 mL, 0.726 mmol, 2.2 
O equiv) and HATU (140 mg, 0.368 mmol, 1.1 equiv).
Stirring was continued for 1 h, whereupon more HATU (140 mg, 0.368 mmol, 1.1 
equiv) was added and the mixture was left to stir over night. Another two portions 
of HATU (2x 1.1 equiv) were added at 4 h intervals and the coupling reaction was 
allowed to proceed overnight. Once TLC indicated complete consumption of the 
starting material, the reaction was worked up by shaking with a saturated solution 
of NaHCO3 (30 mL). The phases were separated, and the aqueous layer was 
extracted using CH2Cl2 (3x 10 mL). The combined organic phases were washed
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with brine and dried over MgSO4 followed by removal of all volatiles in vacuo. 
Subjection of the crude product to flash chromatography (EtOAc/heptane, 2:3 ^  
1:1) furnished the title compound as an off-white, sticky solid (98 mg, 0.247 
mmol, 74%).
Rf 0.38 (EtOAc/heptane, 1:1); Vmax (ATR) 3404 (br), 2971, 2219, 1740, 1714, 1658, 
1459, 1177, 759; Öh (300 MHz, CDG3) 7.35-7.24 (4 H, m), 5.39 (1 H, bs), 4.53 (1
H, d, J  = 19.2 Hz), 4.26-4.03 (4 H, m), 3.74 (3 H, s), 3.59 (1 H, dd, J  = 18.3, 11.2 
Hz), 3.13 (1 H, dd, J  = 18.3, 3.1 Hz), 1.42 (9 H, s); öc (75 MHz, CDG3) 169.1,
168.4, 155.5, 129.2, 128.3 (2 C), 127.7, 127.5, 127.2, 95.7, 92.0, 88.3, 83.1, 79.7,
64.4, 52.7, 42.4, 41.4, 28.2, 19.6; HRMS (ESI) calcd. for C22H24^ N aO 5 (M++Na) 
419.1583, found 419.1563.
(5)-2-Tosyl-2,3,4,5-tetrahydro-1ff-benzo[c]azepm e-3-carboxylic acid methyl ester 
(34)
Cyclic enediyne 19 (78 mg, 0.218 mmol) was dissolved in EtCN (10 
mL), 1,4-cyclohexadiene (2.06 mL, 21.8 mmol, 100 equiv) was added, 
and the reaction mixture was heated to reflux under a protective 
atmosphere of nitrogen for 6 d. All volatiles were removed and the 
Ts' I  crude product was purified by flash chromatography (EtOAc/heptane, 
C° 2Me 1 :4 ) to give 34 as a white solid (24 mg, 0.067 mmol, 31%).
Rf 0.60 (EtOAc/heptane, 1:1); [a p D  = 58.1° (c = 0.42, C ^ C h ); Vmax (ATR) 3031, 
2950, 1740, 1437, 1333; öh (400 MHz, CDCfe) 7.49 (2 H, d, J  = 8.4 Hz), 7.21-7.18 
(1 H, m), 7.16-7.11 (4 H, m), 7.00-6.96 (1 H, m), 4.81-4.73 (2 H, m), 4.64 (1 H, d, J  
= 16.5 Hz), 3.67 (3 H, s), 2.90 (1 H, dd, J  = 15.8, 10.1 Hz), 2.59 (1 H, dd, J  = 15.8,
9.3 Hz), 2.36 (3 H, s), 2.34-2.26 (1 H, m), 2.00-1.92 (1 H, m); öc (75 MHz, CDCfe)
171.4, 143.0, 139.9, 137.2, 136.7, 129.4, 129.2, 128.7, 127.6, 127.1, 126.3, 59.2,
52.3, 48.6, 31.4, 29.3, 21.4; HRMS (ESI) calcd. for C19H21NNaO4S (M++Na) 
382.1089, found 382.1082.
Ts
(S)-2-Tosyl-2,3,4,5-tetrahydro-1H-naphtho[2,3-c]azepine-3-carboxylic acid methyl 
ester (35)
Cyclic enediyne 20 (15 mg, 0.037 mmol), EtCN (3 mL), and 1,4- 
cyclohexadiene (0.35 mL, 3.70 mmol, 100 equiv) were enclosed in a 
sealed tube under a protective atmosphere of nitrogen. The reaction 
vessel was exposed to a temperature of 150 °C for 9 d after which 
time all volatiles were removed in vacuo  and the crude product was 
subjected to preparative TLC (0.5% MeOH in CH2Cl2) resulting in 35 
as a white solid (9 mg, 0.022 mmol, 60%).
Rf 0.49 (EtOAc/heptane, 1:2); [ a p D = 1.1° (c = 0.45, C H ^h ); vmax 
(ATR) 2936, 1733, 1592, 1420, 1333; öh (400 MHz, CDCl3) 7.79-7.75 (1 H, m), 
7.73-7.69 (1 H, m), 7.67 (1 H, s), 7.51 (1 H, s), 7.48 (2 H, d, J  = 2.3 Hz), 7.46-7.42 
(2 H, m), 7.03 (2 H, d, J  = 8.4 Hz), 4.94 (1 H, d, J  = 16.3 Hz), 4.86 (1 H, t, J  = 5.1 
Hz), 4.72 (1 H, d, J  = 16.3 Hz), 3.70 (3 H, s), 3.07 (1 H, dd, J  = 15.3, 11.2 Hz), 2.82 
(1 H, dd, J  = 15.3, 8.1 Hz), 2.48-2.41 (1 H, m), 2.28 (3 H, s), 1.95-1.87 (1 H, m); öc 
(75 MHz, CDCl3) 171.3, 143.1, 138.2, 137.2, 135.1, 132.9, 132.0, 129.2, 127.7,
127.6, 127.5, 127.2, 127.0, 126.1, 125.7, 59.0, 52.4, 49.0, 31.6, 30.1, 21.4; HRMS 
(ESI) calcd. for Ch3Hh4NO4S (M++H) 410.1426, found 410.1422.
CO2Me
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3 .9 .3  H a lf- l ife  d e te rm in a t io n s
3 .9 .3 .1  O b ta in in g  N M R  d a ta
High tem perature NMR experim ents (T <  80 °C)
The NMR probe was heated to a set temperature and allowed to equilibrate until 
the internal temperature remained constant.46 A sealed NMR tube containing an 
enediyne sample (vide infra) was inserted, and 1H-NMR spectra were recorded 
automatically at regular intervals over a period of several hours.
High tem perature experim ents (T >  80 °C)
A sealed NMR tube containing the enediyne sample (vide infra) was immersed 
into an oil bath of constant temperature. At different points in time, the NMR tube 
was removed from the oil bath and immediately cooled to room temperature by 
rinsing with heptane and acetone. The conversion of the BC was then controlled 
by 1H-NMR.
3 .9 .3 .2  A n a l y s i s  o f  N M R  d a ta
All NMR data within one set of experiments was processed in the same way with 
respect to apodization, Fourier transformation, base line correction and scale 
calibration. Phase correction was done manually in all cases. A peak of the 
enediyne starting material that remained isolated over the entire time of the 
experiment was selected, and its integrals were measured relative to the internal 
standard. Firstly, these integral values were normalized (with t = 0 set to 100%) 
and plotted against time. An exponential curve fit was applied to the resulting 
data points. Secondly, the integrals were normalized (with t = 0 set to 1) and the 
natural logarithm of those values was set out against time. A linear function was 
fit over those data points. The resulting plots are visualized in Figures 8 and 11.
3 .9 .3 .3  S a m p le  p r e p a r a t io n  a n d  r e s u l t s  
For enediyne 18
A NMR tube (0 = 5 mm) connected to an argon/vacuum manifold was charged 
with enediyne 18 (20.3 mg, 0.052 mmol) and DMSO-d6 (450 |iL) under an argon 
atmosphere. Of a solution of 1,4-cyclohexadiene in DMSO-d6 (10% v/v) was added 
97 |iL (0.103 mmol, 2 equiv). Cyclohexane was added as internal standard as a 
solution in DMSO-d6 (10% v/v) (14 |iL, 0.013 mmol). The resulting solution was 
degassed by three freeze-pump-thaw cycles and the NMR tube was tipped off by 
flame under partial vacuum. The concentration of 18 in the thus prepared sample 
was 0.093 M. Decay of the starting material was monitored inside a heated NMR 
probe at T = 52 °C and T = 80 °C. To this end, the enediyne's methyl ester peak 
at 3.66 ppm was followed. The decay of 18 displayed first-order behavior in both 
cases.
temperature 52 °C 8 O ° O
exponential fit [min] y  = 99.631e-8 408 '10~4 X y  = 119.787e-1176 ^  X
linear fit [min] y  = -8.408 • 10-4x - 3.695 • 10-3 y  = -1.176 • 10-2 x + 0.1805
goodness of fit (R2) 0.9928 0.9960
rate constant (k) 8.408 ■ 10-4 min-1 1.176 ■ 10-2 min-1
half-life (t1/2) 13.7 h 59 min
For enediyne 19
Following the procedure described for 18, a sample was prepared from enediyne 
19 (17.8 mg, 0.050 mmol) in DMSO-d6 (500 |iL), 1,4-cyclohexadiene (9.5 |iL, 0.100 
mmol), and a solution of dimethyl oxalate in DMSO-d6 (2.5 M) (10 |iL, 0.025 mmol) 
as internal standard. The concentration of 19 in the sample was 0.096 M. A trace 
of a new product was detectable after 24 h at T = 80 °C. Efficient decay of 19 and
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formation of 34 were observed at 90 °C using the oil bath method. The decay of
19 was followed by observing its olefinic protons at 6.05 ppm; the kinetics obeyed 
first-order behavior.
temperature 90 °C
exponential fit [min] y  = 102.616e -4382 • 10^ X
linear fit [min] y  = -4.382 • 10-4x + 2.582 • 10-2
goodness of fit (R2) 0.9976
rate constant (k) 4.382 ■ 10-4 min-1
half-life (t1/2) 26.4 h
For enediyne 20
A sample was prepared as described for 18 from enediyne 20 (12.3 mg, 0.030 
mmol) in DMSO-d6 (550 |iL), 1,4-cyclohexadiene (5.7 |iL, 0.060 mmol, 2 equiv), 
and MeCN in DMSO-d6 (10% v/v) (16 |iL, 0.031 mmol) as internal standard. The 
final concentration of 20 was 0.053 M. No conversion of starting material was 
observed at T = 80 °C. A trace of a new product was visible after 24 h at T = 90 
°C. Decay of 20 and formation of 35 could be followed at 120 °C by monitoring 
the methyl ester peak at 3.50 ppm. The decay of 20 displayed first-order 
behavior.
temperature 120 °C
exponential fit [min] y  = 96.968e -6 570 • 10-5 X
linear fit [min] y  = -6.570 • 10-5 x - 3.079 • 10-2
goodness of fit (R2) 0.9959
rate constant (k) 6.570 ■ 10-5 min-1
half-life (t1/2) 176 h
For enediyne 21
As described for 19, a sample was prepared from enediyne 21 (19.3 mg, 0.052 
mmol) in DMSO-d6 (450 |iL), 1,4-cyclohexadiene in DMSO-d6 (10% v/v) (98 |iL, 
0.104 mmol, 2 equiv) and cyclohexane in DMSO-d6 (10% v/v) (14 |iL, 0.013 mmol) 
as internal standard. The resulting concentration of 21 was 0.093 M. No decay of 
the enediyne was observed at temperatures of 80 °C and 90 °C. After being 
subjected to a temperature of 120 °C for 24 h, a trace amount of a decay product 
was detected by 1H-NMR.
For enediyne 22
Following the procedure described for 18, a sample was prepared from enediyne 
22 (21.8 mg, 0.052 mmol) in DMSO-d6 (450 |iL), 1,4-cyclohexadiene in DMSO-d6 
(10% v/v) (98 |iL, 0.104 mmol, 2 equiv), and cyclohexane in DMSO-d6 (10% v/v) 
(14 |iL, 0.013 mmol) as internal standard. The concentration of 22 in the final 
solution was 0.093 M. No decay of 22 could be observed at temperatures of 80 
°C, 90 °C and 120 °C.
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For enediyne 28
A sample was prepared as described for 18 from enediyne 28 (21.2 mg, 0.050 
mmol) in DMSÜ-gí6 (450 |iL), 1,4-cyclohexadiene in DMSo-d6 (10% v/v) (97 |iL, 
0.103 mmol, 2 equiv) and mesitylene (3 |iL, 0.022 mmol) as internal standard. 
The final concentration of 28 was 0.091 M. Decay of the starting material was 
monitored inside a heated NMR probe at T = 52 °C by following the methyl ester 
peak at 3.65 ppm. The decay of 28 displayed first-order behavior.
temperature 52 °C
exponential fit [min] y  = 356.767e-1395 ^  X
linear fit [min] y  = -1.395 • 10-3 x - 4.396 • 10-2
goodness of fit (R2) 0.9901
rate constant (k) 1.395 ■ 10-3 min-1
half-life (t1/2) 8.28 h
For enediyne 30
According to the procedure described for 18, a sample was prepared from 
enediyne 30 (11.5 mg, 0.048 mmol) in DMSO-d6 (500 |iL), 1,4-cyclohexadiene (9 
|iL, 0.095 mmol, 2 equiv) and mesitylene (4.5 |iL, 0.032 mmol) as internal 
standard. The final concentration of 30 was 0.093 M. A trace of a new product 
could be observed after 24 h at 52 °C. Efficient BC of the enediyne took place at T 
= 80 °C and was could be characterized by following the enediyne's methyl ester 
peak at 3.68 ppm. The decay of 30 displayed first-order behavior.
temperature 80 °C
exponential fit [min] y  = 189.459e-8 642 10^ X
linear fit [min] y  = -8.642 • 10-4x - 8.099 • 10-3
goodness of fit (R2) 0.9959
rate constant (k) 8.642 ■ 10-4 min-1
half-life (t1/2) 13.4 h
For enediynic dipeptide 24
A sample was prepared as described for 18 from enediyne 24 (12.0 mg, 0.026 
mmol) in DMSO-d6 (500 |iL), 1,4-cyclohexadiene (5.0 |iL, 0.053 mmol, 2 equiv) and 
mesitylene (2 |iL, 0.014 mmol) as internal standard. The final concentration of 24 
was 0.051 M. Decay of the starting material was monitored inside a heated NMR 
probe at T = 52 °C by following the combined methyl ester peaks of both 
diastereoisomers at 3.64 and 3.63 ppm. The decay of 24 displayed first-order 
behavior.
temperature 52 °C
exponential fit [min] y  = 91.548e-3130 ^  X
linear fit [min] y  = -3.130 • 10-3x - 8.830 • 10-2
goodness of fit (R2) 0.9846
rate constant (k) 3.130 ■ 10-3 min-1
half-life (t1/2) 3.69 h
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For enediynic dipeptide 31
A sample was prepared as described for 18 from enediyne 31 (20.0 mg, 0.050 
mmol) in DMSO-d6 (500 |iL), 1,4-cyclohexadiene (10 |iL, 0.106 mmol, 2 equiv) and 
mesitylene (4 |iL, 0.029 mmol) as internal standard. The final concentration of 31 
in the sample was 0.097 M. No sign of an aromatization product was detected 
after 24 h at T = 52 °C. Subjecting the sample to temperatures of 80 °C caused 
the enediyne to undergo Bergman Cyclization. Kinetics were established by 
following the enediyne's methyl ester peak at 3.68 ppm. The decay of 31 
displayed first-order behavior.
temperature 80 °C
exponential fit [min] y  = 99.624e-4457 ^  X
linear fit [min] y  = -4.457 • 10-4x - 3.772 • 10-3
goodness of fit (R2) 0.9975
rate constant (k) 4.457 ■ 10-4 min-1
half-life (t1/2) 25.9 h
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Abstract
In  this Chapter, the synthesis of the acety len ic am ino acid  a-Me-a- 
p ropargylg lycine is described w h ich  in tu rn  served  as a build ing b lock for 
a-m ethylated cyc lic  enediyne-containing amino acids. The reactiv ity  of 
the la tte r compounds tow ards Bergm an  Cyclization  under e levated  
tem peratures has been investigated  and kinetic studies have been 
conducted. F ina lly , the su itab ility  of these enediyn ic am ino acids for 
peptide bond-forming reactions has been assessed.
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4.1 Introduction
4.1 .1  a ,a - D ia lk y la t e d  a - a m in o  a c id s
a,a-D ialkylated  a-amino acids, and especia lly  a-Me-a-amino acids 
(AM A A s) have garnered  an increasing  in terest in the fie ld  of 
agrochem icals, drug developm ent and peptide science. N o t only have 
A M A A s found application  in a va r ie ty  of chem ical products, N atu re  
herse lf is also r ich  in  structures contain ing these, unaptly called, non­
natu ra l am ino acids.
A M A A s can act as enzyme inhib itors and a-H amino acid  
antagonists e ither in  the free form  or as constituents of m ore complex 
structures. Fo r instance, the A M P A  antagonist Kaitocephalin  (1, F igu re  
1) could be isolated from  the fungus E u p e n ic illiu m  s h e a r ii.3 Fu rth e r 
exam ples of AM AA-rich structures are peptaibol and peptaib iotic 
antib iotics such as T richodecen in  I (2 ) w h ich  have been extracted  from  
certa in  fungi species.4
h2n^ co2h
Cl
HO
Me
OH
N CO2H H
Cl
HO S"'| T ^  Y O
O^ NH 1 o HN^ O
\ - X  N N N N Y " ' "  H
J  N O np^  O N
Me MeV
h2n co2h
3
Aib
O'
Kaitocephalin Trichodecenin I
Figure 1 Examples of Ca-tetrasubstituted amino acids.
V
h2n co2h
4
TOAC
1 2
O w ing to the restric ted  rotational freedom, incorporation  of a,a- 
d isubstituted a-amino acids in  peptides can induce p articu la r 
conform ations and secondary structures norm ally  not encountered  in a-H 
peptides.5 Am inoisobutyric acid  (a-Me alanine, Aib, 3) residues for 
example, cause the p referen tia l form ation of 310 he lices.6 The ham pered 
rotation of the side chains of C a-tetrasubstituted amino acids has been 
put to use in the developm ent of the spin label TO AC  (4). Due to the 
ra th e r lim ited flex ib ility of this residue, the m ovem ent of the 
corresponding stable free rad ica l probe accu ra te ly  reflects that of its a- 
carbon. O ftentim es, a,a-disubstituted am ino acids also im part an
8 9enhanced resistance to proteins against chem ical and proteo lytic
degradation. M oreover, the lipoph ilic ity  of peptides is genera lly  increased
10upon incorporation  of AM AAs.
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Syntheses of a,a-dialkylated am ino acids can be ach ieved  in 
various w ays. Genera lly , they are accessib le e ither by mono- or 
d ia lky lation  of an appropriate  C a-core, by am ination reactions, by 
introduction of a carboxyl function and also by o ther methods. M anners 
to conduct these reactions in  enantioselective w ays have been described 
and review ed  extensive ly.11 Enzym atic reso lution of C a-tetrasubstituted
racem ic substrates is another m ethod of p reparing  enantiopure a,a-
12d ialky lated  amino acids and has also been applied on large scale.
_ _ amidasefrom ,—. i—i
(R JRR1 M. neoaurum L^ K r )
•N"2 0. ^  H2N ° H * hJ ^ Y NH2
O ------- ► O O
H 2 ^ ?
(±)-aminoacidamide acid amide
enantiomer 1 enantiomer 2
Scheme 1 Enzymatic resolution of a,a-disubstituted amino acid amides by amidases.
A  k inetic enzym atic reso lution of racem ic a,a-disubstituted amino 
acid  am ides by am idases from  M yco b a c te riu m  neoau rum  and 
O ch ro b actru m  an th ro p i (Schem e 1) as developed by D S M  (Geleen, The 
N etherlands) has proven its ve rsa tility  w ith  respect to substrate
13acceptance and ease of scale-up. M oreover, this procedure has been 
em ployed in the reso lution of C a-tetrasubstituted am ides bearing
13 14unsaturated  side chains.
4 .1 .2  M o t iv a t io n
During our research  on cyclic  enediyne-containing amino acids15 (see: 
C hap ter 2), w e w itnessed  p artia l or com plete racem ization during the 
u ltim ate step, i.e . ring closure of the sulfonam ide-protected precursors to 
the cyclic  enediyne (Schem e 2). Racem ization  w as induced even by ve ry  
w eak  bases and also occurred  under the m ild conditions of the M itsunobu 
cyclization.
reduced ee
HN CO2Me 
Ts
Scheme 2 Partial racemization in the last step towards cyclic enediyne-containing amino 
acids.
W e  envisaged that substitution of the a-H for an a-Me group would 
prevent th is undesired scram bling of the stereocenter. Fu rtherm ore , the 
introduction of an additional Ca-substituent could exert a d istortion of the
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enediyne ring, w h ich  m ight be beneficia l for the cycloarom atization  of 
these compounds. Re la ted  to this, the steric dem and of gem-dialkyl amino 
acids is known to enforce tu rn  structures especia lly  in  short peptides .16
In  order to obtain a-methyl-a-propargylglycine 6  (a-propargyl- 
a lan ine), the build ing b lock requ ired  for the assem bly of a-m ethylated 
enediyne amino acids 5, two possible starting compounds w ere  identified  
(Schem e 3). One would  be m ethyl ester 7, suitable for enzym atic 
reso lution by proteases, the other the p rim ary  am ide 8  for reso lution by 
am idases. The am ide, in turn, should be accessib le from  ester 7, w h ich  
m ight be derived  from  alanine.
8
Scheme 3 Retrosynthesis of a-Me enediyne-containing amino acids.
4.2 Towards enantiopure a-propargylalanine
4.2 .1  P r e p a r a t io n  s ta r t in g  f ro m  a la n in e  m e th y l  e s te r
It  w as in itia lly  decided to prepare build ing b lock 7 v ia  a lkylation  of the
17 18O 'Donnell S ch iff base of alan ine m ethyl ester (10, Schem e 4).
HCl ■ H-Ala-OMe ^ ^ B r
Ph + Ph Me KO‘Bu, THF
^ NH CH Cl *  Ph ^ N ^ C O 2Me  * -----*  noconversion
Ph 0° C ^ rt ^  40° C9 rt, o/n 10 (96%)
Scheme 4 Preparation of the diphenylketimine of alanine methyl ester and attempted 
alkylation.
To our dismay, treatm ent of 10 w ith  propargyl brom ide and K O 'Bu  
at 0 °C  did not accom plish propargylation. G radual tem perature  increase 
to room  tem perature  and fina lly  40 °C  appeared  fru itless as well. 
Consum ption of starting m ateria l w as only observed on going to reflux 
tem perature  (66 °C )  for prolonged reaction  tim es (o/n). The m ain product
19of th is reaction, however, w as the propargyl ester 11 (Schem e 5). Its 
form ation most like ly invo lved  O-alkylation of the ester enolate, fo llowed 
by bromide-mediated rem oval of the m ethyl group. Rep lacem ent of
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potassium  for a counterion that binds m ore strongly to oxygen should 
favor C- over O-alkylation. Indeed, the intended a-propargylated product 
12 w as obtained in a y ie ld  of 7 7 %  w hen  sodium hydride w as em ployed as 
a base.
Ph N
Ph Me
J *Ph N
O
^  \ NaH, THF (--ï KO‘Bu,THF
"  CO2Me 40 °C, 60 h ^ reflux, o/n
12 (77%) j
Ph Me Me'
P h ^ * N ^ f O a
Scheme 5 a-Propargylation and transesterification of Schiff base-protected alanine 
methyl ester (1 0 ).
11 (78%) 
Br©
H ydro lysis of the thus obtained im ine by m eans of conc. H C l in 
acetone produced a-propargylalan ine m ethyl ester as its H C l salt (7-HCl, 
Schem e 6). In  o rder to a rrive  at the corresponding amide, 7-HCl w as 
treated  w ith  conc. aqueous amm onia. Depending on the structure of the 
am ino acid  ester, transform ation  to the p rim ary am ide in aqueous 
am m onia produces a considerable fraction  of the free acid  as a 
byproduct. In  our case, the desired  am ide 8 and free acid  6 w ere  
obtained in a —1:1 ratio  as judged  by H -NM R. Separation  of these two 
products w as ach ieved  by treating  an aqueous solution of the m ixture 
w ith  benzaldehyde (1.1 equ iv re la tive  to the am ide) at pH  9. U n d er these 
conditions, se lective form ation of the Sch iff base of the am ide a llow ed 
extraction of the la tte r w ith  organic solvents. A  fina l hydrolysis using 
hydrochloric acid  gave rise to the am ide H C l salt 8-HCl in a y ie ld  of 4 2 %  
from  7-HCl (8 4 %  based on 5 0 %  conversion). The overa ll y ie ld  of this 
route starting  from  alan ine equ iva lent 10 to d ia lky lated  am ide 8-HCl w as 
29% .
12
H N'  \ Me H2N CO2Me HCl 2
7 HCI (91%)
H2N
8:R
6:R
~1:1
H N'  ^ Me H2N CONH2 HCl 2
8HCI 
(42% from 7 HCI 
29% from 10 )
Scheme 6 Preparation of amide 8 . Reagents and conditions: (a) Conc. HCl, acetone, 0 °C, 
2 h; (b) conc. Nh4OH, 24 h, rt; (c) (i) PhCHO, H2O, pH 9, 2 h, then phase separation; (ii) 
conc. HCl, acetone, 0 °C, 0.5 h.
In  an effort to im prove the ra th e r poor m ethyl ester to am ide 
conversion, the diphenylketim ine-protected m ethyl ester 12 w as treated
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w ith  water-free m ethanolic ammonia. A t room  tem perature, no 
conversion w as noticed. Reactions in  a sealed tube at tem peratures of 
80 °C  w ere  requ ired  for the starting m ateria l to be consumed. H ow ever, 
the effic iency of th is reaction  w as low  (1 6 %  isolated y ie ld ) and severa l 
side products w ere  observed.
4 .2 .2  D i r e c t  a lk y la t io n  o f  a la n in a m id e
A  stra igh tfo rw ard  route for the p reparation  of a,a-dialkylated  am ino acid
20am ides has been disclosed by O 'Donnell e t a l. They reported  the 
synthesis of these compounds v ia  d irect a lkylation  of Sch iff base- 
protected amides.
hci
13 14 (33%) 8 HCI (82%)
(27% from 13)
Scheme 7 Direct alkylation of Schiff base-protected alaninamide.
Accord ing  to the genera l procedure, the d iphenylketim ine of 
alan inam ide 13 w as p repared  and subjected to a lkylation  conditions 
using propargyl brom ide and KO lBu  in T H F  at 0 °C  (Schem e 7). The 
reaction  proceeded ra the r sluggish ly and it took 16 h for the starting 
m ateria l to d isappear, a fte r w h ich  tim e the desired  product 14 could be 
isolated in 3 3 %  yield. In  accordance w ith  the report of O 'Donnell, the rest 
of the mass balance consisted m ain ly of byproducts due to N-alkylation 
and N N -d ia lk y la tio n  as ind icated  by L C M S  and N M R  m easurem ents of 
the crude product. Sch iff base 14 w as hydrolyzed by concentrated  H C l in 
acetone to a rrive  at the hydrochloride of a-propargylalaninam ide (8-HCl). 
O verall, th is route accom plished the synthesis of am ide 8-HCl in  a y ie ld  of 
2 7 %  starting from  the benzophenone im ine of alaninam ide.
Hence, the y ie lds of both routes are  com parable (2 9 %  vs. 27% ), 
and w h ile  the approach v ia  the m ethyl ester suffers from  a low  yie ld ing  
conversion  to the amide, the d irect route is ham pered by an ineffic ient 
a lkylation  step.
4 .2 .3  E n z y m a t ic  r e s o lu t io n
P re lim inary  studies on the enzym atic reso lution of 8-HCl w ere  conducted: 
An  aqueous solution of this am ide contain ing 1 m M  Z n SO 4 at pH  8 was
13treated  w ith  am idase from  M . neoau rum  ATC C  25795 and shaken at 37 
°C  for 18 h. The am ide substrate w as digested, however, ne ither the 
isolated am ide nor the acid  showed sign ificant optical activ ity  in  the 
polarim eter. Fu rth e r investigation  into the enzym atic reso lution of am ide
Ph Me KOtBu, THF
acetone, rt, 2 h
conc. HCI
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8 w ith  other am idases or reso lution of m ethyl ester 7 w ith  esterases 
m ight still offer opportunities but w as not ye t explored.
4.3 Cyclic enediyne-containing a-methyl amino acids
4.3 .1  S y n th e s is
Cyclic  enediyne-containing amino acids based on a-propargylalan ine w ere  
assem bled in an analogous fashion to the a-H counterparts15 (see: 
Chapter 2.3.2), i.e. M itsunobu-type ring closure of a sulfonamide- 
p rotected  acyclic  p recursor that in  tu rn  w as m ade ava ilab le  by 
Sonogash ira  couplings.
Thus, the N-term inus of a-propargylalan ine m ethyl ester 7 w as 
protected by converting it into e ither the tosyl- (15 ) or the nosyl-
derivative  (16 ) accord ing to lite ratu re  procedures for a-Me d ialkylated
21
amino acids (Schem e 8).
Scheme 8 Assembly of cyclic enediynes starting from a-methyl-a-propargylalanine. 
Reagents and conditions: (a) TsCl or NsCl, TMEDA, MeCN, rt, o/n; (b) Aryl iodide 17, 
PdCl2(PPh3)2 (cat), CuI (cat), Et2NH, Et2O, rt, o/n; (c) PPh3, DIAD, THF, rt, 15 min.
Sonogashira-type couplings of the protected amino acids to 3-(2- 
iodophenyl)prop-2-yn-1-ol (17 ) gave rise to the acyclic  enediyne alcohols 
18 and 19 in h igh yie lds (8 4 %  for R  = Ts, 7 2 %  for R  = Ns). The 
som ewhat low er y ie ld  of the Ns-compound w as due to the form ation of 
severa l byproducts (as judged  by T LC ) caused by the reduced stab ility  of 
the Ns-group under the basic Sonogash ira conditions. Rapid  
in tram o lecu lar cyclization  of the alcohols 18 and 19 under d ilute 
M itsunobu conditions afforded the 10-membered cyclic  enediynes 20  and 
21 in  6 3 %  and 3 7 %  yield, respectively . Again, side product form ation22 
w as the cause for the reduced y ie ld  of the Ns-derivative.
4 .3 .2  S t r u c tu r a l  d e s c r ip t io n
C rysta ls  suitable for X-ray analysis could be grow n from  enediynes 20 
and 21 by top-layering chloroform  solutions w ith  methanol. F igu re  2 
shows the ir crysta l structure representations.
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20 21
23Figure 2 PLUTON drawings of the crystal structures of enediynes 20 and 21.
The sulfonam ide n itrogen atoms of both 20 and 21 are v irtu a lly  
sp  -hybridized as is the case w ith  all cyclic  enediyne-containing amino 
acids for w h ich  X-ray structures have been elucidated  (see also: Chapters 
2 and 3). In teresting ly, both compounds have the arom atic part of the 
sulfonam ide protecting group folded back in an endo  fashion over the 
enediyne moiety. The alignm ent of the enediyne ring re lative  to the 
sulfonam ide aryl, however, d iverges more from p ara lle lity  than in the 
case of the tosyl-protected a-H counterpart. The a-Me and the sulfonyl 
groups in 20 and 21 are axially arranged  w ith  respect to the plane of the 
enediyne m otif but they protrude in opposite directions.
Table 1 Bond angles around the enediyne moiety and c-d distances of 20 and 21.
ßi
N
ß2
entry com­
pound
c-d a
(A)
ene
dihedral
angle
(°)
ß1 (°) ß2 (°)
Cx-Csp-Csp angles (°) 
a1 a2 a3 a4
1 20 3.20 0.13 116.1 117.2 174.2 165.4 165.9 177.6
2 2 1 3.29 0.40 116.3 117.2 171.2 166.6 168.0 175.6
(a) Transannular distance between the terminal acetylene carbons of the enediyne.
O ther geom etric param eters of the enediyne unit of 20 and 21 
showed that the ene  part in both compounds is nearly  p lanar w ith  
d ihedral angles of 0.13° and 0.40 °, respective ly  (Table 1). Concerning
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other s tructu ra l data, 20 and 21 resem ble each other and the ir a-H 
counterparts: W ith  va lues betw een  116.1° and 117.2°, the v iny lic  angles 
are  som ewhat sm aller than 120°. There  is considerable stra in  in the 
bonds around the acetylenes as judged  by the d istinct deviation  from  
lin ea rity  (165 .4 °-177.6 °). The c-d d istances of 3.20 A  for the Ts 
compound and 3.29 A  for the Ns compound are sm aller than those of the 
corresponding a-H compounds (a-HTs: 3.23 A, a-HNs: 3.34 A), quite 
possib ly ow ing to the gem-dialkyl effect exerted by the Ca- 
tetrasubstitution.
4.4 Towards peptide couplings of a-Me enediynic 
amino acids
4.4 .1  A t te m p te d  ^ - te r m in a l  a m id e  b o n d  fo rm a t io n
Nosyl-deprotection of enediyne 21 w as ach ieved  e ither by treatm ent w ith  
2-mercaptoethanol and D B U  in D M F  or by subjection to th iophenol and 
K 2CO 3 in M e C N  (Schem e 9), w ith  the la tte r conditions provid ing h igher 
y ie lds of the free am ine 22 at shorter reaction  tim es (2 1 %  overn ight vs. 
7 3 %  a fter 2 h).
21 22 (21% via a)
(73% via b)
Scheme 9 Nosyl-deprotection of 21. Reagents and conditions: (a) 2-Mercaptoethanol, 
DBU, DMF, rt, o/n; (b) PhSH, K2CO3, MeCN, 0 °C ^ rt, 2 h.
Peptide bond form ation at the N-term inus of a-H enediynes w as 
found to be ra the r challenging (see: C hap ter 3.4.2). The additional a-Me 
substituent o f the enediynes presented in th is chap ter w as therefore 
expected to im pede peptide bond form ation even further. The reagent
24H A T U  had successfu lly m ediated N-term inal peptide couplings of a-H 
enediynes, and consequently it w as used in an attem pt to couple a-Me 
enediyne 22 to Fmoc-Ala-OH (Table 2, en try  1). To our dismay, the 
reaction  did not proceed, even  a fter the addition o f severa l equ ivalents of 
coupling reagent and reaction  tim es o f severa l days. In  fu rther attem pts, 
the coupling agents BO P-C l25 and P PA A 26 (n-propylphosphonic acid  
anhydride, T3P), both recognized as pow erfu l coupling agents for 
dem anding substrates, fa iled  to establish  a peptide bond betw een 22 and 
Boc-protected alan ine (entries 2 and 3).
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Table 2 Attempted peptide bond formation at the N-terminus of enediyne 22.
V nh
y s i ' Cü 2
Me
22
conditions ^
O PG
J 'L ^ N H  
N 1
J. Me 
CÜ2Me
[ IIMe Mep
23
entry coupling partner conditions result
1 Fmoc-Ala-OH HATU, HOAt, DCM, rt, 7 d no conversion
2 Boc-Ala-OH BOPCl, E t3N, DCM, rt, 7 d no conversion
3 Boc-Ala-OH PPAA, NM M , DCM, rt, 2 d no conversion
4 Fmoc-Ala-F BSA, py, DCM, rt, o/n no conversion
5 Fmoc-Ala-Cl lutidine, DCM, rt, 5 d no conversion
6 Fmoc-Ala-Cl Zn*, DCM, rt, 5 d no conversion
C learly, the steric encum brance of 22 ca lled  for more pow erfu l 
acy lating  methods such as the utilization of am ino acid  halides. The use of 
Fm oc-protected am ino acid  fluorides has been described as a m eans of
27incorporating  ste rica lly  dem anding residues, especia lly  in  com bination
28w ith  the sily lating agent B S A  (N ,0-b is(trim ethylsily l)acetam ide). 
Carp ino and Beyerm ann  reported  the application  of am ino acid  chlorides 
as extrem ely effective coupling partners, even capable of forging
29dipeptides from  N-m ethylam inoisobutyric acid. F ina lly , the com bination 
of am ino acid  ch lorides and activated  zinc dust has been shown to 
effic ien tly  m ediate couplings of N-alkylated am ino acids under non-
30Schotten-Baum ann conditions. Unfortunate ly, in  our hands the desired 
couplings w ere  not accom plished under e ither of these acylating  
conditions (entries 4-6).
It  is w orth  noting that test reactions carried  out w ith  a- 
p ropargyla lan ine 7 instead of the enediyne amino acid  22 did produce 
d ipeptides under the conditions listed in  entries 2-4, i.e . coupling to Boc- 
L-Ala-OH by the action of BO P-C l or P P A A  or coupling to Fmoc-L-Ala-F in 
the presence of B S A  (Schem e 10). O f these three coupling conditions, the 
BOP-Cl m ediated reaction  accom plished the highest y ie ld  of d ipeptide 24 
(75% ). Em ploym ent of P P A A  in the same reaction  gave a ve ry  low  y ie ld  
(2 % ) possib ly due to the sm all scale on w h ich  the reaction  w as carried  
out. The acylation  v ia  the acid  fluoride of Fm oc-protected alan ine 
afforded the d ipeptide 25, a lbeit in a disappointing y ie ld  of 12%.
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Boc-Ala^ a or b
CO2Me
24 (75% via a) 
(2% via b)
Fmoc-Ala^
H CO2Me 
25 (12%)
Scheme 10 Peptide couplings to a-propargylalanine methyl ester. Reagents and 
conditions: (a) Boc-L-Ala-OH, BOP-Cl, Et3N, Ch2C12, rt, o/n (75%); (b) Boc-L-Ala-OH, PPAA, 
NMM, CH2Cl2, rt, o/n; (c) BSA, py, CH2Cl2, rt, o/n, then Fmoc-Ala-F, rt, o/n.
4 .4 .2  A t te m p te d  C - te rm in a l c o u p lin g s
Theoretically , the functionalization of the C-terminus of the cyclic  a-Me
31enediynes should be easier than couplings to the N -terminus. The 
requ ired  free acid  26 w as obtained by saponification of the Ts-protected 
m ethyl ester 20 upon overn ight treatm ent w ith  L iO H  in a TH F/w ate r 
m ixture at 5 °C  (Schem e 11). In  an in itia l coupling attem pt, 26 was 
subjected to BOP-Cl-m ediated condensation conditions (BOP-Cl, D iP EA ) 
as these had resu lted  in the highest y ie lds for the couplings of a- 
p ropargyla lan ine (v id e  su p ra ). G lyc ine m ethyl ester w as chosen as 
coupling partner to m inim ize steric repulsion. H ow ever, no consum ption 
of starting m ateria l w as observed, and m ultip le additions of BOP-Cl and 
base did not have any effect in  that respect. In  a fina l effort, enediyne- 
carboxylic acid  26 w as in s itu  converted  into the acid  ch loride by the 
action  of th ionyl ch loride in CH2Cl2. M uch  to our dismay, subsequent 
addition of g lycine m ethyl ester hydrochloride and a large excess of 
D iP E A  failed  to C-functionalize the enediyne.
J b or c— X —
Scheme 11 Attempts to functionalize the C-terminus of 26. Reagents and conditions: (a) 
LiOH, THF/H2O (3/1), 5 °C, o/n; (b) HCl-H-Gly-OMe, BOP-Cl, DiPEA, CH2Cl2, 0 °C ^ rt, 4 
d; (c) (i) SOCl2, CH2Cl2, 0 °C ^ rt, 2 h; (ii) HCl-H-Gly-OMe, DiPEA, CH2Cl2, rt, 4 d.
a
C learly, the steric encum brance of the C a-tetrasubstituted cyclic  
enediyne amino acids by v irtue  of the ir a,a,N-substituents is of such 
ca lib er that they probably requ ire  extrem ely forcing conditions in  order 
to be coupled to other am ino acid  residues. This is true for the carboxylic 
function and even  m ore so for the N-term inus. A lthough the possib ilities 
to realize such couplings have not been exhaustive ly pursued in this
95
Chapter 4
work, it is quite obvious that in tegration  of this kind of enediynes into 
peptides is far from  triv ia l.
4.5 Kinetics and half-life determinations
4.5 .1  D e c a y  e x p e r im e n ts
time (min) time (min)
time (min) time (min)
time (min) time (min)
Figure 3 Plots of the fraction of enediyne vs. time (left column) and plots of the natural 
logarithm of the normalized amount of enediyne vs. time (right column). Exponential and 
linear trend lines are shown together with their equations. All decay experiments were 
conducted at T = 52 °C. [A] Decay of enediyne 20; [B] decay of 21; [C] decay of enediyne 
22.
The propensity of cyclic  enediynes 20-22 to undergo B C  at 
e levated  tem peratures w as assessed in the same w ay  as described for a ­
H  enediynes in  C hap ter 3.3. Thus, solutions of the enediynes in DMSO-dß 
w ere  p repared  contain ing 2 equ ivalents of 1,4-cyclohexadiene as 
hydrogen donor and m esitylene as in terna l standard. These sam ples w ere  
sealed in N M R  glass tubes under an inert atm osphere and subjected to
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tem peratures of 52 °C  (325 K ) inside an N M R  probe. The consum ption of 
starting m ateria l w as followed in regu lar in terva ls  by H -N M R  
m easurem ents. F igu re  3 shows the plots of the am ount of enediyne vs. 
tim e (left colum n) as w e ll as the natu ra l logarithm  of the am ount of 
enediyne vs. tim e (right column).
A ll enediynes decayed e ffic ien tly  at 52 °C . T he ir consum ption 
d isplayed first-order k inetics as ind icated  by the lin ea r relationship  
betw een the reaction  tim e and the natu ra l logarithm  of the concentration  
of starting m ateria l (F ig u re  3, righ t colum n). The results of the kinetic 
experim ents are sum m arized in Tab le  3.
Table 3 Half-lives and kinetic data of BC at 52 °C for enediynes 20-22.
Me
CÜ2Me
R
T= 52 °C  
CHD (2 equiv) 
DMSO-dg 
mesitylene (int. standard)
Me
CO 2Me
c = 0.1 M sealed NMR tube
entry compound R  half-life (h) k (min-1)
1 20 Ts 8.43 1.371-10"3
2 21 Ns 4.05 2.856-10"3
3 22 H 5.21 2.217-10"3
The Ts-protected enediyne 20 showed a half-life of 8.43 h at 52 °C  
w ith  an associated rate  constant of k = 1.371-10-3 m in-1 (2.285-10-5 s-1, 
en try  1). The Ns-protected equ iva lent 21 (en try  2) d isp layed a rate  more 
than tw ice  as h igh (k  = 2.856-10-3 m in-1 = 4.760-10-5 s-1) and accord ing ly 
had a shorter half-life of 4.05 h. The free am ine 22 (en try  3) w as found to 
have an in term ediate reactiv ity : w ith  a half-life of 5.21 h (k  = 2.217-10-3 
m in-1 = 3.695-10-5 s-1) it underw ent B C  faster than the Ts-compound, but 
s low er than its Ns-derivative.
4 .5 .2  C o m p a r is o n  o f  a - M e  a n d  a-H e n e d iy n e s
In teresting ly , a ll a-Me enediynes cycloarom atized considerab ly more 
qu ick ly than the a-H counterparts (Table 4): The a-Me sulfonam ides w ere  
consum ed roughly tw ice  as fast. Conceivab ly, the additional m ethyl 
substituent com presses the N-Ca-Cß angle (Thorpe-Ingold effect) and 
rig id ifies the enediyne ring even  fu rther at regions that are flexible to 
some degree in  the a-H enediynes. As a consequence, the ring stra in  
should be increased  favoring the progression of the BC . Furtherm ore, a 
forced a lignm ent of the acetylenes could result, thereby preorganizing 
the enediynes in  a favorable conform ation for the cycloarom atization.
M ost in trigu ing  is the re la tive ly  short half-life of the a-m ethylated 
free am ine 22. W h ile  the a-H counterpart reacted  m uch s low er than  the
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sulfonam ide derivatives (Ts- or Ns-protected) and in fact did not oyolize 
effic ien tly  a t 52 °C , the a-Me free am ine showed a reactiv ity  even h igher 
than that of the Ts-protected derivative  20. The underly ing  reason for this 
contrasting behavior rem ains unclear.
Table 4 Comparison of half-lives of a-H vs. a-Me enediynic amino acids at T = 52 °C.
0
-R1
-CO2
R2
Me
entry 1 2 3 4 5 6
R 1 Ts Ns H
R2 H Me H Me H Me
compound Ch3-18 a 20 Ch3-28 b 21 Ch3-30 b 22
t1/2 c (h) 13.7 8.43 8.28 4.05 d 5.21
c-d (Â) 3.23 3.20 3.34 3.29 n/a e n/a e
(a) See: Chapter 3.3; (b) see: Chapter 3.5; (c) half-life at 52 °C; (d) no efficient decay 
under the conditions applied; (e) X-ray structural data not available.
4.6 Conclusion
In  th is chapter, w e described the synthesis of a-propargylalanine 
derivatives, both as the m ethyl ester and as the p rim ary amide. The la tte r 
could be p repared  e ither by d irect a lkylation  starting from  alan inam ide as 
build ing b lock or by conversion of the m ethyl ester into the amide.
Cyclic enediyne-containing a-Me am ino acids could be successfu lly 
assem bled from  a-propargylalanine fo llow ing the genera l procedure 
presented  in C hap ter 2. The propensity of the enediynes to undergo B C  at 
e levated  tem peratures (52 °C )  w as investigated. The Ns-protected va rian t 
21 had the shortest half-life (4.05 h), fo llowed by the free am ine 22 (5.21 
h) and fina lly  the Ts-protected compound 20 (8.43 h). In  contrast to the 
corresponding a-H enediynes, the free am ine showed a reactiv ity  
com parable to that of the sulfonam ide-protected derivatives. In trigu ing ly, 
a ll a-Me enediyn ic am ino acids cycloarom atized s ign ifican tly  faster than 
the ir a-H counterparts. Fo r those compounds of w h ich  crysta l structures 
for both varian ts  w ere  ava ilab le  (i.e . a-H and a-Me), the C a-tetra- 
substituted enediynes d isp layed a shorter c-d d istance, conceivab ly 
ow ing to the gem-dialkyl effect (Thorpe-Ingold effect).
Peptide couplings to the enediyne-containing amino acids 
presented  in this chap ter could not be realized  in  spite of evaluating  a 
va r ie ty  of coupling conditions. Apparently, the steric bu lk  exerted by the 
a,a,N-substitution strongly inhib its couplings to the N-term inus as w e ll as
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to the C-terminus. It  is questionable w hether these types of enediynes can 
be incorporated  into peptides by p ractica l m anners.
4.7 Outlook
Currently, the investigation  of the enzym atic reso lution of am ide 8  
through the agency of M . neoau rum  o r O. an th ro p i is still ongoing in 
co llaboration  w ith  D SM . M oreover, the resolution of m ethyl ester 7 by 
CLEA-A lcalase® is being looked at.
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4.9 Experimental section
4.9 .1  G e n e r a l  in fo rm a t io n
Fo r genera l inform ation about methods, m ateria ls and instrum entation, 
see experim ental section of Chapter 2.
4 .9 .2  P r e p a r a t iv e  p ro c e d u re s
2-(Benzhydrylideneamino)propionic acid prop-2-ynyl ester (11)
Ph Me ^  Diphenylketimine protected alanine methyl ester 10 (2.04 g, 
Ph n 7. 48 mmol) was dissolved in dry THF (20 mL) in a three-neck 
O round-bottom flask. The stirred solution was cooled to 0 °C
and KO’Bu (1.00 g, 8.98 mmol) was added in small portions 
over the course of 30 min. The resulting red solution was treated with LiI (10 mg, 
0.08 mmol) followed by the dropwise addition of propargyl bromide (80% wt. in 
toluene; 1.00 mL, 8.98 mmol). The temperature was gradually increased until a 
gentle reflux had been established and the reaction mixture was kept at that 
temperature overnight. Upon quenching with saturated aqueous NH4Cl (50 mL), 
the phases were separated and the water layer was extracted with Et2O (3x 20 
mL). The combined organic phases were washed with water (2x 10 mL) and brine 
(10 mL), followed by drying over Na2SO4 and concentration in vacuo. The crude 
product was obtained as a yellowish oil (1.69 g, 5.80 mmol, 78%) of sufficient 
purity for characterization.
Rf 0.59 (EtOAc/heptane, 1:3); <5H (200 MHz, CDCl3) 7.83-7.18 (10 H, m), 4.76 (1 H, 
dd, J  = 15.5, 2.5 Hz), 4.66 (1 H, dd, J  = 15.5, 2.5 Hz), 4.21 (1 H, q, J  = 6.7 Hz), 2.46 
(1 H, t, J  = 2.5 Hz), 1.45 (3 H, d, J  = 6.7 Hz); <5C (75 MHz, CDCl3) 172.06, 170.12, 
139.39, 136.14, 132.38, 130.37, 130.03, 128.79, 128.68, 128.62, 128.25, 128.04, 
127.65, 74.87, 60.43, 52.31, 19.10; LC-MS calcd. for C19H18NO2 (M++H) 292.1, 
found 292.1.
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2-(Benzhydrylideneamino)-2-methylpent-4-ynoic acid methyl ester (12)
^  A three-neck round-bottom flask, equipped with a cooler, was 
ph f  charged with dry THF (100 mL), diphenylketimine protected 
ph^ kJ^-M e alanine methyl ester 1018 (6.23 g, 23.3 mmol), and propargyl 
C02Me bromide (80% wt. in toluene; 3.12 mL, 28.0 mmol). The stirred 
solution was cooled to 0 °C and NaH (60% in mineral oil; 1.12 g, 28.0 mmol) was 
added in small portions over the course of 20 min. The temperature of the 
reaction mixture was gradually increased to 40 °C, and stirring was continued for 
60 h. Thereafter, the contents of the flask were allowed to come to room 
temperature, and the reaction mixture was quenched by careful addition of 
saturated aqueous NH4Cl (100 mL) followed by separation of the phases. The 
aqueous layer was extracted with Et2O (3x 50 mL), and the combined organic 
phases were washed subsequently with water (70 mL) and brine. After drying over 
Na2SO4 and removal of all volatiles, the crude product was subjected to flash 
chromatography (EtOAc/heptane, 1:9) to provide the title compound 12 as a 
yellowish oil that crystallized on standing (5.47 g, 17.9 mmol, 77%).
Rf 0.26 (EtOAc/heptane, 1:9); vmax (ATR) 2116, 1623, 1446, 1269, 1200, 1122, 
767;
öh (300 MHz, CDG3) 7.84-7.11 (10 H, m), 3.31 (3 H, s), 2.93-2.80 (2 H, m), 2.01 (1
H, t, J  = 2.7 Hz), 1.58 (3 H, s); öc (75 MHz, CDCh); 173.2, 167.2, 140.4, 136.4,
132.2, 130.0, 129.8, 128.5, 128.3, 128.2, 128.1, 127.7, 127.6, 79.9, 70.8, 66.0,
51.4, 32.8, 24.0; HRMS (EI) calcd. for C20H20NO2 (M++H) 306.1494, found 
306.1503.
2-Amino-2-methylpent-4-ynoic acid methyl ester hydrochloride (7-HCl)
To a stirred solution of diphenylketimine 12 (5.31 g, 17.4 mmol) in 
acetone (100 mL) at 0 °C was added conc. HCl (1.6 mL, 19.2 mmol). 
, x .... After 2 h, the reaction mixture was concentrated in vacuo  and any 
HC| C02Me excess HCl was removed by repeated co-evaporation with *BuOH. The 
title compound was obtained as an off-white solid (2.81 g, 15.8 mmol,
91%).
Rf 0.0 (EtOAc/heptane, 1:1); vmax (ATR); 3274, 2841, 2565, 2002, 1739, 1510, 
1346, 1134; öh (200 MHz, MeOH-d4) 3.87 (3 H, s), 2.96 (1 H, dd, J  = 17.4, 2.7 Hz),
2.82 (1 H, dd, J  = 17.3, 2.7 Hz), 2.73 (1 H, t, J  = 2.7 Hz), 1.64 (3 H, s); öc (75 MHz, 
MeOH-d4) 171.5, 76.6, 75.8, 60.2, 54.3, 28.1, 22.1; HRMS (CI) calcd. for C7H12NO2 
(M++H) 142.0868, found 142.0873.
2-Amino-2-methylpent-4-ynoic acid am ide hydrochloride (8*HCl)
via aminolysis of methyl ester 7
In a stoppered flask, methyl ester hydrochloride 7-HCl (2.00 g, 11.26 
Me mmol) was dissolved in concentrated aqueous ammonia (25%, 50 
2N conh2 mL) and stirred at room temperature until the starting material hadh2nHCl been consumed (~24 h). All volatiles were removed in vacuo, and the 
residue, containing the acid and the amide in a ~ 1 : 1  ratio, was dissolved in water 
(60 mL). The solution was brought to pH 9 with 10 M NaOH, followed by the 
addition of PhCHO (0.61 mL, 6.0 mmol). After stirring vigorously for 2 h, the 
emulsion was extracted with CH2Cl2 (3x 30 mL), and the combined organic 
phases were dried over Na2SO4 and concentrated to dryness. The resulting oil was 
taken up in acetone (20 mL) and treated with conc. HCl (0.5 mL, 6.0 mmol) over a 
period of 0.5 h. To the emulsion was added water (5 mL) whereupon a precipitate 
formed that could be filtered off and dried to yield the amide hydrochloride 8 -HCl 
as a waxy, white solid (0.77g, 4.73 mmol, 42%).
via hydrolysis of imine 14
In a stoppered flask, a stirred solution of diphenylketimine 14 (0.15 g, 0.52 mmol) 
in acetone (2 mL) was treated with conc. HCl (0.05 mL, 0.6 mmol) at room 
temperature. After stirring for 2 h, water (0.4 mL) was added resulting in the
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formation of a precipitate that could be filtered off to provide the amide as its 
hydrochloride in the form of a waxy, white solid (0.05 g, 0.43 mmol, 82%).
Rf 0.0 (EtOAc/heptane, 1:1); vmax (ATR) 3265, 2920, 2064, 1675, 1506, 1381, 
1109, 970; öh (300 MHz, MeOH-d4) 8.48 (2 H, bs), 7.89 (1 H, s), 7.53 (1 H, s), 2.95 
(1 H, dd, J  = 17.5, 2.7 Hz), 2.84 (1 H, dd, J  = 17.5, 2.7 Hz), 2.70 (1 H, t, J  = 2.7 Hz),
1.65 (3 H, s); öc (75 MHz, MeOH-c/4) 173.4, 76.90, 75.56, 60.26, 28.28, 22.20; 
HRMS (EI) calcd. for C6Hn N2O (M+ + H) 127.0871, found 127.0884.
2-Benzhydrylideneamino-2-methylpent-4-ynoic acid am ide (14)
 ^ To a cooled (0 °C) solution of diphenylketimine-protected 
ph f  alaninamide 1320 (1.00 g, 3.96 mmol) in THF (30 mL) was added
p h A A M L  KO*Bu (0.53 g, 4.72 mmol) in small portions. After stirring the 
conh2 reaction mixture for 20 min, propargyl bromide (80% wt. in 
toluene; 0.53 mL, 4.76 mmol) was slowly added. The reaction 
mixture was stirred for 16 h followed by quenching with saturated aqueous NH4Cl 
(50 mL). The phases were separated and the aqueous layer was extracted with 
EtOAc (2x 30 mL), and the combined organic layers were washed with water (3x
20 mL) and brine (20 mL). Drying over MgSO4, removal of all volatiles and flash 
chromatography (EtOAc/heptane = 1:3) of the resulting residue furnished the title 
compound as a yellowish oil that solidified on standing (0.38 g, 1.31 mmol, 33%). 
Rf 0.45 (EtOAc/heptane/Et3N, 25:75:1); vmax (ATR) 3429, 3296, 2116, 1679, 1242, 
1122, 972; öh (200 MHz, CDCfe) 8.03 (1 H, bs), 7.57-7.30 (10 H, m), 5.62 (1 H, bs),
2.86 (1 H, dd, J  = 16.8, 2.6 Hz), 2.10 (1 H, dd, J  = 17.1, 2.6 Hz), 1.96 (1 H, t, J  =
2.6 Hz), 1.34 (3 H, s); öc (75 MHz, CDCfe); 178.6, 167.9, 140.9, 137.8, 130.5,
128.7, 128.2, 128.1, 128.0, 127.7, 80.7, 70.5, 66.5, 27.8, 25.2; HRMS (EI) calcd. 
for C19H19N2O (M++H) 291.1497, found 291.1496.
2-Methyl-2-tosylaminopent-4-ynoic acid methyl ester (15)
A stirred solution of a-propargylalanine methyl ester hydrochloride 
(7-HCl) (1.05 g, 5.93 mmol) in MeCN (30 mL) was treated successively 
HN- \"Me with TMEDA (5.37 mL, 35.58 mmol) and TsCl (1.38 g, 7.24 mmol).
Ts C02Me After stirring overnight at room temperature, the volatiles were 
removed in vacuo. The residue was partitioned between EtOAc (30 
mL) and 1 M HCl (30 mL), and the phases were separated followed by extraction 
of the water phase with EtOAc (2x 15 mL). The combined organic layers were 
washed with brine and dried over Na2SO4 followed by removal of all volatiles. 
Subjection of the resulting crude product to flash chromatography (EtOAc/heptane 
= 1:3) furnished the title compound as a white solid (1.29 g, 4.35 mmol, 73%).
Rf 0.75 (EtOAc/heptane/MeOH, 10:10:3); vmax (ATR) 3252, 2950, 1920, 1429, 
1312, 1238, 1087, 815; öh (300 MHz, CDCfe) 7.74 (2 H, d, J  = 8.3 Hz), 7.24 (2 H, d, 
J  = 8.3 Hz), 5.72 (1 H, s), 3.63 (3 H, s), 2.74 (1 H, dd, J  = 16.9, 2.6 Hz), 2.66 (1 H, 
dd, J  = 16.9, 2.6 Hz), 2.36 (3 H, s), 1.97 (1 H, t, J  = 2.6 Hz), 1.46 (3 H, s); öc (75 
MHz, CDG3) 172.2, 143.1, 138.9, 129.2, 126.9, 77.9, 72.1, 60.9, 52.7, 29.4, 22.3, 
21.2; HRMS (ESI) calcd. for C14H18NO4S (M++H) 296.0957, found 296.0957.
2-Methyl-2-(2-nitrobenzenesulfonylamino)pent-4-ynoic acid methyl ester (16)
a-Propargylalanine methyl ester hydrochloride (7-HCl) (6.88 g, 38.73 
mmol) was dissolved in dry MeCN (270 mL); the solution was cooled 
_ _Me down to 0 °C, and then TMEDA (35.1 mL, 232 mmol) and o-NsCl (10.31 
Ns C02Me g, 46.50 mmol) were added whilst stirring. The reaction mixture was 
allowed to warm to room temperature, and stirring was continued 
overnight. An additional quantity of o-NsCl (2.50 g, 11.28 mmol) was added, and 
after a further 3 h of stirring, all volatiles of the mixture were removed in vacuo. 
The resulting residue was partitioned between EtOAc (250 mL) and 1 M HCl (250 
mL), the phases were separated, and the aqueous layer was extracted with EtOAc 
(3x 50 mL). The combined organic phases were washed with brine, dried over 
Na2SO4 and concentrated to dryness. Column chromatography (EtOAc/heptane,
HN
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1:2) of the crude product afforded the title compound as an off-white solid (10.92 
g, 33.46 mmol, 86%).
Rf 0.67 (EtOAc/heptane/MeOH, 10:10:3); vmax (ATR) 3287, 3088, 2950, 1735, 
1537, 1346, 1161, 1113, 733; öh (300 MHz, CDCh) 8.12-8.06 (1 H, m), 7.93-7.87 
(1 H, m), 7.77-7.68 (2 H, m), 6.42 (1 H, s), 3.68 (3 H, s), 2.83 (2 H, d, J  = 2.6 Hz),
1.86 (1 H, t, J  = 2.6 Hz), 1.61 (3 H, s); öc (75 MHz, CDCh) 171.9, 147.4, 136.2,
133.3, 133.0, 129.9, 125.4, 77.6, 72.3, 62.2, 53.1, 28.9, 24.2; HRMS (ESI) calcd. 
for C13H14N2NaO6S (M+ + Na) 349.0470, found 349.0477.
_ -Me 
HN C02Me
5-(2-(3-Hydroxyprop-1-ynyl)phenyl)-2-methyl-2-(tosylamino)pent-4-ynoic acid  
methyl ester (18)
A stirred solution of 4-(2-iodophenyl)prop-3-yn-1-ol (17)32 (0.75 
g, 2.91 mmol) in Et2O (40 mL) was treated with PdCl2(PPh3)2 
(105 mg, 0.150 mmol), CuI (58 mg, 0.305 mmol) and Et2NH 
(1.51 mL, 14.6 mmol). Once a clear homogenous solution had 
been formed, Ts-protected a-propargylalanine 15 (0.86 g, 2.91 
mmol) was added. After stirring overnight, the reaction mixture 
was poured into one aliquot of saturated aqueous NH4Cl. The 
phases were separated, and the aqueous phase was extracted with EtOAc (3x 10 
mL). The combined organic phases were washed with brine and dried over MgSO4 
followed by removal of all volatiles in vacuo. Purification of the crude product by 
flash chromatography (EtOAc/heptane, 2:7) yielded the title compound as a 
yellowish, viscous oil (1.04 g, 2.44 mmol, 84%).
Rf 0.50 (EtOAc/heptane, 1:1); vmax (ATR) 3470, 3240, 2930, 1750, 1150; öh (300 
MHz, CDCl3) 7.80 (2 H, d, J  = 8.4 Hz), 7.43-7.36 (1 H, m), 7.26-7.18 (3 H, m), 7.12 
(2 H, d, J  = 8.4 Hz), 6.42 (1 H, s), 4.58 (2 H, dd, J  = 6.0, 2.3 Hz), 3.71 (3 H, s), 3.42 
(1 H, t, J  = 6.0 Hz), 3.02 (1 H, d, J  = 17.3 Hz), 2.93 (1 H, d, J  = 17.3 Hz), 2.25 (3 H, 
s), 1.58 (3 H, s); öc (75 MHz, CDCh) 172.9, 143.0, 139.1, 131.9, 131.5, 129.2,
127.8, 127.6, 126.9, 125.4, 125.1, 91.3, 87.7, 83.9, 82.7, 61.2, 53.0, 51.3, 30.2,
23.0, 21.2; HRMS (ESI) calcd. for C23H24NO5S (M++H) 426.1375, found 426.1386.
5-(2-(3-Hydroxyprop-1-ynyl)phenyl)-2-methyl-2-(2-nitrobenzenesulfonylamino)pent-
4-ynoic acid methyl ester (19)
According to the procedure described for the synthesis of 18, a 
solution of aryl iodide 17 (3.00 g, 11.62 mmol) in Et2O (150 mL) 
was allowed to react with PdCl2(PPh3)2 (390 mg, 0.556 mmol), 
CuI (0.214 mg, 1.12 mmol), Et2NH (5.74 mL, 55.5 mmol) and Ns- 
protected a-propargylalanine 16 (3.62 g, 11.09 mmol). After 
stirring overnight, the reaction mixture was worked-up. Flash 
chromatography (EtOAc/heptane, 2:3) of the crude product gave 
the title compound as a yellow, viscous oil (3.67 g, 8.03 mmol, 72%).
Rf 0.20 (EtOAc/heptane, 1:1); vmax (ATR) 3326, 2950, 2241, 1956, 1727, 1537, 
1156, 1018; öh (300 MHz, CDCl3) 8.13 (1 H, dd, J  = 7.8, 1.3 Hz), 7.71-7.57 (2 H, 
m), 7.48 (1 H, dt, J  = 7.8, 1.4 Hz), 7.37-7.27 (1 H, m), 7.22-7.09 (3 H, m), 6.78 (1 
H, bs), 4.51 (2 H, s), 3.70 (3 H, s), 3.12 (2 H, s), 2.97 (1 H, bs), 1.70 (3 H, s); öc (75 
MHz, CDCl3) 172.4, 146.9, 135.9, 133.0, 132.8, 131.9, 131.7, 129.8, 127.7, 125.2,
124.8, 124.8, 91.4, 87.3, 83.3, 82.8, 62.5, 53.2, 51.3, 29.7, 24.4; HRMS (ESI) 
calcd. for C22H20N2NaO7S (M+ + Na) 479.0889, found 479.0882.
5-M ethyl-4-tosyl-1,2,7,8-tetradehydro-3,4,5,6-tetrahydro-4-benzazecine-5-carboxylic 
acid methyl ester (20)
Triphenylphosphine (0.96 g, 3.66 mmol) was dissolved in a stirred, 
dilute solution (c = 8 mM) of enediyne alcohol 18 (1.04 g, 2.44 
mmol) in THF (300 mL). DIAD (0.73 mL, 3.68 mmol) was added via 
syringe, and stirring was continued for 15 min at room temperature. 
All volatiles were removed in vacuo, and the crude product was 
subjected to flash chromatography (EtOAc/heptane, 1:3). Careful 
concentration of the appropriate column fractions at ambientTs Me
C02Me
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temperature caused the product to precipitate as a white crystalline solid that 
could be isolated by filtration (0.63 g, 1.54 mmol, 63%). Crystals suitable for X-ray 
analysis could be grown from a CHCl3 solution top-layered with MeOH.
Rf 0.74 (EtOAc/heptane, 1:1); vmax (ATR) 3503, 2946, 2107, 1735, 1325, 1148, 
1031; öh (300 MHz, CDCfe) 7.84 (2 H, d, J  = 8.3 Hz), 7.24-7.19 (2 H, m), 7.19-7.12 
(2 H, m), 7.07 (2 H, d, J  = 8.3 Hz), 4.63 (1 H, d, J  = 20.2 Hz), 4.27 (1 H, d, J  = 20.2 
Hz), 3.85 (3 H, s), 3.72 (1 H, d, J  = 18.5 Hz), 3.04 (1 H, d, J  = 18.5 Hz), 2.15 (3 H, 
s), 1.92 (3 H, s); öc (75 MHz, CDCfe) 174.1, 143.4, 136.9, 129.1, 128.0, 127.9,
127.8, 127.4, 127.3, 127.2, 94.4, 94.0, 88.1, 83.7, 66.3, 53.0, 36.3, 28.8, 23.0, 
21.2; HRMS (ESI) calcd. for C23H21NNaO4S (M++Na) 430.1089, found 430.1092. 
For X-ray crystal data and refinement parameters, see Table 7 at the end of this 
section.
Table 5 Selected structural data of compound 20.
selected bond lengths (Â)
S(1)-N(1) 1.6328(16) C(5)-C(6) 1.439(3)
N(1)-C(14) 1.477(2) C(6)-C(11) 1.406(3)
N(1)-C(2) 1.490(2) C(11)-C(12) 1.433(3)
C(2)-C(3) 1.543(3) C(12)-C(13) 1.187(3)
C(3)-C(4) 1.454(3) C(13)-C(14) 1.467(3)
C(4)-C(5) 1.198(3)
selected bond angels (Â)
C(14)-N(1)-C(2) 122.80(16) C(4)-C(5)-C(6) 165.9(2)
C(14)-N(1)-S(1) 116.12(13) C(11)-C(6)-C(5) 117.17(19)
C(2)-N(1)-S(1) 120.99(13) C(6)-C(11)-C(12) 116.07(19)
N(1)-C(2)-C(3) 113.45(16) C(13)-C(12)-C(11) 165.4(2)
C(4)-C(3)-C(2) 114.26(18) C(12)-C(13)-C(14) 174.2(2)
C(5)-C(4)-C(3) 177.6(2) C(13)-C(14)-N(1) 111.93(16)
transannular distance (Â)
C(4)-C(13) 3.202
Ns Me
C02Me
5-M ethyl-4-(2-nitrophenyl)sulfonyl-1,2,7,8-tetradehydro-3,4,5,6-tetrahydro-4- 
benzazecine-5-carboxylic acid methyl ester (21)
To a stirred solution of triphenylphosphine (3.20 g, 12.20 mmol) and 
enediynyl alcohol 19 (3.67 g, 8.04 mmol) in THF (1.20 L; cenediyne = 
7 mM) was added DIAD (2.40 mL, 12.11 mmol). Stirring was 
continued for 15 min, followed by removal of all volatiles in vacuo  at 
room temperature. The resulting residue was subjected to flash 
chromatography (EtOAc/heptane, 1:2) to give the title compound 
contaminated with DIAD-H2. The impure product was suspended in 
cold MeOH, filtered off and washed with small quantities of cold MeOH to afford
21 as an off-white solid (1.29 g, 2.94 mmol, 37%). Crystals suitable for X-ray 
analysis could be grown from a CHCl3 solution top-layered with MeOH.
Rf 0.41 (EtOAc/heptane, 1:1); vmax (ATR) 3114, 2976, 2941, 1700, 1541, 1368, 
1338, 1251, 720; öh (300 MHz, CDCfe) 8.34 (1 H, d, J  = 8.0 Hz), 7.50 (2 H, d, J  =
4.1 Hz), 7.42-7.30 (2 H, m), 7.30-7.15 (3 H, m), 4.67 (1 H, d, J  = 20.2 Hz), 4.33 (1 
H, d, J  = 20.2 Hz), 3.81 (3 H, s), 3.69 (1 H, d, J  = 18.7 Hz), 3.17 (1 H, d, J  = 187 
Hz), 2.01 (3 H, s); öc (75 MHz, CDCfe) 173.2, 149.1, 133.7, 131.9, 131.0, 130.4,
128.7, 128.4, 128.2, 127.7, 127.5, 127.1, 123.5, 94.0, 93.8, 88.5, 84.4, 67.4, 53.1,
36.4, 29.1, 22.9; HRMS (ESI) calcd. for C22H18N2NaO6S (M++Na) 461.0783, found
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461.0773. For X-ray crystal data and refinement parameters, see Table 7 at the 
end of this section.
Table 6 Selected structural data of compound 21.
selected bond lengths (Â)
S(1)-N(1) 1.621(2) C(5)-C(6) 1.436(4)
N(1)-C(14) 1.481(3) C(6)-C(11) 1.416(3)
N(1)-C(2) 1.490(3) C(11)-C(12) 1.430(4)
C(2)-C(3) 1.549(3) C(12)-C(13) 1.192(4)
C(3)-C(4) 1.466(4) C(13)-C(14) 1.458(3)
C(4)-C(5) 1.186(4)
selected bond angels (Â)
C(14)-N(1)-C(2) 123.3(2) C(4)-C(5)-C(6) 168.0(3)
C(14)-N(1)-S(1) 115.34(16) C(11)-C(6)-C(5) 117.2(2)
C(2)-N(1)-S(1) 121.38(15) C(6)-C(11)-C(12) 116.3(2)
N(1)-C(2)-C(3) 113.9(2) C(13)-C(12)-C(11) 166.6(3)
C(4)-C(3)-C(2) 112.7(2) C(12)-C(13)-C(14) 171.2(2)
C(5)-C(4)-C(3) 175.6(3) C(13)-C(14)-N(1) 111.49(19)
transannular distance (Â)
C(4)-C(13) 3.288
5-M ethyl-1,2,7,8-tetradehydro-3,4,5,6-tetrahydro-4-benzazecine-5-carboxylic acid  
methyl ester (22)
To a cooled (0 °C) solution of 21 (650 mg, 1.48 mmol) in freshly 
distilled MeCN (50 mL) was added K2CO3 (620 mg, 4.45 mmol). 
Whilst stirring, thiophenol (310 |iL, 2.96 mmol) was added, and the 
reaction mixture was allowed to reach room temperature. After 2 h 
of stirring, the reaction was complete (TLC), and the volatiles were 
C02Me removed in vacuo. The title compound (272 mg, 1.07 mmol, 73%) 
Me was obtained as an amber-colored solid after flash chromatography
(EtOAc/heptane, 1:3).
Rf 0.32 (EtOAc/heptane, 1:3); vmax (ATR) 3369, 2950, 2219, 1722, 1455, 1247, 
1109; öh (300 MHz, CDCl3) 7.38-7.31 (1 H, m), 7.30-7.18 (3 H, m), 3.77 (2 H, d, J  =
3.7 Hz), 3.75 (3 H, s), 2.93 (1 H, d, J  = 17.4 Hz), 2.75 (1 H, d, J  = 17.4 Hz),2.23 (1
H, bs), 1.77 (3 H, s); öc (75 MHz, CDCl3) 175.7, 129.4, 128.9, 128.1, 127.5, 127.5,
127.3, 100.0, 95.2, 86.7, 83.4, 61.8, 52.7, 34.4, 32.8, 18.0; HRMS (ESI) calcd. for 
C16H16NO2 (M+ + H) 254.1181, found 254.1187.
2-((5)-2-teri-Butoxycarbonylaminopropionylamino)-2-methyl-pent-4-ynoic acid  
methyl ester (24)
^  a-Propargylalanine methyl ester hydrochloride (7-HCl) (82 
H o SM  mg, 0.46 mmol) and Boc-L-Ala-OH (113 mg, 0.60 mmol) were 
R 'N ^ X ^  J c c0 M dissolved in dry DCM (10 mL), followed by the addition of 
Me N Et3N (196 |iL, 1.47 mmol) and BOP-Cl (153 mg, 0.60 mmol).
After stirring overnight, the reaction was quenched with an 
aqueous solution of 1.0 M HCl (10 mL). The layers were separated and the organic 
phase was washed with saturated aqueous NaHCO3 (3x 5 mL) and brine. The 
organic layer was dried (MgSO4) and concentrated in vacuo. Flash 
chromatography (EtOAc/heptane, 1:1) of the crude product provided the title
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compound as a 1 : 1  mixture of diastereoisomers in the form of a colorless, sticky 
solid (108 mg, 0.35 mmol, 76%).
Rf 0.60 (EtOAc/heptane/MeOH, 10:10:3); vmax (ATR) 3300, 2989, 2933, 2116, 
1662, 1515, 1364, 1165, 1243, 1126, 637; öh (200 MHz, CDCfe) 7.04 (1 H, bd, J  =
10.5 Hz), 4.15 (1 H, bs), 4.11-4.00 (1 H, m), 3.70 (0.5x 3 H, s), 3.69 (0.5x 3 H, s), 
3.00-2.81 (2 H, m), 1.95 (1 H, t, J  = 2.6 Hz), 1.53 (0.5x 3 H, s), 1.51 (0.5x 3 H, s),
1.39 (9 H, s), 1.29 (3 H, d, J  = 7.0 Hz); öc (75 MHz, CDCh) 173.1, 172.1, 155.4,
80.0, 79.3, 79.1, 71.1, 71.0, 58.4, 58.2, 52.8, 52.7, 49.9, 28.2, 26.2, 26.1, 22.7,
18.2, 18.1; HRMS (ESI) calcd. for C15H24N2NaO5 (M++Na) 335.1583, found 
335.1611.
2-((5)-2-(((9ff-Fluoren-9-yl)methoxy)carbonylamino)propanamido)-2-methylpent-4- 
ynoic acid methyl ester (25)
^  In a flame-dried Schlenk tube containing 4 Â molecular 
H o f  sieves, a-propargylalanine methyl ester hydrochloride
 ^ (7-HCl) (59 mg, 0.33 mmol) and pyridine (165 uL, 0.66Fmoc V  N C02Me ' , , . , ' . .. .Me h 2 mmol) were dissolved in dry DCM (10 mL). Whilst stirring, 
BSA (250 uL, 1.00 mmol) was added and stirring was 
continued overnight. Fmoc-L-Ala-F 33 (125 mg, 0.40 mmol) was added to the 
reaction and stirring was again continued overnight. The reaction was quenched 
by adding a small amount of silica (~ 100  mg), and the resulting mixture was 
filtered over Hyflo. After removing the volatiles, the residue was dissolved in 
EtOAc (10 mL) and washed consecutively with 1.0 M HCl (3x 3 mL), saturated 
aqueous NaHCO3 (3x 5 mL) and brine. The organic phase was dried over MgSO4 
and concentrated. Preparative TLC (EtOAc/heptane/MeOH, 10:10:3) was used to 
purify the title compound which was obtained as a 1 : 1  mixture of 
diastereoisomers (17.5 mg, 0.04 mmol, 12%).
Rf 0.67 (EtOAc/heptane/MeOH, 10:10:3); vmax (ATR) 3296, 2950, 2241, 2111, 
1666, 1506, 1442, 1221, 1122, 906, 728, 638; öh (200 MHz, CDCh) 7.77 (2 H, d, J  
= 6.8 Hz), 7.60 (2 H, d, J  = 7.2 Hz), 7.45-7.27 (4 H, m), 6.77 (1 H, bs), 5.41 (1 H, 
bd, J  = 6.7 Hz), 4.40 (2 H, d, J  = 7.4 Hz), 4.33-4.19 (2 H, m), 3.77 (0.5x 3 H, s), 
3.75 (0.5x 3 H, s), 3.12-2.86 (2 H, m), 1.95 (0.5x 1 H, t, J  = 2.6 Hz), 1.90 (0.5x 1 
H, t, J  = 2.6 Hz), 1.60 (0.5x 3 H, s), 1.59 (0.5x 3 H, s), 1.41 (3 H, d, J  = 7.0 Hz); öc 
(75 MHz, CDG3) 173.0, 172.9, 171.5, 155.8, 143.7, 141.2, 127.7, 127.0, 125.0,
120.0, 79.1, 79.0, 71.2 (2 C), 67.1, 58.7, 58.6, 53.0 (2 C), 50.4, 47.1, 26.2 (2 C),
22.8, 22.7, 18.7; HRMS (ESI) calcd. for C25H26N2NaO5 (M++Na) 457.1739, found 
457.1736.
5-M ethyl-4-tosyl-1,2,7,8-tetradehydro-3,4,5,6-tetrahydro-4-benzazecine-5-carboxylic 
acid (26)
Ô In a stoppered flask, a cooled (0 °C) solution of methyl ester 20 (57 mg, 0.140 mmol) in THF (5 mL) was treated with an aqueous solution of LiOH (1.0 M; 1.6 mL, 1.6 mmol) and left stirring at 5 °C overnight. \ The acidity of the solution was adjusted to pH 7 followed by removal 
of the organic volatiles in vacuo, resulting in a concentrate that was 
Co2ih partitioned between EtOAc (15 mL) and 0.1 M HCl (15 mL). After 
Ts Me phase separation, the aqueous layer was extracted with EtOAc (3x 5 
mL), and the combined organic layers were washed with water (5 mL) and brine 
and then dried over MgSO4. Evaporation of the solvents gave the title compound 
as a white solid (37 mg, 0.094 mmol, 67%).
Rf 0.22 (EtOAc/heptane/MeOH, 10:10:3); öh (200 MHz, DMSO-d6) 13.11 (1 H, bs),
7.85 (2 H, d, J  = 8.4 Hz), 7.72-7.63 (4 H, m), 7.37 (2 H, d, J  = 8.4 Hz), 4.53 (1 H, d, 
J  = 18.1 Hz), 4.04 (1 H, d, J  = 18.1 Hz), 3.42 (1 H, d, J  = 18.3 Hz), 3.20 (1 H, d, J  =
18.3 Hz), 2.36 (3 H, s), 1.67 (3 H, s); HRMS (ESI) calcd. for C22H19NNaO4S (M++Na) 
416.0933, found 416.0949.
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4 .9 .3  H a lf- l ife  d e te rm in a t io n s  o f  th e  e n e d iy n e s
4 .9 .3 .1  G e n e r a l  in fo rm a t io n
The half-lives of 20-22 were determined by subjecting samples of the enediynes 
to a temperature of 52 °C inside a heated34 NMR probe. 1H-NMR data recordings 
and analyses were performed as described in Chapter 3.9.3. Plots of, firstly, the 
amounts of enediyne vs. time and, secondly, the natural logarithm of the amounts 
of enediyne vs. time are shown in Figure 3.
4 .9 .3 .2  S a m p le  p r e p a r a t io n  a n d  r e s u l t s  
For enediyne 20
A NMR tube (0 = 5 mm) connected to an argon/vacuum manifold was charged 
with enediyne 20 (21.1 mg, 0.052 mmol) and DMSO-d6 (450 uL) under an argon 
atmosphere. Of a solution of 1,4-cyclohexadiene in DMSO-d6 (10% v/v) was added 
97 uL (0.103 mmol, 2 equiv). Mesitylene (3 uL, 0.022 mmol) was employed as 
internal standard. The resulting solution was degassed by three freeze-pump-thaw 
cycles, and the NMR tube was tipped-off by flame under partial vacuum. The 
concentration of 20 in the thus prepared sample was 0.095 M. Decay of the 
starting material was monitored inside a heated NMR probe at T = 52 °C. To this 
end, the enediyne a-Me peak at 1.85 ppm was followed. The decay of 20 
displayed first-order.
temperature 5 tsJ ° O
exponential fit [min] y  = 94.264e -1371 '10-3 x
linear fit [min] y  = -1.371 • 10 3 x - 5.907 • 10 2
goodness of fit (R2) 0.9945
rate constant (k) 1.371 ■ 10-3 min-1
half-life (t1/2) 8.43 h
For enediyne 21
As described for 20, a sample was prepared from enediyne 21 (22.2 mg, 0.051 
mmol) in DMSO-d6 (450 uL), 1,4-cyclohexadiene in DMSO-d6 (10% v/v) (97 uL, 
0.103 mmol, 2 equiv) and mesitylene (3 uL, 0.022 mmol) as internal standard. 
The final concentration of 21 was 0.093 M. Decay of the starting material was 
monitored inside a heated NMR probe at T = 52 °C by observing the enediyne a ­
Me peak at 1.95 ppm. Under these conditions, BC of 21 followed first-order decay.
temperature 52 °C
exponential fit [min] y  = 95.641e -2 856 ^  x
linear fit [min] y  = -2.856 • 10-3x - 4.457 • 10-2
goodness of fit (R2) 0.9889
rate constant (k) 2.856 ■ 10-3 min-1
half-life (t1/2) 4.05 h
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For enediyne 22
As described for 20, a sample was prepared from enediyne 22 (12.9 mg, 0.051 
mmol), DMSO-d6 (450 |iL), 1,4-cyclohexadiene in DMSO-d6 (10% v/v) (98 |iL, 0.104 
mmol, 2 equiv) and mesitylene (3 |iL, 0.022 mmol). The resulting concentration of
22 was 0.093 M. Consumption of the enediyne was monitored inside a heated 
NMR probe at T = 52 °C by following its a-Me peak at 1.64 ppm. The decay of 22 
obeyed first-order kinetics.
temperature 5 tsJ ° O
exponential fit [min] y  =  86.757e ~2'217 ' 10~3 x
linear fit [min] y  = -2.217 • 10-3 x -1.421 • 10-1
goodness of fit (R2) 0.9882
rate constant (k) 2.217 ■ 10-3 min-1
half-life (t1/2) 5.21 h
4 .9 .4  X - ra y  c r y s t a l  s t r u c tu r a l  d a ta
Table 7 Crystal data and structure refinements for 20 and 21.
compound number 20 21 • CHCI3
CCDC No. — —
crystal color translucent colorless translucent colorless
crystal shape rather regular rod very regular fragment
crystal size 0.30 x 0.14 x 0.07 mm 0.23 x 0.14 x 0.09 mm
empirical formula C23 H21 N O4 S C23 H 19 Cl3 N2 O6 S
FW 407.47 557.81
Temperature 208(2) K
radiation / À MoKa (graphite mon.) / 0.71073 Â
crystal system / space group Monoclinic, P 21/n Monoclinic, P 21/a
unit cell dimensions a 13.3115(6) Â 11.7714(6) Â
b 6.6146(2) Â 11.8605(10) Â
c 23.4079(13) Â 17.7787(9) Â
a 9 O O 9 O O
ß 104.657(4) ° 94.376(3)°
Y 9 O O 9 O O
volume 1994.00(15) Â3 2474.9(3) Â3
Z / calc. density 4 / 1.357 Mg/m3 4 / 1.497 Mg/m3
absorption coefficient 0.192 mm-1 0.497 mm-1
diffractometer / scan Nonius KappaCCD with area detector 9 and w scan
F(000) 856 1144
0 range 2.01 to 27.50° 2.07 to 27.50°
index ranges -16<=h< = 17 -15<=h< = 15
8=<=<7- -15<=k< = 15
-30<=l<=30 -23<=l< = 23
reflections collected / 
unique 33507 / 4586 66137 / 5690
■Rint 0.0341 0.0486
reflections observed 3632 [7>2ct (Í)] 4381 [î >2ct (I)]
absorption correction SADABS multiscan correction (Sheldrick, 1996)
refinement method Full-matrix least-squares on F2
computing SHELXL-97 (Sheldrick, 1997)
continued on next page
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Table 7 continued
data / restraints / 
parameters 4586 / 0/265 5690 / 0/318
goodness-of-fit on F2 1.104 1.161
SHELXL-97 weight 
parameter 0.0394, 1.3506 0.0304, 2.6946
final R  indices [I>2ct (I)] R1 = 0.0540, wR2 = 0.1065
R1 = 0.0622, 
wR2 = 0.1053
R  indices (all data) R1 = 0.0751, wR2 = 0.1143
R1 = 0.0905, 
wR2 = 0.1146
largest diff. peak and hole 0.278 and -0.356 e-A-3 0.392 and -0.426 e-A-3
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Fmoc-L-Ala-F was prepared according to ref. 27a.
Precautionary note: It is of importance to measure the actual temperature inside the 
NMR probe rather than rely on the displayed temperature. See Chapter 3.9.3 for details.
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Abstract
The preparations of a-CF3-a-propargylglycine and a-CF3-a- 
hom opropargylg lycine are  disclosed along w ith  a b rie f exploration of 
the ir k inetic enzym atic resolution. Peptide bond form ations of the 
fluorinated  am ino acids proceeded w e ll a t the C-terminus follow ing 
standard  protocols w hereas functionalization of the N-term inus requ ired  
harsher conditions, i.e . reaction  w ith  acy l chlorides. T ransform ations at 
the C= C  trip le  bond (hydrogenation, Pauson-Khand reaction) provided 
fluorinated  deriva tives and scaffolds. F ina lly , efforts tow ards cyc lic  a-CF3- 
contain ing enediyn ic am ino acids are detailed.
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5.1 Introduction
5.1.1 O rg a n o f lu o r in e  c o m p o u n d s
F luorine  is the lightest of a ll halogens and is positioned in the second 
period of the Period ic Tab le  of the elem ents. It  is the most 
e lectronegative  of a ll elem ents w ith  a Pau ling  e lectronegativ ity  of x =
3.98.1 M oreover, m olecu lar fluorine (F 2) is the e lem ent w ith  the highest
chem ica l activ ity : it is able to react at room  tem perature  w ith  m ateria ls
2
such as glass, carbon and m any metals. Despite being the most abundant 
halogen in the Ea rth 's  crust w ith  concentrations of inorganic fluoride (F -) 
ranging from  270-740 ppm, there are  ve ry  few  natu ra lly  occurring  
fluorinated  organic compounds. This sharp ly contrasts w ith  the steadily 
grow ing num ber of man-made organofluorine com pounds ,4,5 covering  a 
w ide range of applications (F igu re  1), e.g . the chem ica lly  inert and heat 
resistant polym er P T F E  (1 ),6 the notorious freon-12 re frigeran t and
7 8propellant (2 ) but also drugs such as 5-fluorouracil (3 ) and flunisolide 
(4 ),9 insecticides such as transflu th rin  (5 )10 and applications in 
e lectron ics (fluorinated  liquid crystals, 6).11
Figure 1 Fluorinated compounds are encountered in a wide range of applications.
Nowadays, fluorinated  organic entities are frequently encountered
12 13in the fields of m ed icinal chem istry, agrochem istry and m ateria l 
sc ience 14 for a num ber of reasons. F irs t of all, incorporation  of fluorine 
can a lte r the p referred  conform ation of a m olecule due to ste ric 15 and 
e lectron ic properties. F luorination  w ill also perturb  the p K a at strateg ic 
positions, viz. it can increase the ac id ity  of nearby heteroatom-bound 
hydrogens. F luorine  can partic ipate  in  e lectrostatic  in teractions and the 
presence of fluoroalkyl groups in fluences the lipoph ilic ity  of drug-like 
molecules. F ina lly , fluorination  results in an increased  chem ical and heat
112
Preparation and Evaluation o f  a-CF3-Containing Acetylenic Amino Acids
resistance, and it a llow s the tuning of severa l o ther physica l param eters 
such as optical, d ie lectric  and elastic properties.
The trifluorom ethyl group (Tfm ) is appreciated  in m edicinal 
chem istry as a substituent of outstanding va lu e .16 It  is electron-rich, ve ry  
hydrophobic and conveys a high in v ivo  stability. In  term s of steric bulk, 
falling in  betw een  a m ethyl and an iso-propyl group ,17 it m akes a good 
m im ic of n atu ra lly  occurring  residues (M e, ‘Pr, Ph). N o t surprisingly, 
there  is a large num ber of trifluorom ethylated  compounds among drugs 
and agrochem icals. Som e exam ples are depicted in F igu re  2.
,CFa
F3C N=*
HO HN-
7: mefloquine 
(antimalarial agent)
O2N O  
0
O n 02
FaC
10: fluorodifen 
(herbicide)
F3C
FaC
8: efavirenz 
(antiretroviral agent)
O
. / - a
- C M
O o'
N
CF3
11 :fluxofenim 
(herbicide safener)
y=\ MeyH-o N
- L ^ H
N"^.
9: aprepitant 
(antiemetic drug)
FC
f 3c-
Me
12: thifluzamide 
(fungicide)
Figure 2 Examples of trifluoromethyl-containing drugs (7-9) and agrochemicals (10-12).
F
O
A  special subclass of trifluorom ethyl-contain ing compounds 
consists of the a-trifluoromethyl-a-amino acids (T fm Aaas ).18 The steric 
dem and of the a-Tfm m oiety imposes conform ational restrictions on 
peptide chains, a p roperty shared w ith  a,a-disubstituted amino acids 
(see: C hap ter 4.1). Consequently, ce rta in  secondary structures are
1Q 20favored. M oreover, Tfm Aaa-containing peptides genera lly  d isp lay a 
g rea tly  enhanced hydro lytic stab ility1Qb'21 and, by v irtue  of the com m only 
h igher lipophilic ity, a llev ia te  ce ll m em brane penetration. O f nine of the 
na tu ra lly  occurring  amino acids (i.e . Ala, Asp, Gly, Leu, Phe, Pro, Ser, 
Thr, Va l), the corresponding a-CF3 derivatives have been synthesized 
along w ith  Tfm -derivatives of severa l non-natural am ino ac id s .22
5.1 .2  A im  o f  th e  r e s e a r c h
Insp ired  by the synthesis of the a-Me-substituted amino acids (see: 
Chapter 4.2) and the prospected re levan t p roperties of the corresponding 
trifluorom ethylated  amino acids, w e aim ed to synthesize unsaturated, a- 
C F 3-amino acids. W e  envisaged that enantiopure acetylen ic Tfm Aaas 
should be accessib le v ia  enzym atic reso lution techn iques applied on
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23suitable T fm  substrates. Those, in  turn, would  serve as build ing blocks 
for cyc lic  a-CF3-containing enediynes (13, Schem e 1). Besides these 
p a rticu la r applications, w e w ere  more genera lly  in terested  in the 
chem istry  of acety len ic Tfm Aaas.
,CF,
N' r 2
13
- -cf3
hN2 co2r 1 R2
15
Scheme 1 Retrosynthesis of trifluoromethylated cyclic enediyne-containing amino acids.
5.2 Towards a-CF3-a-amino acids via trifluoromethyl 
ketones
5.2.1 A lk y la t io n  o f  4 ,4 ,4 - tr if lu o ro a c e to a c e ta te
Retrosyn thetic  analysis of the desired  unsaturated  a-CF3 amino acids 
revea led  a possible route: The target compounds 16 should be availab le
24by Strecker-type reactions on trifluorom ethylketones 17, w h ich  should 
be accessib le by decarboxylation of a lkylated  trifluoroacetoacetates 18. 
Thus, potentia l starting m ateria ls for the synthesis of am ino acids 16 are 
esters of 4 ,4 ,4-trifluoroacetoacetate (19).
co2r 1
^R Strecker /R decarbox- R alkulation
H X cf3 ^^on^ S=o f3^ y V 0R' = >  F WH2N^ Co2>H '  F3C O O O O
R = CH2C=CH, 17 18 19
CH2CH=CH2
16
Scheme 2 Retrosynthesis of unsaturated a-CF3-a-amino acids, identifying 4,4,4-trifluoro- 
acetoacetates as starting materials.
The group of Lang lo is has described the p reparation  of severa l 
trifluorom ethylketones by the pathw ay shown in Schem e 2 starting from  
ethyl 4 ,4 ,4-trifluoroacetoacetate (2 0 ) .25 They reported  the C-alkylation of 
sodium  or potassium  enolates of 2 0  w ith  activated  a lky l halides in  the 
presence of cata lytic  amounts of N a l or K I. In  our hands, however, 
fo llow ing the Langlois protocol w ith  e ither p ropargyl or a lly l brom ide as 
a lkylating  agents did not furnish the desired a lkylated  compounds (Table
1). Varia tion  of the tem peratu re  and addition of A g2O had no positive 
effect.
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Table 1 Attempted alkylations of 4,4,4-trifluoroacetoacetate.
R
F3C^ '"ifOEt R-Br B F3C^l..^OEt
O O conditions O O 
20 21
entry R base catalyst solvent T (°C ) result a
1 propargyl KHM DS KI THF 0 no conversion
2 allyl NaHM DS NaI THF 0 unidentifiable
products
3 allyl NaHM DS NaI DM F 0 unidentifiable
products
4 allyl NaHM DS NaI DM F 110 decomposition
5 allyl NaHM DS NaI/Ag2O DM F 0 no conversion
6 allyl NaHM DS NaI/Ag2O DM F 50 unidentifiable
products
7 allyl NaHM DS NaI/Ag2O DM F 70 unidentifiable
products
8 allyl NaHM DS NaI/Ag2O DM F 90 decomposition
a) Reactions were monitored by TLC, GCMS and F-NMR.
In  the same paper ,25 the authors described the effic ient C- 
a lkylation  of acetoacetate  2 0  by reacting  its pre-formed sodium  enolate 
(22 ) w ith  a lky l halides in  the presence of cata lytic  am ounts of K I in 
acetone at reflux tem peratures. This approach, too, w as m et w ith  fa ilure 
w hen  22 w as treated  w ith  e ither propargyl or a lly l brom ide (Schem e 3). 
No conversion  of the starting m ateria l to products w as observed in both 
cases, even after prolonged reaction  tim es (72 h).
20
NaH
Na'
0O O 
F3C ^"''^O Et 
22 (quant)
^ ^ B r  or * ^ Br 
------ X-----► (no conversion)
Et2O, rt, 1 h
Scheme 3 Attempted alkylation of the sodium enolate of 22.
KI (cat), acetone 
rfx, 72 h
In  a re lated  pub lication ,26 A ubert et al. d isclosed the a lkylation  of a 
dioxolane-protected derivative  of 20. Presum ably, transform ation  of the 
ketone functionality  into the dioxolane com pensates for the deactivating  
effect of the trifluorom ethyl group, thereby p reventing O -alkylation and 
hence favoring C-alkylation of this substrate. Thus, acetoacetate 20 w as 
converted  into dioxolane 23 by the action of K 2CO 3 and 2-chloroethanol in 
refluxing T H F  (Schem e 4). W e  w ere  then pleased to find that compound 
23 w as e ffic ien tly  a lkylated  using e ither a lly l or p ropargyl brom ide in 
T H F  and em ploying N a H M D S  as the base to afford products 24 and 25 in 
70 and 5 5 %  yield, respectively. The addition of 3 equ iv of H M P A
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augm ented the y ie lds to 8 3 %  for the a lly l and to 7 0 %  for the propargyl 
compound.
20
OEt
F3C
24 (83%)
OEt F3X - ° 0 H
23 (70%)
F3C
25 (70%)
OEt
Scheme 4 Preparation and alkylation of dioxolane-protected acetoacetate 23. Reagents 
and conditions: (a) 2-Chloroethanol, K2CO3, THF, rfX, 48 h; (b) allyl bromide, NaHMDS, 
HMPA, THF, -78 °C ^ rt, 4 h; (c) propargyl bromide, NaHMDS, HMPA, THF, -78 °C ^ rt, 
4 h.
a
b c
In  o rder to obtain the a lkylated  acetoacetate, deprotection of the 
dioxolane to regenerate  the ketone w as necessary at th is stage. As 
a lready noted by A ubert et a l.,26 rem arkab ly  harsh  m easures are requ ired  
to do so. Indeed, they reported  the use of 7 0 %  aqueous perch loric acid  at 
reflux tem perature  to enact th is transform ation. Sapon ification  and 
decarboxylation occurred  as w e ll under these conditions, d irectly  giving 
the trifluorom ethylketones. In  accordance w ith  our anticipated  doubt 
w hether the C-C m ultip le bonds of substrates 24 and 25 would  survive 
such a treatm ent, upon exposing e ither of these compounds to aqueous 
solutions of H C lO 4 (7 0 % ) or H IO 4 (7 0 % ) at reflux tem peratures, 
decom position of the starting m ateria ls w as w itnessed and the desired 
products could not be isolated. In  an attem pt to decarbethoxylate 24 
under m ilder conditions, it w as first successfu lly saponified w ith  5 %  
aqueous N aO H  fo llowed by stirring  in 5 0 %  H 2SO 4 at am bient 
tem perature  for 24 h. Unfortunate ly, however, deprotection of the 
dioxolane and decarboxylation did not take p lace in this case.
5 .2 .2  G r ig n a r d  a d d it io n s  to  W - (t r i f lu o r o a c e ty l )p ip e r id in e
S ince  the synthesis of hom opropargylic and hom oallylic 
trifluorom ethylketones by sequentia l a lkylation  and decarboxylation of 
4,4,4-trifluoroacetoacetate (2 0 ) had fa iled  so far, a d ifferent approach 
was pursued. N ,N -Disubstituted am ides of trifluoroacetic  acids are known 
to y ie ld  trifluorom ethylketones 28 upon treatm ent w ith  G rignard
27reagents v ia  the stable te trahed ra l in term ediate 27 (Schem e 5). In  
particu lar, N -(trifluoroacetyl)p iperid ine (26), p repared  from  
trifluo roacetic  anhydride and piperidine, has found w idespread
application  as a suitable p recursor functionality for the introduction of a
28trifluo roacety l moiety.
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XXf3c o c f3
C nh
EtaN 
Et2O 
0°C, o/n
O
X
F3C no
RMgX MgX
F3C^ 0
work-up
XF3C R 
28
26 (91%) 27
Scheme 5 General route towards trifluoromethylketones employing N-(trifluoroacetyl)- 
piperidine (26) as precursor.
W e  set out to fu rther explore this m ethodology by focusing on 
a lly lic  and propargylic ketones. T reatm ent of 26 w ith  e ither
29propargylm agnesium  brom ide or TM S-protected  propargylm agnesium  
brom ide at tem peratures rang ing  from  -78 °C  to rt in  d iethyl e ther did 
not resu lt in  the form ation of any identifiab le products (Schem e 6 ).
19Instead, G C M S  and F-N M R  m easurem ents ind icated  the form ation of a 
m ultitude of d ifferent species. On the other hand, addition of 
a lly lm agnesium  brom ide to 26 in  d iethyl e ther at -78 °C  fo llowed by slow 
w arm ing  to room  tem peratu re  provided the desired  ketone 29 accord ing 
to G C M S  m onitoring of the reaction  m ixture. A fte r work-up and isolation, 
the trifluorom ethylketone w as im m ediate ly stored at low  tem perature 
(-80 °C )  to p revent isom erization of the double bond. Such  w as deem ed 
necessary since a C D C l3 solution of 29 contained a considerable fraction
30of the conjugated isom er 30 after standing for 2 h at room  tem perature. 
Th is is in accordance w ith  previous reports that ß,y-unsaturated 
trifluorom ethyl ketones convert to the corresponding a,ß-unsaturated
31isom ers ra the r quickly.
multiple 
unidentified products
/ ^  R BrMg
R = H, TMS
Me
Et2O 
-78 °C ^ rt 
o/n
26
j^ü-^MgBr on standing
FaC 'O 
29 (41%)
Scheme 6 Treatment of N-(trifluoroacetyl)piperidine (26) with Grignard reagents.
Et2O 
-78 °C ^ rt 
o/n
FaC 'O  
30
Faced  w ith  the unsuccessfu l synthesis of the acetylene-containing 
trifluorom ethylketones and the undesired  isom erization of the ß,y-double 
bond of 29, it seem ed questionable at this point w hether S tre cke r 
reactions on trifluorom ethylketones would  provide a v iab le  route towards 
the targeted  a-CF3-containing unsaturated  amino acids.
5.3 Preparation of acetylene-containing a-CF3-a-amino 
acids
A  ra the r conven ient synthesis of a-CF3-a-amino acids has been published 
by the groups of B u rg e r and Osipov em ploying the addition of G rignard
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reagents to strongly e lectroph ilic im ines derived  from  m ethyl 3,3,3- 
trifluo ropyruvate  (31, Schem e 7 ).32
O 1) NH2-PG N
A . . . .  ............. "
,PGn RMgX 3
HN CO2Me
F3C  'CO2Me 2) dehydration F3C' 'CO2Me Pg
31 PG = Boc, Cbz, SO2Ph 33
32
Scheme 7 Organometallic additions to imines of 3,3,3-trifluoropyruvate (31) according to 
Burger and Osipov.
The la tte r m ethod is com patible w ith  some of the most common 
carbam ate-based N-protecting groups such as Boc and Cbz, and it w as 
put to use in  the p reparation  of a va r ie ty  of orthogonally p rotected  a-CF3 
amino acids. W e  set out to apply this procedure to the synthesis of a-CF3 
acety len ic a-amino acids (Schem e 8 ). Thus, m ethyl 3,3,3-trifluoropyruvate 
(31 ) w as allow ed to react w ith  te r t-butyl urethane to a rrive  at hem iam inal 
34 in quantitative yield . Dehydration  by the action  of trifluoroacetic 
anhydride and pyrid ine furnished Boc-protected im ine 35 a fter d istillation  
under reduced pressure as a colorless oil in  9 3 %  yield.
O
X
F3C CO2Me 
31
Boc 
HN^DH _
F3C CO2Me 
34 (quant)
BrMgr ~ =
,BocN
‘  AF3C CO2Me 
35 (93%)
BrMg
i CO 2Me Boc
36 (77%)
,-TMS F3C
i CO 2Me Boc
37 (1.5%)
TMS
38 (79%)
____HN CO2Me
d Boc
Scheme 8 Syntheses of acetylenic a-CF3-a-amino acids. Reagents and conditions: (a) 
BocNH2, CH2Cl2, rt, 3 d; (b) pyridine, (CF3CO)2O, Et2O, 0 °C, 4 h; (c) THF, -78 °C, o/n; (d) 
THF, -78 ^ -30 °C, o/n.
c
M uch  to our delight, treatm ent of 35 w ith  propargylm agnesium
29brom ide in T H F  at -78 °C  overn ight smoothly afforded the desired Boc- 
protected a-CF3-a-propargylglycine (36, T fm PG ) in good yie ld  (7 7 % ). In  
addition, the allene isom er 37 w as form ed as a byproduct to an extent of 
1 .5%. It  is w orth  noting that this G rignard  addition w as also successfully 
perform ed on 1 0 0  mmol scale w ithout com prom ising the yie ld  or purity. 
Along the same line, exposure of 35 to TM S-protected homopropargyl-
33m agnesium  brom ide provided access to a-CF3-a-homopropargylglycine 
(38 ) in sim ilar effic iency (79% ). Attem pts to prepare the Ts-protected
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counterpart of im ine 35 rem ained  fru itless because dehydration  of the 
corresponding hem iam inal by m eans of SO C l2 and pyrid ine accord ing to
34lite ratu re  procedures did not succeed in our hands. In  addition, 
dehydration  using T F A A  and pyrid ine or the com bination P P h 3 and D IAD  
w ere  probed, but these efforts w ere  also m et w ith  failure. M eanw h ile , a 
synthesis of Boc-Tfm PG-OMe (36 ) via  the same route as outlined in 
Schem e 8 w as published by Shchetn ikov e t a l.34b
5.4 Enzymatic resolution of TfmPG
Enzym atic resolutions of a,a-dialkylated  amino acids have been 
perform ed on a va rie ty  of these substrates. E sp ec ia lly  the reso lution of 
p rim ary am ides by am idases has proven successful for a,a-disubstituted 
amino acids35 (see also: C hap ter 4.1.1) and also for some a-CF3 amino
23acids, in  particu la r T fm Ala and Tfm Phe.
Boc Boc Boc HCl
36 39 (quant) 40 (92%) 41 (75%)
Scheme 9 Conversion of ester 36 into carboxamide 41. Reagents and conditions: (a) 
LiOH, THF / MeOH / H2O, 0 °C ^ rt, o/n; (b) BnO(CO)Cl, Et3N, NH3 in dioxane (0.5 M), 0 
°C ^ rt, o/n; (c) HCl in EtOAc, rt, 4 h.
In  o rder to convert 36 into suitable substrates for am idases, the 
m ethyl ester had to be transform ed into the corresponding p rim ary am ide 
(Schem e 9). O ptim al conditions for this in terconversion 36 w ere  found in 
saponification of the ester to give the free acid  39, fo llowed by 
consecutive treatm ent w ith  benzyl ch loroform ate in  the presence of E t 3N  
and a solution of am m onia in  dioxane. Boc-protected am ide 40  obtained 
by this sequence w as then deprotected  using H C l in  E tO A c to a rrive  at 
am ine 41 as its H C l salt.
37Fo llow ing  a known procedure, an aqueous solution of 41 was 
incubated w ith  an am inopeptidase obtained from  O ch ro b a c tru m  an th rop i 
N C IM B  4032138 in the presence of Z n SO 4 (c = 1 m M ) at pH  8.1 at 40 °C , 
but no conversion could be detected  a fter 24 h (Schem e 10). S ince  the 
am idase of O. an th rop i d isp lays the broadest substrate to lerance of the 
am idases com m only used for enzym atic reso lutions,23a,:39 w e set out to 
look into other enzymes. W e  anticipated  that stereoselective digestion of 
the m ethyl ester of T fm PG  by a lca lase  m ight provide an a lte rnative  w ay  of 
perform ing the enzym atic resolution. Reso lution experim ents revealed  
that by using an excess of cross-linked enzyme aggregate a lca lase (C L E A  
A lca lase® ; pH  7.5, phosphate buffer, 20 °C , 48 h) se lective saponification
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of one enantiom er of Boc-protected m ethyl ester 36 took place (Schem e 
10). Thus, the free acid  (+)-39 w as obtained w ith  an ee  of 8 1 %  in a yie ld  
of 8 7 %  (based on 5 0 %  conversion). The absolute configuration of the 
reso lved  am ino acid, however, has not been determ ined as of yet.
CF.
amidase of 
O. anthropi
--- ^---► no conversion
H2N COnH2 ZnSO4, pH 8.1
HCl 40 °C, 24 h
41
HN
CLEA Alcalase
3
I CO2Me pH 7.5, 20 °C Boc 48 h36
HN CO2H Boc
(+)-39 (87%) 
81 % ee
F3C" . 
MeO2C NH Boc
36a
Scheme 10 Enzymatic resolution of TfmPG using different enzymes.
5.5 Coupling reactions of TfmPG
5.5.1 P e p t id e  c o u p lin g s  to th e  C - te rm in u s
Peptide coupling of Boc-protected amino acid  39 w ith  g lycine m ethyl 
ester hydrochloride w as accom plished sm oothly by e ither using ED C  and 
H O B t in the presence of D iP E A  in good y ie ld  (8 3 % ) or by H A T U  in the 
presence of D iP E A  in near quantitative  e ffic iency (Schem e 11).
F3C.
HIN iBoc O 
39
OH HCl ■ H-Gly-OMe
a or b F3C.
HN' iBoc O
Gly-OMe
42 (83% via a)
(quant via b)
Scheme 11 Peptide coupling to the C-terminus of 39. Reagents and conditions: (a) EDC, 
HOBt, DiPEA, CH2Cl2, rt, o/n; (b) HATU, DiPEA, CH2Cl2, rt, o/n.
Apparently, am ide bond form ation w as not s ign ificantly im peded by 
the steric bu lk  around the quaternary  amino acid  carbon. Furtherm ore, 
the strong ly e lectron-w ithdraw ing a-CF3 group most probably has an 
activating  effect on coupling to the C -terminus of Tfm PG .
5 .5 .2  P e p t id e  b o n d  fo rm a t io n  a t th e  W - te rm in u s
Peptide bond form ation at the N-term inus of T fm PG  w as expected to be 
quite cum bersom e as, in  addition to the steric hinder, the nucleoph ilic ity  
o f the a-nitrogen is considerab ly decreased  due to the strongly electron- 
w ithd raw ing  a-CF3 group. In  fact, chain  elongations of a-CF3 am ino acids
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at the am ino group are considered challenging reactions .193 Indeed, 
attem pted couplings of H-TfmPG-OMe (43), p repared  by HCl-m ediated 
deprotection  of 36, w ith  Boc-Gly-OH by em ploying e ither D IP C D I or 
H A T U  failed  (Schem e 12). In  both cases, no consum ption of the trifluoro- 
m ethylated  am ino acid  w as observed.
HNIBoc
CF3
CO2Me
HCl (2.5 M in 
EtOAc)
rt, 4h
-CF3
CO2Meh2n
HCl
36 43 (85%) ""w " - 44
CH2Cl2, rt, 24 h
Scheme 12 Attempts to effect N-terminal peptide bond formation on TfmPG.
Boc-Gly-OH 
HATU, DiPEA
---- X---- i
CH2Cl2, rt, 24 h
Boc-Gly-OH 
DiPCDI, HOBt 
DiPEA
---- X----
Boc O
hB.— O CF3
CO2Me
W e  reasoned that more forcing conditions w ere  requ ired  to 
elongate the N-term inus of 43. There  are some reports in  lite ratu re  
describ ing peptide coupling to a-CF3 amino acids, m ostly by using acid  
halides as acy lating  reagen ts .40 Thus, the acid  ch loride of Fm oc-protected 
g lycine (45 ) w as p repared  and added to a solution of H-TfmPG-OMe 
(Schem e 13) in  T H F  in the presence of an excess of 2,6-lutidine. 
G ratifying ly, the d ipeptide Fmoc-Gly-TfmPG-OMe (46 ) could be isolated, 
a lbeit in a ra the r low  y ie ld  of 2 1 % .
2,6-lutidine, O i
H , n-CF3 + HN C °a  ----------► FmocHN^X ^C F3
2 CO2Me Fmoc THF, rt, 90 min n CO2Me
HCl 43 45 46 (21 %)
Scheme 13 Incorporation of TfmPG into a dipeptide via reaction with acid chloride 45.
5 .5 .3  O th e r  W - fu n c t io n a liz a t io n s
The g reatly  reduced reactiv ity  of the N-term inus of T fm PG  becam e 
also apparent w hen  try ing  to repro tect 43 w ith  carbamate- or 
sulfonamide-based protecting groups. W e  w ere  especia lly  in terested  in 
the insta llation  of a sulfonam ide in o rder to be able to fo llow  the genera l 
protocol for the synthesis of enediynes as disclosed in C hap ter 2.3. 
Despite probing a num ber of conditions, the N-term inus of 43 could not 
be protected  by the action of e ither TsCl, TsF, M sC l, T f2O or Bo c2O (Table 
2). No consum ption of starting m ateria l w as observed under any of these 
conditions.
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Table 2 Conditions probed for the N-protection of 43.
entry reagent conditions entry reagent conditions
1 Boc2O Na2CO3,
H 2O/dioxane
5 TsCl Me2N(CH2)3NMe2,
MeCN
2 Boc2O E t3N, MeCN/CH2Cl2 6 TsF DBU, BSA, CH 2Cl2
3 TsCl E t3N, DMAP, CH 2Cl2 7 MsCl Et3N, CH 2Cl2
4 TsCl TMEDA, DMAP, 
M eCN
8 Tf2O py, CH 2Cl2
All reagents were mixed at 0 °C followed by gradual increase of temperature to rt and 
finally to 50 °C.
In  analogy to the peptide couplings, the only successful 
functionalization of am ine 43 em ployed acy l ch lorides (Schem e 14). 
Sub jecting  43 to e ither AcC l, BzC l or 4-NO2C 6H 4(C O )C l in  M eC N  at 
am bient tem perature  under basic conditions afforded the am ides 47-49 
in m ediocre y ie lds (25-49%).
43 47, R =Me (49%)
48, R =Ph (25%)
49, R =4-NO2C6H4(41%)
Scheme 14 N-Acylation of TfmPG using acyl chlorides.
5.6 Miscellaneous reactions of TfmPG
5.6.1 H y d ro g e n a t io n
The propargyl functionality  of T fm PG  endows this amino acid  w ith  
synthetic ve rsa tility  since it can be easily  reduced  to provide the 
corresponding a lly l or n-propyl derivatives (Schem e 15). Hydrogenolysis 
of 36 catalyzed by Pd  on charcoa l gave access to fu lly  p rotected  a-CF3- 
norvaline (50), w h ile  reduction by the action  of L in d la r cata lyst in  the 
presence of quinoline led to a-CF3-allylglycine 51. Bo th  reactions 
proceeded in excellent y ie lds of 90 and 93% , respectively.
Me
CF3
CO2Me
H2Pd/C
EtOH, rt, 1 h
CF3 
CO 2Me
H2
Lindlar catalyst 
quinoline --------- »
EtOH, rt, 2 h HN
CF3
i CO 2Me Boc
50 (90%) 36
Scheme 15 Full and partial hydrogenation of 36.
51 (93%)
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5.6 .2  P a u s o n - K h a n d  r e a c t io n
R ig id  am ino acid ic scaffolds as w e ll as functionalized heterocycles 
are  a ttractive  targets in the fields of peptide research  and m edicinal
41chem istry. In tram o lecu lar Pauson-Khand (P K ) reactions on unsaturated  
a-H-amino acids such as a lly lg lycine  and propargylg lycine have been put 
to use by the groups of Bo lton  and Kotha in o rder to a rrive  at 
cyclopentenone-fused p ipecolic acid  d eriva tives .42 The group of Bonnet- 
Delpon has investigated  the use of the P K  reaction  of C F 3-substituted aza-
43enynes for the synthesis of fluorinated  piperidines. These lite ratu re  
p recedents spurred us to look into in tram o lecu lar P K  reactions em ploying 
T fm PG  as substrate (Schem e 16).
Boc-protected m ethyl ester 36 w as N-allylated by treatm ent w ith  
a lly l brom ide and sodium hydride in  a T H F/D M F  mixture, g iving rise to 
enyne 52.44 Addition of Co2(C O )8 caused the form ation of the typ ica l 
in term ediate cobalt com plex w ith in  2.5 h in  C H 2C l2 at am bient 
tem perature. Subsequent oxidative decom position of th is complex by the 
action of N-methylmorpholine-N-oxide (N M O ) at tem peratures going from
0 °C  to room  tem perature  afforded the b icyclic  fluorinated  amino acid  53 
in a y ie ld  of 30% . Accord ing to L C M S  m easurem ents, the isolated product 
consisted of two diastereo isom ers in  a ratio  of 1 :1 0 .
-ÿÿ:s'.~.'Br 
NaH, THF/DMF
1)Co2(CO)8,CH2Cl2 
rt, 2.5 h
-CF3
i CO2Me Boc 2)NMO, CH2Cl2 0°C ^ rt, o/n
HN CO2Me 0°C ^ rt, o/n NBoc 
36 52 (56%)
Scheme 16 Intramolecular Pauson-Khand reaction of TfmPG.
CF3
N CO2Me 
Boc
53 (30%) 
dr = 1:10
5.7 Towards cyclic CF3-containing enediyne amino 
acids
One of the intended applications for T fm PG  w as the construction  of the 
corresponding cyclic  enediyne-containing amino acids. The genera l 
p rocedure for the synthesis of such enediyne amino acids v ia  an 
in tram o lecu lar M itsunobu reaction  as outlined in C hap ter 2.3.2 could not 
be applied in  th is case due to the need for a reasonab ly acid ic 
sulfonam ide nucleoph ile .45 Unfortunate ly, in  our hands the tosylated 
derivative  of T fm PG  could not be synthesized (v id e  s u p ra ). As an 
a lte rnative  for the M itsunobu cyclization, w e turned our attention to a 
strategy based on in tram o lecu lar nucleophilic d isp lacem ent as depicted
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in  Schem e 17. Thus, acyclic  enediyne alcohol 55 w as assem bled in good 
y ie ld  (8 5 % ) by a Sonogashira-type reaction  betw een  Boc-protected T fm PG  
36 and a ry l iodide 5 4 .46 Conversion of 55 into the corresponding 
m esylate 56 proceeded sm oothly upon treatm ent w ith  M sC l and E t3N  in 
C H 2C l2. W ith  the m esylate at hand, the stage w as set for a base-induced 
cyclization. Exposure of 56 in T H F  to L iH M D S  at -78 °C  followed by 
w arm ing up to 0 °C , however, qu ick ly led to decom position of the 
substrate w ithout noticeable product form ation. On the other hand, 
addition of N a H  to a d ilute solution of 56 in D M F  at 0 °C  resu lted  in  the 
consum ption of starting m ateria l w ith  concom itant appearance of a new  
spot on T L C  at a m uch h igher R f  value. The T LC  characteristics  of the 
reaction  ve ry  m uch resem bled  that of a successful enediyne cyclization.
Scheme 17 Route towards a trifluoromethylated cyclic enediyne-containing amino acid. 
Reagents and conditions: (a) Aryl iodide 54, PdCl2(PPh3)2 (cat), CuI (cat), Et2NH, Et2O, rt, 
4 h; (b) MsCl, Et3N, CH2Cl2, 0 °C, 2 h; (c) NaH, DMF, 0 °C, 2 h.
Work-up fo llowed by flash chrom atography afforded an im pure 
product fraction  which, accord ing to L C M S  m easurem ents, contained 
approxim ately 2 2 %  of a compound w ith  an m/z corresponding to that of 
target structure 57. Fu rth e r support for the form ation of 57 w as provided
1
by H -N M R  spectra of the product fraction  show ing peak patterns that 
a re  typ ica l of the propargylic N -C H 2 and the ß-H protons in  cyclic  
enediyn ic am ino acids. Fu rth e r experim entation and characterization , 
however, are  requ ired  for conclusive s tructu ra l proof.
5.8 Conclusion
The synthesis of orthogonally protected  a-CF3-a-propargylglycine 
(T fm PG ) and a-CF3-a-hom opropargylglycine has been disclosed. In  
addition, k inetic enzym atic resolutions of the T fm PG  am ide and m ethyl 
ester w ere  b rie fly  explored. Enan tiose lective  saponification of the m ethyl 
ester w as ach ieved  by the action  of C L E A  a lca lase  to provide the 
corresponding optica lly  enriched  free acid. Enzym atic reso lution of the 
am ino acid  am ide using an am idase from  O. an th rop i ream ained 
unsuccessful. Peptide couplings to the C-terminus of T fm PG  w ere
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successfu lly realized by comm on coupling reagents i.e. H A TU , ED C . 
Functionalizations of the am ine, on the other hand, requ ired  m ore harsh 
conditions in  the form  of acy l ch loride coupling partners.
Fu rth e r exploration of the chem istry of T fm PG  w as aim ed at 
exploiting the C= C trip le  bond. A  b icyclic  a-CF3-substituted am ino acid  
w as p repared  from  T fm PG  by m eans of a Pauson-Khand reaction. 
Sub jection  to p artia l or fu ll hydrogenation conditions gave rise  to the 
corresponding a lly lg lycine  and norvaline am ino acids, respectively.
F ina lly , experim ents tow ards the synthesis of cyclic  trifluoro- 
m ethylated  enediyne-containing amino acids have been perform ed.
5.9 Acknowledgements
M artijn  Klop is g ra te fu lly  acknow ledged for his synthetic endeavours into 
the trifluorom ethyl ketones. I am  indebted to Dr. Pe te r J. L. M . Quaedflieg 
and Tim o Nuijens (D SM  Pharm aceu tica l Products, Geleen, The 
N etherlands) for tak ing care  of the enzym atic reso lution of T fm PG  36. 
Tom as van  Nassau  and Jo rg  de Ru ijte r are k ind ly thanked for probing the 
reactiv ity  of 43 tow ards acy l chlorides. A straZeneca  R & D  (M acclesfie ld , 
U K ) is k ind ly thanked for g iving me the opportunity to partic ipate  in a 
C A S E  p lacem ent. The fru itfu l d iscussions w ith  Dr. Sam  Bu tte rw o rth  
(A straZeneca  R & D , M acclesfie ld , U K ) w ere  m uch appreciated.
5.10 Experimental section
5.10.1 G e n e r a l  in fo rm a t io n
F o r  genera l in form ation about methods, m ateria ls and instrum entation, 
see experim ental section of Chapter 2.
5.10.1 P r e p a r a t iv e  p ro c e d u re s
(2-Trifluorom ethyl-1,3-dioxolan-2-yl)acetic ac id  e thyl e s te r  (23)
I—\ A solution of ETFAA (0.40 g, 2.17 mmol) and K2CO3 (0.60 g, 4.34
° w °  ft mmol) in THF (6 mL) was added 2-chloroethanol (0.16 mL, 2.39 
F3c ^ x ''iD E t  mmol). The reaction mixture was refluxed for 24 h and then poured 
into saturated aqueous NH4Cl (10 mL). After phase separation, the organic layer 
was dried over Na2SO4 and concentrated in vacuo. Reduced pressure distillation 
yielded the title compound as a colorless oil (0.35 g, 1.53 mmol, 70%). 
öh (300 MHz, CDG 3) 4.24-4.13 (6 H, m), 2.89 (2 H, s), 1.27 (3 H, t, J  = 7.1 Hz); <5c 
(75 MHz, CDG 3) 166.7, 123.8 (q, 1Jcf = 291 Hz), 103.9 (q, 2Jcf = 32 Hz), 6 6 .8 ,
60.4, 36.4, 13.6; öf (282 MHz, CDCl3) -84.27; the characterization data were 
consistent with ref. 26.
2-(2-Trifluorom ethyl-1,3-dioxolan-2-yl)pent-4-enoic ac id  ethy l e s te r  (24)
/-\ A solution of dioxolane 23 (200 mg, 0.87 mmol) in THF (5 mL) at -
^ / °  fî 78 0C was treated with NaHMDS (1.0 M in THF; 0.90 mL, 0.90 
F3c ^ ^ f i ° E t  mmol) and stirred for 30 min followed by the addition of HMPA 
(0.45 mL, 2.59 mmol, 3 equiv). Stirring was continued for another
10 min before allyl bromide (0.14 mL, 0.87 mmol) was added
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whereupon the temperature was gradually raised to ambient temperature over 
the course of 4 h. The reaction mixture was partitioned between saturated 
aqueous NH4Cl (10 mL) and Et2O (10 mL), and the phases were separated. The 
aqueous phase was extracted with Et2O (2x 4 mL) and the combined organic 
phases were washed with water and brine followed by drying over Na2SO4. 
Removal of all volatiles and bulb-to-bulb distillation of the residue under reduced 
pressure afforded the alkylated dioxolane 24 as a clear yellowish oil (194 mg,
0.72 mmol, 83%).
öh (300 MHz, CDG 3) 5.8-5.6 (1 H, m), 5.2-5.0 (2 H, m), 4.3-4.1 (6 H, m), 3.1-2.4 (3
H, m), 1.25 (3 H, t); öc (75 MHz, CDG3) 169.4, 133.5, 122.5 (q, 1Jcf = 291 Hz),
116.7, 104.7 (q, 2Jcf = 124 Hz), 66.9 (2 C), 60.2, 48.0, 30.3, 13.5; Öf (282 MHz, 
CDCl3)-81.57; MS (ESI) m/z 269 ([M + H]+), 241 ([M]+-C2H4), 227 ([M]+-allyl), 183, 
163, 141, 127, 85, 69 (CF3).
2-(2-Trifluorom ethyl-1,3-dioxolan-2-yl)pent-4-ynoic ac id  ethy l e s te r  (25)
/—\ Following the procedure described for 24, dioxolane 23 (200 mg,
° v , °  Q 0.87 mmol) in THF (5 mL) was alkylated by the action of NaHMDS 
F3c ^ S p o E t  (1.0 M in THF; 0.90 mL, 0.90 mmol), HMPA (0.45 mL, 2.59 mmol, 3 
k .. equiv) and propargyl bromide (80% wt solution in toluene; 0.97 mL, 
^  0.87 mmol). Work-up and short path distillation furnished the 
propargylated dioxolane 25 as a yellow oil (162 mg, 0.61 mmol, 70%) 
öh (300 MHz, CDG 3) 4.3-4.1 (4 H, m), 3.47 (2 H, q), 2.9-2.3 (3 H, m), 1.85 (1 H, m),
I.27 (3 H, t); öc (75 MHz, CDG 3) 168.7, 122.3 (q, 1Jcf = 191 Hz), 104.1 (q, 2Jcf = 
13 Hz), 79.6, 69.6, 66.8 (2 C), 60.8, 47.8, 16.2, 13.5; Öf (282 MHz, CDCh) -81.80; 
MS (ESI) m/z 267 ([M + H]+), 227([M]+-propargyl), 187, 159, 149, 141, 83, 69 (CF3); 
LCMS 3.79 min (m/z = 267).
^ -(T rifluo roacety l)p iperid ine  (26)
o The title compound was prepared by an adapted literature
r A  procedure from ref. 28b. Thus, a cooled (0 °C) solution of piperidine 
f f k  J  (3.8 mL, 40 mmol) and Et3N (4.6 mL, 32 mmol) in Et2O (45 mL) was 
treated dropwise with a solution of trifluoroacetic anhydride (4.6 mL, 
32 mmol) in Et2O (10 mL). After stirring overnight, the reaction mixture was 
washed with 0.2 M HCl (2x 30 mL) and then with water to neutrality, followed by 
washing with brine. Drying over Na2SO4 and removal of all volatiles gave 26 as a 
clear, colorless liquid sufficiently pure for further use (5.33 g, 29 mmol, 91%). 
öh (300 MHz, CDG 3) 3.55-3.44 (4 H, m), 1.67-1.52 (6 H, m); Öc (75 MHz, CDCh)
154.6 (q, 2Jcf = 35 Hz), 116.1 (q, 1Jcf = 288 Hz), 46.1, 43.9, 25.7, 24.7, 23.5; Öf 
(282 MHz, CDG 3) -70.11.
1,1,1-Trifluoropent-4-en-2-one (29)
n A stirred solution of N-(trifluoroacetyl)piperidine (26; 1.00 g, 5.52 mmol) 
^  in Et2O (40 mL) at -78 °C was treated dropwise with a solution of 
L allylmagnesium bromide (1.0 M in Et2O; 5.6 mL, 5.6 mmol). The reaction 
F3C °  mixture was stirred overnight during which time it was allowed to come 
to ambient temperature. Saturated aqueous NH4Cl (100 mL) was added slowly 
and the layers were separated. The ether layer was washed with 1 M KHSO4 and 
brine followed by drying over MgSO4. Careful removal of the solvent in vacuo 
provided the title compound as a yellowish fluid (0.31 g, 2.24 mmol, 41%). 
Caution: 1,1,1-trifluoropent-4-en-2-one is a strong lachrymator.
0H (300 MHz, CDCl3) 6.0-5.8 (1 H, m), 5.33-5.18 (2 H, m), 2.7-2.5 (2 H, m), 2.3-2.0 
(2 H, m); öC (75 MHz, CDCl3) 188.3 (q, 2J cf = 35 Hz), 129.5, 118.4, 114.6 (q, 1J CF = 
290 Hz), 32.2; öF (282 MHz, CDCl3) -75.0; GCMS (EI): 2.19 min, m/z 139 ([M + H]+), 
115, 95, 91, 71, 69 (CF3), 67, 51, 42, 41, 39).
A CDCl3 solution of the title compound contained a considerable amount of isomer 
30 upon standing at ambient temperature for 2 h .30
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2-feri-B utoxycarbonylam ino-3,3,3-trifluoro-2-hydroxypropionic ac id  m ethy l e s te r  
(34)
h °  nhboc The title compound was synthesized according to a procedure of 
X  Dessipri et al.47 A three-neck round-bottom flask equipped with aF C c °  Me i l i
3 2 reflux condenser was put on a water bath (ambient temperature). The 
flask was charged with tert-butyl carbamate (18.56 g, 158.4 mmol) and the 
minimum volume of CH2CI2 to dissolve the latter (~40 mL). Methyl 
trifluoropyruvate (24.97 g, 160.0 mmol) was added, causing a slight increase of 
temperature. The contents of the flask were stirred for 3 days after which time all 
volatiles were removed in vacuo to provide crude hemiaminal 34 as a white solid 
(42.92 g, 157.1 mmol, quant).
Rf 0.64 (EtOAc/heptane, 1:1); öh (300 MHz, CDCI3) 5.78 (1 H, s), 5.40 (1 H, br s), 
3.93 (3 H, s), 1.44 (9 H, s); öc (75 MHz, CDCI3) 166.7, 153.9, 121.4 (q, 1Jcf = 288 
Hz), 82.5, 81.0 (q, 2Jcf = 32 Hz), 54.7, 28.0; öf (282 MHz, CDCI3) -81.17.
2-feri-B utoxycarbonylim ino-3,3,3-trifluoropropionic ac id  m ethy l e s te r  (35)
, Boc The title compound was produced following the procedure in ref. 47. 
N Thus, crude hemiaminal 43 (42.90 g, 157.0 mmol) was dissolved in
f 3c  c o 2Me Et2O (350 mL) inside a three-neck round-bottom flask equipped with 
thermometer and septa. The solution was cooled to 0 °C whereupon 
pyridine (29.0 mL, 358.6 mmol, 2.3 equiv) and trifluoroacetic anhydride (25.0 mL,
179.7 mmol, 1.1 equiv) were added simultaneously dropwise via syringe over a 
period of 2 h. Care was taken for the internal temperature not to exceed 3 °C. 
Stirring was continued for an additional 2 h before the precipitate formed was 
removed by filtration and washed with iso-hexane.48 The combined filtrates were 
concentrated in vacuo and the oily residue thus obtained was taken up in iso­
hexane (~150 mL) and cooled to 0 °C causing the formation of additional 
quantities of precipitate. The suspension was filtered, the residue was washed 
with iso-hexane, and the combined filtrates were concentrated by rotary 
evaporation to give a yellowish oil (39.5 g). Reduced pressure distillation (1.0 
mbar, 42 °C) afforded pure 35 as a colorless, clear liquid (37.2 g, 145.8 mmol, 
93%).
öh (300 MHz, CDCI3) 3.91 (3 H, s), 1.54 (9 H, s); öc (75 MHz, CDCI3) 156.9, 155.5,
145.9 (q, 2Jcf = 38 Hz), 117.9 (q, 1Jcf = 279 Hz), 85.4, 53.8, 27.7; öf (282 MHz, 
CDCI3) -70.72; GCMS (EI) 9.07 min, m/z 145 ([M-*BuOCO]+), 128 (HC=NBoc+), 96 
(CF3C=NH+), 69 (CF3), 57 (*Bu).
2-feri-B utoxycarbonylam ino-2-trifluorom ethylpent-4-ynoic ac id  m ethy l e s te r  (36) 
and
2-feri-B utoxycarbonylam ino-2-trifluorom ethylpenta-3,4-dienoic ac id  m ethy l e s te r
(37) 29Preparation of propargylmagnesium bromide29 
A three-neck round-bottom flask equipped with addition
hn_ N CF3 and hn^-CF3 funnel, reflux condenser, thermometer, nitrogen inlet 
BocC° 2Me nocC° 2Me and a big stirring bar was loaded with snippets of
magnesium ribbon (4.4 g, 181 mmol) and HgCl2 (100 mg,
0.37 mmol). The flask was evacuated, heated with a heat gun and then allowed to 
come to room temperature while its atmosphere was replaced with nitrogen. The 
magnesium snippets were covered with Et2O (~50 mL), and the addition funnel 
was charged with propargyl bromide (80% wt in toluene; 16.5 mL, 148 mmol). 
Approximately one 10 of the propargyl bromide was added to the magnesium 
along with one crystal of iodine, causing the exothermic reaction to start 
immediately. While adding more of the propargyl bromide very slowly, an 
additional portion of Et2O (90 mL) was transferred into the flask, and stirring was 
started. The flask was put on an ice bath and the remainder of the bromide was 
added at such a rate to keep the internal temperature below 10 °C. After the 
addition of the bromide was complete, stirring was continued for 2 h on a 
water/ice bath. Stirring was stopped, and the heterogenous reaction mixture was
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allowed to settle. The clear, greyish supernatant was transferred into a Schlenk 
flask via cannula and stored at -20 °C for further use. Caution: the "sediment" of 
the reaction mixture contains elemental mercury.
Titration: The Grignard reagent was titrated against a solution of (±)- 
menthol (1 mmol) in THF (5 mL) using 1,10-phenanthroline as indicator (end 
point: yellow ^  pink / brown). The titer was found to be 1.1 molL-1.
Grignard reaction
A three-neck round-bottom flask equipped with addition funnel, nitrogen inlet and 
a big stirring bar was charged with THF (130 mL) and imine 35 (26.67 g, 104.5 
mmol), and the resulting solution was cooled to -78 °C. A solution of 
propargylmagnesium bromide (1.1 M in Et2O; 100 mL, 110 mmol) was transferred 
into the addition funnel. This Grignard reagent was added dropwise to the 
vigorously stirred imine over a period of 1 h, resulting in a yellow, slurry-like 
reaction mixture that remained stirrable. Stirring was continued at -78 °C 
overnight after which time 19F-NMR of a worked-up sample indicated completion 
of the reaction. The reaction mixture was carefully neutralized using 0.5 M HCl 
(~250 mL) while keeping the temperature below 10 °C. Solid NaCl (10 g) was 
added, the phases were separated, and the aqueous layer was extracted with 
Et2O (3x 50 mL). The combined organic layers were washed with a saturated 
solution of NaHCO3 and brine followed by drying over MgSO4. Removal of all 
volatiles and flash chromatography (EtOAc/iso-hexane, 1:10 ^  1:5) of the crude 
product afforded the propargylated compound 36 (22.43 g, 76.0 mmol, 73%) and 
the allenyl compound 37 (447 mg, 1.51 mmol, 1.5%) as white solids. 
Characterization data of 36 :
Rf 0.67 (EtOAc/heptane, 1:1); vmax (ATR) 3407, 3299, 2124, 1748, 1731, 1498, 
1307, 1255, 1161, 1018, 637; Öh (300 MHz, CDCI3) 5.67 (1 H, br s), 3.90 (3 H, s), 
3.69 (1 H, br d, J  = 16.8 Hz), 3.10 (1 H, dd, J  = 16.8 Hz, 2.7 Hz), 2.05 (1 H, t, J  =
2.7 Hz), 1.46 (9 H, s); 1H-NMR data were consistent with those reported in ref. 
34b; öc (75 MHz, CDCI3) 166.2 (q, 3Jcf = 1.4 Hz), 153.2, 123.3 (q, 1Jcf = 288 Hz), 
80.9, 76.2, 72.1, 64.5 (q, 2Jcf = 29 Hz), 54.1, 28.0; Öf (282 MHz, CDCI3) -74.77; 
HRMS (ESI) calcd. for C12H16F3NNaO4 (M+ + Na) 318.0924, found 318.0927. 
Characterization data of 37 :
Rf 0.62 (EtOAc/iso-hexane, 1:2); Öh (400 MHz, CDCI3) 5.60 (1 H, t, J  = 6.7 Hz), 5.19 
(2 H, d, J  = 6.7 Hz), 3.84 ( 1 H, s), 1.44 ( 9 H, s); Öc (126 MHz, CDCI3) 207.6, 165.7,
153.4, 123.3 (q, 1Jcf = 292 Hz), 87.3, 81.9, 81.3, 63.4 (q, 2Jcf = 29 Hz), 53.3, 27.9; 
öf (471 MHz, CDCI3) -75.19.
2-ferf-B utoxycarbonylam ino-2-trifluorom ethyl-6-trim ethylsilanylhex-5-ynoic acid  
m ethy l e s te r  (38)
S¡Me3 Preparation of 4-(trimethylsilyl)but-3-ynylmagnesium bromide33 
II Magnesium snippets (2.90 g, 119 mmol) were covered with THF (50
II mL) inside a three-neck round-bottom flask equipped with reflux 
J  condenser, nitrogen inlet and addition funnel. The addition funnel was 
charged with (4-bromobut-1-ynyl)trimethylsilane (14.37 g, 70 mmol). 
HN c ° FMe A crystal of iodine was added to the magnesium along with 1/10th of 
b o c  2 the alkyl bromide. Once the exothermic reaction had started, stirring 
was initiated, and an additional quantity of THF (80 mL) was added. The 
remainder of the bromide was added at such a rate to maintain a temperature of 
50 °C. After the addition was complete and the exothermic reaction had subsided, 
the reaction mixture was heated to reflux for another 15 min. The heat source 
was removed and the reaction mixture was left to stand in order to settle. The 
clear, slightly greenish supernatant was used in the next step.
Titration: the supernatant was titrated against a solution of (±)-menthol 
(1.00 mmol) in THF (5 mL) using 1,10-phenanthroline as indicator (end point: 
yellow ^  red / brown). The titer was found to be 0.35 molL-1.
Grignard reaction
A three-neck round-bottom flask equipped with addition funnel, nitrogen inlet and 
a big stirring bar was charged with THF (60 mL) and imine 35 (10.06 g, 39.42
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mmol), and the resulting solution was cooled to -78 °C. The Grignard reagent 
(0.35 M in THF; 120 mL, 42 mmol) was transferred into the addition funnel and 
slowly added to the vigorously stirred imine over a period of 30 min. Stirring was 
continued overnight, allowing the temperature to rise to -30 °C. Water (60 mL) 
followed by 1 M HCl (60 mL) were added carefully to the amber-colored reaction 
mixture while keeping its temperature below 10 °C. Et2O (100 mL) and NaCl (5 g) 
were added, the phases were separated, and the aqueous phase was extracted 
with Et2O (3x 40 mL). The combined organic layers were washed with a saturated 
solution of NaHCO3, then with brine and finally dried over MgSO4. Purification by 
flash chromatography (Et2O/iso-hexane, 0% ^  10%) yielded 38 as a colorless 
syrup that slowly solidified on standing (11.87 g, 31.12 mmol, 79%).
Rf 0.52 (EtOAc/iso-hexane, 1:7); öh (400 MHz, CDCI3) 5.66 (1 H, br s), 3.86 (3 H, s),
2.82 (1 H, br s), 2.45-2.32 (2 H, m), 2.24-2.12 (1 H, m), 1.45 (9 H, s), 0.15 (9 H, s); 
öc (101 MHz, CDCI3) 167.0, 153.3, 124.0 (q, 1Jcf = 288 Hz), 104.5, 86.0, 80.9, 65.1 
(q, 2Jcf = 29 Hz), 53.7, 28.5, 28.0, 14.6, 0.1; Öf (471 MHz, CDCI3) 74.87; HRMS (EI) 
calcd. for C n H ^ N O ^ i  (M+-Boc) 281.1059, found 281.1048.
2-ferf-B utoxycarbonylam ino-2-trifluorom ethylpent-4-ynoic ac id  (39)
via chemical saponification
Methyl ester 36 (8.87 g, 30.0 mmol) was dissolved in THF (50 mL). 
HN' \ _CF3 Methanol (250 mL) was added and the resulting solution was cooled to 
Bocc02H 0 °C. A cold (~4 °C) aqueous solution of LiOH (1 M; 100 mL, 100 mmol) 
was added in four portions, and the reaction mixture was stirred 
overnight during which time it was allowed to reach ambient temperature. The pH 
was adjusted to 7 using 4 M HCl, and the organic solvents were removed in vacuo. 
The aqueous remainder was acidified to pH 1 with 4 M HCl, and EtOAc (100 mL) 
was added. The phases were separated and the water layer was extracted with 
EtOAc (3x 30 mL) followed by consecutive washing of the combined organic 
phases with water (1x 30 mL) and brine (1x 30 mL). Drying over MgSO4 and 
concentration to dryness yielded the crude product. Traces of acetic acid49 and 
water were removed by repeated co-evaporation with toluene. The title compound 
was obtained as a slightly yellowish, clear mass that solidified on standing (8.36 g,
29.7 mmol, quant).
Rf 0.17 (EtOAc/heptane/MeOH, 10:10:3); vmax (KBr) 3407, 3310, 2984, 1746, 1660, 
1398, 1171, 1043, 656; Öh (400 MHz, CDCI3) 9.94 (1 H, br s), 5.72 (1 H, br s), 3.58 
(1 H, br s), 3.17 (1 H, dd, J  = 16.9, 2.5 Hz), 2.09 (1 H, t, J  = 2.5 Hz), 1.47 (9 H, s); 
öc (75 MHz, DMSO-de) 166.1, 153.3, 124.1 (q, 1Jcf = 286 Hz), 79.3, 76.9, 74.4,
62.9 (q, 2Jcf = 27 Hz), 27.8, 22.5; Öf (282 MHz, DMSO-de) -71.89; HRMS (ESI) 
calcd. for Cn H15F3NO4 (M++H) 282.09532, found 282.09497.
via enzymatic resolution
I Methyl ester 36 (50 mg, 0.169 mmol) was dissolved in ’BuOH (3 mL;
HNA '”CF3 pre-heated to 45 °C) followed by the addition of phosphate buffer (3 
Bocc02H mL; pH 7.5, buffer strength 50 mM). CLEA Alcalase® (900 mg) was 
enantiomeri added, and the sample was agitated with 200 rpm at 20 °C. After 48
h, the reaction mixture was filtrated over a P4 glass filter, and the 
residue was washed with phosphate buffer (2x 10 mL; pH 7.5, buffer strength 50 
mM). The combined filtrates were washed with CH2CI2 (2x 25 mL) and then 
acidified to pH 2.5 with 2 M HCl. The acidic aqueous phase was extracted with 
CH2CI2 (2x 25 mL), and the organic extracts were washed with brine (25 mL) and 
dried over Na2SO4. Removal of all volatiles followed by co-evaporation with 
toluene (2x 20 mL) and CHCl3 (2x 20 mL) furnished optically enriched (+)-39 as a 
clear colorless oil (21 mg, 0.074 mmol, 87% based on 50% conversion).
[a ]22D = +8.3° (c 0.54, MeOH); ee = 81%.
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1-C arbam oyl-1-trifluorom ethyl-but-3-ynylcarbam ic ac id  ferf-butyl e s te r  (40)
A cooled (0 °C) solution of carboxylic acid 39 (7.53 g, 26.77 mmol) in 
THF (75 mL) was treated with Et3N (5.2 mL, 37.5 mmol) and stirred for 
. x-cf3 15 min. Benzyl chloroformate (5.3 mL, 37.5 mmol) was added causing 
noc cONH2 the formation of a white precipitate. Stirring was continued at 0 °C for
1 h before ammonia (0.5 M in dioxane; 100 mL, 50 mmol) was added. 
The reaction mixture was left to stir overnight during which time it was allowed to 
reach ambient temperature. All volatiles were removed, and the resulting residue 
was partitioned between EtOAc (150 mL) and 1 M KHSO4 (150 mL). The phases 
were separated, and the aqueous layer was extracted with EtOAc (3x 30 mL). The 
combined organic phases were washed with 2 M K2CO3 (30 mL), water (30 mL) 
and brine, followed by drying over MgSO4. Concentration to dryness and flash 
chromatography (EtOAc/iso-hexane, 20% ^  60%) afforded the title compound as 
a white, fluffy solid (6.93 g, 24.73 mmol, 92%).
Rf 0.37 (EtOAc/iso-hexane, 1:2); vmax (ATR) 3425, 3304, 2975, 2924, 2124, 1688, 
1675, 1528, 1182, 1005; Öh (500 MHz, DMSO-de) 7.88 (2 H, br d, J  = 15.9 Hz), 6.96 
(1 H, s), 3.44 (1 H, br d, J  = 14.2 Hz), 3.20 (1 H, dd, J  = 17.1, 2.1 Hz), 2.92 ( 1 H, t, 
J  = 2.1 Hz), 1.40 ( 9 H, s); Öc (126 MHz, DMSO-de) 165.3, 152.8, 124.0 (q, 1Jcf =
287 Hz), 79.2, 77.3, 73.8, 62.9 (q, 2Jcf = 27 Hz), 27.8, 19.6; Öf (376 MHz, MeOH- 
d4) -76.18; HRMS (ESI) calcd. for Cn H15F3N2NaO3 (M++Na) 303.09270, found 
303.09251.
2-A m ino-2-trifluorom ethylpent-4-ynoic ac id  am id e  hydroch lo ride  (41)
Boc-protected amide 40 (109 mg, 0.389 mmol) was dissolved in a 
solution of HCl in EtOAc (2.5 M; 2 mL) and stirred for 4 h at room 
, _r3 temperature. Et2O (2 mL) was added, causing the formation of a 
H2N conh2 white precipitate that was filtered-off and washed with Et2O (2x 0.5 
HCl mL). The residue was dried under vacuum to give 41 as a white,
hygroscopic powder (63 mg, 0.291 mmol, 75%).
Rf 0.83 (CHCl3/MeOH/NH4OHaq, 2:2:1); Öh (400 MHz, MeOH-d4) 8.15 (1 H, br d, J  =
31.3 Hz), 3.44 (1 H, dd, J  = 17.8, 2.7 Hz), 3.15 (1 H, dd, J  = 17.8, 2.7 Hz), 2.83 (1 
H, t, J  = 2.7 Hz); Öc (126 MHz, MeOH-d4) 164.0, 124.1 (q, 1Jcf = 285 Hz), 76.9,
74.0, 65.4 (q, 2Jcf = 29 Hz), 22.1; Öf (376 MHz, MeOH-d4) -76.25; GCMS (EI) 8.18 
min, m/z 141 ([M-CH2CCH]+), 136 ([M-CONH2]+), 116 ([M-CONH2-HF)]+; MS (ESI) 
181 (M++H).
2-(2-ferf-B utoxycarbonylam ino-2-trifluorom ethylpent-4-ynoyl)am m oacetic acid  
m ethy l e s te r  (42)
To a suspension of HCl-H-Gly-OMe (86 mg, 0.69 mmol) in CH2CI2 
F3¡c^ ^  (10 mL) were added consecutively carboxylic acid 39 (106 mg,
^ Y G|y-OMe 0.38 mmol), HATU (230 mg, 0.61 mmol) and DiPEA (0.23 mL, 1.39 
Boc O mmol). The reaction mixture was stirred overnight at ambient
temperature. All volatiles were removed in vacuo, and the residue 
was taken up in EtOAc (30 mL). The solution was washed with 1 M KHSO4 (2x 10 
mL), water (10 mL), a saturated solution of NaHCO3 (10 mL) and brine. Drying 
over MgSO4 followed by concentration to dryness yielded the pure title compound 
as a colorless, glassy solid (133 mg, 0.38 mmol, quant).
Rf 0.42 (EtOAc/heptan, 1:1); vmax (ATR) 3369, 3304, 2976, 2124, 1731, 1679, 
1489, 1368, 1165, 1005; öh (200 MHz, DMSO-de) 8.72 (1 H, t, J  = 5.7 Hz), 7.48 (1 
H, s), 3.86 (2 H, d, J  = 5.7 Hz), 3.61 (3 H, s), 3.36-3.19 (2 H, m), 2.95 (1 H, t, J  =
2.4 Hz), 1.39 ( 9 H, s); öc (75 MHz, MeOH-d4) 171.0, 167.5, 155.7, 125.3 (q, 1J CF = 
286 Hz), 81.8, 77.9, 73.4, 65.3 (q, 2J cf = 27 Hz), 52.6, 42.5, 28.5, 21.8; HRMS (ESI) 
calcd. for C14H19F3N2NaO5 (M+ + Na) 375.11438, found 375.11337.
2-A m ino-2-trifluorom ethylpent-4-ynoic ac id  m ethy l e s te r  hydroch lo ride  (43)
In a stoppered flask, Boc-protected amino acid 36 (5.53 g, 18.73 
mmol) was dissolved in a solution of HCl in EtOAc (2.5 M; 40 mL, 100 
, .  c f3 mmol). The solution was stirred overnight at ambient temperature. All
H2N CO2Me 
HCl
HNI
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volatiles were removed in vacuo and the resulting residue was co-evaporated with 
*BuOH (3x 50 mL) and CHCl3 (3x 50 mL), providing the title compound as an off- 
white powder (3.70 g, 15.98 mmol, 85%).
Rf 0.53 (EtOAc/heptane/MeOH, 10:10:3); öh (200 MHz, CDCI3) 8.74 (br s), 3.97 (3 
H, s), 3.22 (1 H, dd, J  = 17.3, 2.7 Hz), 3.03 (1 H, dd, / = 17.3, 2.7 Hz), 2.29 ( 1 H, t, 
J  = 2.7 Hz); öc (75 MHz, MeOH-d») 164.4, 123.4 (q, Jc f  = 285 Hz), 77.5, 73.7, 65.4 
(q, 2Jcf = 29 Hz) 55.9, 22.8; öf (282 MHz, DMSO-d6) -73.30; MS (ESI) m/z 196 
([M + H]+), 136 ([M-CO2Me]+).
2-(2-(9ff-Fluoren-9-ylm ethoxy)carbonylam m oacetyl)am m o-2-trifluorom ethylpent-4- 
ynoic ac id  m ethy l e s te r  (46)
Fmoc-Gly-OH (1.286 g, 4.33 mmol) and oxalyl chloride (0.41
mL, 4.8 mmol) were added to THF (15 mL) at 0 °C. A catalytic 
Fmoc-Gly-N A “CF3 amount of DMF (20 |iL) was added, and the mixture was stirred 
H cO2Me at 0 °C for 20 min followed by stirring at room temperature 
until the gas evolution had ceased (~1 h). The resulting solution was injected into 
a mixture of amino acid hydrochloride 43 (401 mg, 1.73 mmol) and 2,6-lutidine 
(1.8 mL, 15 mmol) in THF (15 mL). After 75 min of stirring at ambient 
temperature, the reaction was quenched by the addition of ice (3 g). All volatiles 
were removed in vacuo, and the resulting residue was partitioned between 0.5 M 
KHSO4 (30 mL) and EtOAc (30 mL). The phases were separated, the aqueous layer 
was extracted with EtOAc (3x 10 mL), and the combined organic phases were 
washed with a saturated solution of NaHCO3 (20 mL) and then with brine. Drying 
over MgSO4 and concentration to dryness followed by column chromatography 
(EtOAc/heptane, 1:3 ^  1:2) afforded the dipeptide 46 as an off-white solid (174 
mg, 0.367 mmol, 21%).
Rf 0.68 (EtOAc/heptane, 1:1); vmax (KBr) 3370, 3300, 3067, 2956, 1757, 1698, 
1520, 1246, 1045, 741; Öh (300 MHz, CDCI3) 7.76 (2 H, d, J  = 7.5 Hz), 7.59 (2 H, d, 
J  = 7.4 Hz), 7.40 (2 H, t, J  = 7.4 Hz), 7.31 (2 H, dt, J  = 7.5, 1.1 Hz), 7.19 (1 H, br s), 
5.53 (1 H, br s), 4.43 (2 H, d, J  = 7.0 Hz), 4.23 (1 H, t, J  = 7.0 Hz), 4.00 (2 H, d, J  =
5.5 Hz), 3.89 (3 H, s), 3.77 (1 H, br d, J  = 16.9 Hz), 3.16 (1 H, dd, J  = 16.9, 2.5 Hz),
2.00 (1 H, t, J  = 2.5 Hz); Öc (75 MHz, CDCI3) 168.5, 165.9, 156.5, 143.7, 141.3,
127.7, 127.1, 125.0, 123.1 (q, 1Jcf = 288 Hz), 120.0, 75.9, 72.5, 67.4, 64.8 (q, 2Jcf 
= 29 Hz), 54.4, 47.0, 44.9, 20.8; Öf (282 MHz, CDCI3) -74.09; HRMS (ESI) calcd. for 
C24H21F3N2NaO5 (M++Na) 497.13003, found 497.12886.
2-A cetam ido-2-trifluorom ethylpent-4-ynoic ac id  m ethy l e s te r  (47)
A mixture of amine hydrochloride 43 (420 mg, 1.81 mmol, 1 
o f  equiv) and DiPEA (1.05 mL, 6.34 mmol, 3.5 equiv) in MeCN (10 
MeX N^ O F 3 mL) was treated with AcCl (260 |iL, 3.66 mmol, 2.0 equiv). The 
h co2Me reaction mixture was stirred at ambient temperature overnight. 
Saturated aqueous NH4Cl (10 mL) was added to quench the reaction followed by 
removal of all organic volatiles by rotary evaporation. The remainder was 
partitioned between Et2O (20 mL) and water (10 mL); the phases were separated 
and the aqueous layer was extracted with Et2O (3x 10 mL). The combined organic 
phases were washed consecutively with 1 M HCl (10 mL), water (10 mL), a 
saturated solution of NaHCO3 (10 mL) and brine. Drying over MgSO4 was followed 
by concentration in vacuo and flash chromatography of the resulting crude 
product to give amide 47 as a clear, colorless oil (210 mg, 0.89 mmol, 49%).
Rf 0.44 (EtOAc/heptane, 1:1); vmax (ATR) 3278, 3058, 2950, 2846, 2116, 1761, 
1662, 1545, 1182, 1035; Öh (300 MHz, CDCI3) 6.89 (1 H, s), 3.81 (3 H, s), 3.52 (1
H, dd, J  = 17.1, 2.7 Hz), 3.13 (1 H, dd, J  = 17.1, 2.7 Hz), 2.04 (3 H, s), 2.02 (1 H, J  
= 2.7 Hz); öc (75 MHz, CDCI3) 169.9, 166.0, 123.2 (q, 1Jcf = 287 Hz), 76.3, 72.1,
64.3 (q, 2Jcf = 29 Hz), 54.0, 23.2, 21.0; Öf (282 MHz, CDCI3) -73.95; HRMS (ESI) 
calcd. for C9H ^ N N a O 3 (M+ + Na) 260.05105, found 260.05042.
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2-B enzam ido-2-(trifluorom ethyl)pent-4-ynoic ac id  m ethy l e s te r  (48)
^  Following the procedure described for the synthesis of 47, amine
o  f  hydrochloride 43 (337 mg, 1.46 mmol) was allowed to react with 
X nJ^-cf3 DiPEA (0.85 mL, 5.14 mmol) and BzCl (415 mg, 2.95 mmol). Work- 
in c o 2Me up and flash chromatography (EtOAc/heptane, 10% ^  35%) 
provided the title compound as a colorless, viscous oil (109 mg, 0.36 mmol, 25%). 
Rf 0.57 (EtOAc/heptane, 1:1); Vmax (ATR) 3390, 3296, 3049, 2954, 2124, 1748, 
1670, 1528, 1312, 1195, 1039, 719; <5h (200 MHz, CDCh) 7.90-7.74 (2 H, m), 7.62­
7.40 (3 H, m), 7.20 (1 H, br s), 3.94 (1 H, dd, J  = 16.9, 2.7 Hz), 3.94 (3 H, s [in 
between dd]), 3.26 (1 H, dd, J  = 16.9, 2.7 Hz), 2.04 (1 H, t, J  = 2.7 Hz); <5c (75 MHz, 
CDG3) 169.6, 166.4, 133.7, 132.2, 128.7, 127.2, 123.3 (q, 1Jcf = 288 Hz), 76.3,
72.4, 65.0 (q, 2Jcf = 29 Hz), 54.4, 20.8; <5f (282 MHz, CDG 3) -73.81; HRMS (ESI) 
calcd. for CMH12F3NNaO3 (M++Na) 322.06670, found 322.06673.
2-(4-N itrobenzam ido)-2-trifluorom ethylpent-4-ynoic ac id  m ethy l e s te r  (49)
Following the procedure described for the synthesis of 47, 
amine hydrochloride 43 (200 mg, 0.86 mmol) was treated 
- c f 3 with DiPEA (0.50 mL, 3.03 mmol) and p-nitrobenzoyl 
C02Me chloride (322 mg, 1.74 mmol). Work-up and purification by 
O2N' ^  column chromatography (EtOAc/heptane, 10% ^  35%)
afforded the title compound as a yellowish viscous oil (121 mg, 0.35 mmol, 41%). 
Rf 0.31 (EtOAc/heptane, 1:2); Vmax (ATR) 3375, 3283, 3105, 3044, 2954, 2919, 
2846, 1748, 1684, 1523, 1307, 1195, 723; <5h (200 MHz, CDG 3) 8.35-8.27 (2 H, 
m), 8.02-7.94 (2 H, m), 7.30 (1 H, br s), 3.99 (1 H, dd, J  = 16.9, 2.6 Hz), 3.97 (3 H, 
s), 3.25 (1 H, dd, J  = 16.9, 2.6 Hz), 2.04 (1 H, t, J  = 2.6 Hz); <5c (75 MHz, CDG3) 
170.2, 166.2, 149.8, 129.9, 128.4, 124.0, 123.1 (q, 1Jcf = 288 Hz), 75.9, 72.6, 65.4 
(q, 2Jcf = 29 Hz), 54.8, 20.5; <5f (282 MHz, CDG3) -73.72; MS (ESI) m/z 343.3 ([M­
H]-).
2-feri-B utoxycarbonylam m o-2-trifluorom ethylpentanoic ac id  m ethy l e s te r  (50)
Me A round-bottom Schlenk flask was charged with a solution of Boc- 
J  protected TfmPG methyl ester (36; 402 mg, 1.36 mmol) in EtOH (25 
f  CF mL). Nitrogen was bubbled through for 15 min. Palladium on charcoal 
HN co Me (10%  wt; 9 mg) was added whereupon H2 was led via a needle 
Boc 2 through the vigorously agitated reaction mixture for 75 min. The 
hydrogen atmosphere was then replaced by nitrogen, water (3 mL) was added, 
and the contents of the flask were filtered over Hyflo®. All volatiles of the filtrate 
were removed in vacuo, and the resulting residue was taken up in Et2O (60 mL). 
This solution was washed consecutively with 1 M KHSO4 (20 mL), a saturated 
solution of NaHCO3 (20 mL), water (20 mL) and finally brine (20 mL). After drying 
over MgSO4 and concentration to dryness, a-CF3-norvaline 50 was obtained as a 
clear colorless oil (365 mg, 1.22 mmol, 90%).
Rf 0.61 (EtOAc/heptane, 1:2); Vmax (ATR) 3412, 2967, 2867, 1731, 1714, 1502, 
1251, 1156; öh (300 MHz, CDG 3) 5.47 (1 H, br s), 3.84 (3 H, s), 2.62 (1 H, br s),
2.01 (1 H, ddd, J  = 13.8, 11.9, 4.7 Hz), 1.43 (9 H, s), 1.40-1.25 (1 H, m), 1.20-1.03 
(1 H, m), 0.93 (3 H, t, J  = 7.3 Hz); öc (75 MHz, CDG 3) 167.7, 153.2, 124.1 (q, 1Jcf 
=288 Hz), 80.4, 65.8 (q, 2Jcf = 28 Hz), 53.7, 31.2, 28.1, 16.9, 13.8; öf (282 MHz, 
CDG3) -74.98; HRMS (ESI) calcd. for C12H20F3NNaO4 (M+ + Na) 322.12421, found 
322.12381.
2-feri-B utoxycarbonylam m o-2-trifluorom ethylpent-4-enoic ac id  m ethy l e s te r  (51)
A round-bottom Schlenk flask was charged with Boc-protected TfmPG 
methyl ester (36; 1.505 g, 5.10 mmol), EtOH (80 mL) and quinoline 
-cF3 (0.60 mL, 5.1 mmol). Nitrogen was led through the solution for 15 min 
HN co2ivie before Lindlar's catalyst (5% Pd on CaCO3, poisoned with lead; 54 mg) 
Boc was added. Hydrogen was bubbled via a needle through the
vigorously stirred reaction mixture for 2 h. The contents of the flask were filtered 
through a plug of Hyflo®, the residue was rinsed with EtOAc, and the filtrate was
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concentrated to dryness. The crude product was dissolved in Et2O (100 mL), 
followed by washing with 1 M KHSO4 (2x 30 mL), water (30 mL), a saturated 
solution of NaHCO3 (30 mL) and finally brine (20 mL). Drying over MgSO4 and 
removal of all volatiles afforded a-CF3-allylglycine 51 as a clear, slightly yellowish
oil (1.411 g, 4.75 mmol, 83%).
Rf 0.58 (EtOAc/heptane, 1:2); Vmax (ATR) 3421, 2976, 1727, 1489, 1238, 1156; öh 
(300 MHz, CDCl3) 5.72-5.55 (1 H, m), 5.42 (1 H, br s), 5.26-5.16 (2 H, m), 3.85 (3
H, s), 3.39 (1 H, br s), 2.79 (1 H, dd, J  = 14.1, 7.7 Hz), 1.44 (9 H, s); öc (75 MHz, 
CDG 3) 167.1, 153.2, 129.9, 123.9 (q, 1Jcf = 288 Hz), 121.1, 80.7, 65.2 (q, 2Jcf = 
29), 53.6, 33.9, 28.1; öf (282 MHz, CDG 3) -74.32; HRMS (ESI) calcd. for 
C12H18F3NNaO4 (M+ + Na) 320.10856, found 320.10850.
2-(A llyl-teri-butoxycarbonylam m o)-2-trifluorom ethylpent-4-ynoic ac id  m ethy l e s te r  
(52)
A solution of amino acid 36 (295 mg, 1.00 mmol) in THF (5 mL) was 
transferred dropwise into a stirred suspension of NaH (60% in 
N \ _cF3 mineral oil; 80 mg, 2.00 mmol) in DMF (8 mL) at 0 °C. The mixture 
Boc° ° 2Me was allowed to come to ambient temperature over a period of 30 
min at which point allyl bromide (170 |iL, 1.96 mmol) was added. 
After being stirred overnight,50 the reaction mixture was poured into an ice-cold, 
saturated aqueous NH4Cl (50 mL). Et2O (20 mL) was added, and the layers were 
separated. The aqueous layer was extracted with Et2O (2x 20 mL); the combined 
organic phases were washed with water (2x 20 mL) and brine (10 mL) followed by 
drying over MgSO4. Evaporation of all volatiles in vacuo and subjection of the 
crude product to flash chromatography (EtOAc/heptane, 1:5) yielded 52 as a 
clear, colorless oil (186 mg, 0.56 mmol, 56%). A minor fraction of the 
corresponding allene compound was found to be present in the product.
Rf 0.74 (EtOAc/heptane, 1:1); Vmax (ATR) 3304, 2976, 1761, 1701, 1376, 1156; öh 
(300 MHz, CDG 3) 5.97-5.72 (1 H, m), 5.35-5.07 (2 H, m), 4.13 (1 H, br d, J  = 16.5 
Hz), 3.84-3.69 (1 H, m), 3.79 (3 H, s [in between m]) 3.12-2.95 (2 H, m), 2.10 (1 H, 
t, J  = 2.7 Hz), 1.40 (9 H, s); öc (75 MHz, CDG 3) 165.9, 154.3, 134.9, 124.3 (q, 1JCF 
= 289 Hz), 115.5, 85.8, 76.2, 72.4, 67.6 (q, 2JCF = 29 Hz), 52.7, 47.4, 27.9, 22.9; 
öf (282 MHz, CDG 3) -72.35; HRMS (ESI) calcd. for C15H20F3NNaO4 (M++Na) 
358.12421, found 358.12421.
2-feri-Butyl 3-m ethyl 6-oxo-3-trifluorom ethyl-2,3,4,6,7,7a-hexahydro-1H - 
cyclopen ta[c]pyrid ine-2 ,3 -d icarboxylate  (53)
A solution of enyne 52 (105 mg, 0.31 mmol) in CH2Cl2 (9 mL) was 
treated with Co2(CO)8 (90-95%; 140 mg, ~0.38 mmol) and stirred 
for 150 min at ambient temperature. As soon as the starting 
c f 3 material had disappeared51 (monitored by 19F-NMR), the reaction 
'N ' ^oo2Me mixture was cooled to 0 °C, and NMO (78 mg, 0.67 mmol) was 
Boc added in small portions causing the appearance of gas bubbles.
After stirring overnight at room temperature, an additional portion of NMO (105 
mg, 0.90 mmol) was added and stirring was continued until 19F-NMR indicated 
complete consumption of the intermediate (~48 h). All volatiles were removed, 
the crude product was loaded on silica and subjected to flash chromatography 
(EtOAc/heptane, 1:2). The title compound was obtained as an inseparable mixture 
of diastereoisomers in a 1:10 ratio (white solid, 34 mg, 0.094 mmol, 30%).
Rf 0.48 (EtOAc/heptane, 1:1); Vmax (ATR) 3503, 3408, 2980, 1748, 1701, 1359, 
1247, 1152, 1031; öh (400 MHz, CDCl3) 6.03 (1 H, t, J  = 1.8 Hz), 4.52 (1 H, br s),
3.83 (3 H, s), 3.31 (1 H, d, J  = 15.3 Hz), 3.07 (1 H, d, J  = 15.3 Hz), 3.03-2.93 (1 H, 
m), 2.83 (1 H, m), 2.59 (1 H, dd, J  = 18.7, 6.5 Hz), 2.02 (1 H, dd, J  = 18.7, 2.5 Hz),
I.45 (9 H, s); öc (75 MHz, CDCl3) 206.2, 172.8, 166.8, 154.1, 129.1, 124.9 (q, 1J CF 
= 291 Hz), 83.0, 65.3 (q, 2J CF = 29 Hz), 53.0, 48.9, 38.9, 38.3, 32.9, 28.0; öf (282 
MHz, CDCl3) -69.72; HRMS (ESI) calcd. for C16H20F3NNaO5 (M++Na) 386.11913, 
found 386.11823; LCMS 4.22 min, peak area 5%: m/z 305 (M-Boc+H + MeCN), 264
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(M-Boc+H); 4.44 min, peak area 52%: m/z 305 (M-Boc +H + MeCN), 264 (M- 
Boc+H).
2-ferf-Butoxycarbonylam ino-5-(2-(3-hydroxyprop-1-ynyl)-phenyl)-2- 
trifluorom ethylpent-4-ynoic ac id  m ethy l e s te r  (55)
A stirred solution of 4-(2-iodophenyl)prop-3-yn-1-ol (54; 775 mg, 
3.00 mmol)46 in Et2O (40 mL) was treated with PdCl2(PPh3)2 (105 
mg, 0.150 mmol), CuI (60 mg, 0.30 mmol), and Et2NH (1.60 mL,
15.5 mmol). Stirring was continued until a clear, homogeneous 
solution had been formed, and TfmPG 36 (805 mg, 2.88 mmol) 
BocC° 2Me ° H was added. After 4 h at ambient temperature, the reaction 
mixture was poured into an aliquot of saturated aqueous NH4Cl, the phases were 
separated, and the aqueous layer was extracted with EtOAc (3x 15 mL). The 
combined organic layers were washed with brine, dried over MgSO4, and all 
volatiles were removed by rotary evaporation. Purification by flash 
chromatography (EtOAc/heptane, 2:3) provided 55 as a yellow solid (1.044 g, 2.45 
mmol, 85%).
Rf 0.31 (EtOAc/heptane, 1:2); vmax (ATR) 3408 (br), 2967, 1709, 1722, 1490, 1247, 
1169, 1010, 750; öh (300 MHz, CDCh) 7.68 (1 H, br s), 7.43-7.32 (2 H, m), 7.26­
7.18 (2 H, m), 6.20 (1 H, br s), 4.54 (2 H, d, J  = 6.2 Hz), 4.01-3.75 (1 H, m) 3.89 (3
H, s [within m]), 3.40 (1 H, d, J  = 17.1 Hz), 1.42 (9 H, s); öc (75 MHz, CDCh) 166.5, 
153.6, 131.8 (2 C), 127.9 (2 C), 127.6, 125.2, 123.1 (q, 1Jcf = 288 Hz), 91.3, 85.7,
83.7, 82.7, 81.2, 64.7 (q, 2Jcf = 29 Hz), 54.1, 51.3, 28.0, 22.3; öf (282 MHz, CDCh) 
-74.60; HRMS (ESI) calcd. for C21H22F3NNaO5 (M++Na) 448.13478, found 
448.13414.
, -cf3
HN C02Me Boc OMs
2-ferf-Butoxycarbonylam ino-5-(2-(3-m esyloxyprop-1-ynyl)-phenyl)-2- 
trifluorom ethylpent-4-ynoic ac id  m ethy l e s te r  (56)
A cooled (0 °C) solution of alcohol 55 (335 mg, 0.79 mmol) in 
CH2Cl2 (8 mL) was treated with MsCl (90 |iL, 1.16 mmol) and 
Et3N (0.16 mL, 1.15 mmol). The mixture was stirred at 0 °C for
2 h52 and then poured into saturated aqueous NH4Cl (20 mL). 
The phases were separated, the aqueous layer was extracted 
with CH2Cl2 (3x 5 mL), and the combined organic phases were 
washed with water (10 mL) and brine (10 mL). Drying over 
MgSO4 followed by concentration in vacuo and subjection of the resulting crude 
product to flash chromatography (1% MeOH in CHCl3) afforded mesylate 56 as an 
off-white solid (279 mg, 0.55 mmol, 70%).
Rf 0.59 (EtOAc/heptane, 1:1); vmax (ATR) 3010, 2950, 1761, 1627, 1165, 1035, 
746; öh (200 MHz, CDCl3) 7.56-7.18 (4 H, m), 5.78 (1 H, br s), 5.17 (2 H, s), 3.90 (3
H, s), 3.82 (1 H, br s), 3.39 (1 H, d, J  = 17.1 Hz), 3.18 (3 H, s), 1.43 (9 H, s); öc (75 
MHz, CDCl3) 166.4, 153.3, 132.4 (2 C), 129.1, 128.1, 125.7, 123.5, 123.4 (q, 1J CF =
288 Hz), 87.6, 86.4, 84.4, 82.3, 81.2, 64.1 (q, 2J CF = 29 Hz), 58.4, 54.1, 39.0, 28.1, 
22.4; HRMS (ESI) calcd. for C22H24F3NNaO7S (M+ + Na) 526.11233, found 
526.11158.
T reatm en t of m esy la te  56 w ith sod ium  hydride
cF3 Mesylate 56 (60 mg, 0.12 mmol) was dissolved in dry DMF 
V -co 2Me (10 mL) resulting in a concentration of ~11 mM. The solution 
/N^Boc was cooled to 0 °C and NaH (60% in mineral oil; 15 mg, 0.38 
mmol) was added in three portions whilst stirring. Stirring 
(Exad Mass: 407,13) was continued at 0 °C for 2 h, at which time TLC indicated 
complete conversion of the starting material (Rf 0.32; EtOAc/heptane, 1:2) with 
concomitant formation of a single new spot (Rf 0.64; EtOAc/heptane, 1:2). The 
reaction mixture was poured into a mixture of Et2O and saturated aqueous NH4Cl 
(40 mL each), and the phases were separated. The aqueous layer was extracted 
with Et2O (3x 10 mL), the combined organic phases were washed with water (3x 
10 mL) and brine (10 mL), and they were dried over Na2SO4. All volatiles were
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removed in vacuo  at room temperature, and the resulting residue was loaded on 
silica and subjected to flash chromatography (EtOAc/heptane, 2:9). A slightly 
yellowish solid was obtained (29 mg).
Rf 0.64 (EtOAc/heptane, 1:2); LCMS 9.97 min, peak area 22%: m/z 308 (407- 
Boc+H), 349 (407-Boc+H + MeCN), 408 (407+H).
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Towards Enediynes Linked Chapter
to Plasmonically Heated ANanoparticles : 'U
a Possible Future
Direction for Enediyne-
Based Therapies
-f/- B
Abstract
The concept of triggering  the Bergm an  Cyclization  of enediynes linked to
gold nanopartic les by m eans of p lasm onic heating is presented.
Rud im entary experim ental w o rk  tow ard  this goal is described.
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6.1 Introduction
The u ltim ate goal in  enediyne-based m ed ica l treatm ent is the selective, 
localized, noninvasive triggering  of the Bergm an  Cyclization  (B C ) of an 
enediyne drug bound to targe t tissue. Contro lled  activation  of enediynes 
by m eans of chem ical triggers, m etal ion-complexation, pH-dependent 
triggering  and heating, however, have m et d ifferent levels of success.
A  few  exam ples of triggering  strateg ies are shown in Schem e 1 .
2 +The group of Buchw ald  disclosed that chelation  of Pd  ions by a linear, 
phosphine-capped enediyne ( 1 ^ 2 ) d ram atica lly  decreased  the threshold  
tem perature  at w h ich  B C  occurred. M a ie r  made use of a d icobalt 
complex to p rotect the enediyne m otif in  3. A  reactive  enediyne (4 ) w as 
obtained upon oxidative dem etallation. Ban fi e t al. addressed the 
problem  of se lective ly  triggering  the B C  by fusing a cyclic  enediyne to a 
base-labile ß-lactam m oiety (5 ) serving as a locking device that opens 
above pH  7.5 .4
PPh2
PPh2
1
NMO
(COfeCo'I- Co(C°)3
reactive at 243 °C reactive at 61 °C
OH
reactive at 37 °C
Scheme 1 Examples of triggering strategies in simplified enediynes.
H ow ever, none of such sim plified enediynes have found therapeutic  
applications yet. W h ile  there  are ongoing studies targeted  at the 
developm ent of antineop lastic agents based on natu ra l enediynes ,5 as of 
now, only two derivatives have been actua lly  used in cancer therapy. One 
being neocarzinostatin  bound to poly(styrene-co-maleic acid ) (S M A N C S )6 
and the other gem tuzum ab ozagam icin (M y lo ta rg ® )7 consisting of 
ca licheam ic in  linked v ia  a spacer to a m alignant tissue-targeting antibody 
(see also: Chapter 1.2.4). The recent w ithd raw a l of the la tte r drug from  
the U S  m arket due to adverse side effects a ll the m ore dem onstrates
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that novel and innovative strategies are requ ired  to harness the pow er of 
enediynes.
Photo-activation of enediynes is an in teresting and prom ising 
approach tow ard  that end ,9 since B C  of typ ica l enediyne chrom ophores 
can be induced by U V  light. Unfortunate ly, therapeutic  application  of 
e lectrom agnetic rad iation  of such short w ave leng th  is ham pered by low  
tissue transparency and the in fliction of skin burns.
6.2 Plasmonically heated nanoparticles linked to 
enediynes
10W e  envisaged that gold nanoparticles (A uN Ps) m ight address the issue 
of activation  and provide a prom ising en try  into enediyne-based therapy. 
Th ree  properties of A u N Ps  stand out that would  qualify them  for a 
therapeutic use in com bination w ith  enediynes:
1. A u N Ps  have been used in in v ivo  applications for severa l decades 
and are considered to be c lin ica lly  com patib le11
2. The surface of A u N Ps  can be conven iently functionalized by th iol 
chem istry10,12
3. Essen tia l w ith  respect to enediynes: A u N Ps  ve ry  effic ien tly  
generate heat upon irrad iation  w ith  e lectrom agnetic rad iation  by 
v irtue  of a phenom enon called  surface plasm on resonance
A u N Ps  absorb e lectrom agnetic rad iation  depending on the ir size; 
the induced surface plasm on resonance energy is u ltim ate ly  converted  to
13heat that is d issipated into the nanopartic le 's d irect surrounding. N ea r 
in frared  (N IR )  light is able to excite A u N Ps  w ith  d iam eters ranging from
10-100 nm .14,13a,11d A  tem peratu re  increase of up to 50 °C  of the 
im m ediate surroundings of the nanoparticles can  be observed w h ile  the 
bulk m edium  essentia lly  rem ains at its in itia l tem peratu re .15,13b M ost 
im portantly, N IR  rad iation  has a re la tive ly  high tissue penetration, and 
the com bination of A u N Ps  and in frared  light has led to prom ising 
developm ents in  the field  of hypertherm al cancer the rapy .16
W e  conceived  a strategy in  w h ich  a therm ally  triggerab le  enediyne 
and a m alignant cell-targeting antibody are coupled to a A uN P. The 
antibody would  attach  the conjugate to a ta rge t ce ll and subsequent 
through-tissue irrad ia tion  w ith  N IR  light would  heat the surroundings of 
the A u N P  causing the enediyne to generate cell-dam aging rad ica ls  
(Schem e 2).
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Scheme 2 Concept of cell lysis by plasmonic heating of an enediyne-AuNP-antibody 
conjugate.
To the best of our knowledge, there  is one re lated  record  in 
lite ratu re  by the group of Jones covering the com bination of a non-cyclic 
enediyne, a A u N P  and an antibody .17 The sole purpose of the A u N Ps  in 
that account w as the visualization  of the products by m eans of transition  
e lectron  m icroscopy.
6.3 Synthesis
W e  set out to explore the synthesis of enediynes linked to A u N Ps  as 
nanoscale heat sources. A  retrosynthesis is depicted in Schem e 3.
x ¿ > s h
10
\  /
SH SH
'“ '"""'SH  Au HS-~'"~'~- 
SH SH
/  \
9
Scheme 3 Retrosynthesis of a AuNP-enediyne compound.
11
O
io
Conjugate 8  should be accessib le v ia  ligand d isp lacem ent of thiol- 
capped A u N Ps  (9 ) w ith  enediyne 10 featuring  a thiol-bearing spacer. This 
enediyne, in turn, could be derived  from  the enediyne-containing amino 
acid  1 1  by attachm ent of a th io l spacer.
Schem e 4 depicts the synthesis of the requ isite enediyne. The 
benzofused ten-membered enediyne 1 2  w as chosen as starting m ateria l 
because its corresponding m ethyl ester has shown to be stable at room 
tem peratu re  and be reactive  at tem peratures above 50 °C  (see: Chapter
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3.3). Thus, enediyne 12 w as subjected to a condensation reaction  w ith
11-bromoundecan-l-ol in  o rder to attach  a brom oalkyl tail. Unfortunate ly, 
only a re la tive ly  sm all am ount of product could be isolated, and, as M S  
analysis indicated, it tu rned  out to be chloro derivative  14 instead of the 
intended brom ide 13. Presum ably, ch loride ions in  the reaction  mixture, 
most like ly stem m ing from  ED C , had substituted the bromide. As the 
ch loride should also be am enable to the next synthetic transform ation,
i.e. conversion to a thiol, ch loride 14 w as subjected to dehalogenative 
th io lation  conditions. The com bination of hexam ethyld isilath iane and 
tetrabutylam m onium  fluoride, form ing tetrabutylam m onium  trimethyl- 
sily lth io late in situ , effected the conversion of the ch loride into th io l 15 in 
8 8 %  y ie ld .19
I  %
BrC11H22OH 
EDC, HOBt, DMAP
DMF, rt, 2 h
N ^  N
Ts CO2H Ts'
O
12 13 (0%)
Scheme 4 Synthesis of an enediyne with a thiol spacer.
(Me3Si)2S, TBAF
THF,-5 °C ^  rt, 4 h
O¿ V C' 
W11
W ith  the th io l spacer attached  to the enediyne, the stage w as set 
for the decoration of A u N Ps  w ith  15. T H F  solutions of 15 of d ifferent 
concentrations w ere  treated  w ith  va ry ing  am ounts of com m ercia lly  
ava ilab le  octanethiol-capped A uN Ps. The m ixtures w ere  shaken at 120 
rpm  for 18 h at room  tem perature. M uch  to our dismay, eve ry  single 
batch  resu lted  in a brow n suspension contain ing a tar-like, lum py mass 
that could not be w orked up to anyth ing suitable for characterization .
6.4 Discussion and conclusion
Due to d ifficu lties in  the form ation of enediyne-linked A uN Ps, no 
experim ents could be conducted that would probe the concept of 
Bergm an  Cyclization  induced by plasm onic heating w ith in  the tim efram e 
of the project. There  are, however, severa l a lte rnative  pathw ays that m ay 
a llow  the p reparation  of such conjugated nanopartic les a fter all.
It  is known that thiols are prone to undergo disulfide form ation, 
w h ich  could have ham pered a p roper ligand exchange. An in s itu  
conversion of halide 14 to th io l 15 in the presence of A u N Ps  could
19address that problem . Another approach would  com prise the synthesis 
o f A u N Ps  by reduction  of hydrogen tetrach lo roaureate  in  the presence of 
th io l 15.20
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The topic of se lective ly  triggering  the B C  of enediynes is an 
in teresting one w ith  potentia lly  far-reaching im plications on clin ica l 
u tility. G iven  the fa irly  lim ited successes in  the past w ith  m edical 
applications of enediynes, I am  personally  convinced that the princip le  of 
p lasm onically heated  nanopartic les could provide an elegant and 
applicab le solution to that end.
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6.6 Experimental section
6.6.1 G e n e r a l  in fo rm a t io n
Fo r genera l inform ation about methods, m ateria ls and instrum entation, 
see experim ental section of Chapter 2.
6 .6 .2  P r e p a r a t iv e  p ro c e d u re s
11-Chloroundecyl 4-tosyl-1,2,7,8-tetradehydro-3,4,5,6-tetrahydro-4-benzazecine-5- 
carboxylate  (14)
To a solution of enediyne carboxylic acid 12 21 (469 mg, 1.236 
mmol) in DMF (15 mL) were added 11-bromoundecan-1-ol (408 
mg, 1.624 mmol), DMAP (381 mg, 3.12 mmol), HOBt (306 mg, 2.26 
mmol) and EDC (351 mg, 1.83 mmol). The resulting solution was 
stirred for 2 h at room temperature after which time TLC 
O , . Ci (EtOAc/heptane/HOAc = 10/10/3) indicated complete conversion. 
w 11 The reaction mixture was partitioned between EtOAc and water 
(50 mL each). After phase separation, the aqueous layer was 
extracted with EtOAc (3x 20 mL), and the combined organic phases were washed 
sequentially with 10% aqueous citric acid (50 mL), saturated aqueous NaHCO3 (50 
mL) and brine (50 mL). Drying over Na2 SO4 and removal of the volatiles in vacuo 
gave a crude product that was purified by flash chromatography (5% ^  50% 
EtOAc in heptane) to furnish the title compound as a waxy solid (64 mg, 0.112 
mmol, 9%).
Vmax (ATR) 2920, 2855, 1735, 1156, 724, 659; <5H (200 MHz, CDCl3) 7.81 (2 H, d, J 
=  8.3 Hz), 7.29-7.20 (4 H, m), 7.11 (2 H, d, J =  8.3 Hz), 4.75 (1 H, d, J =  19.1 Hz), 
4.38-4.10 (4 H, m), 3.53 (2 H, t, J =  6.7 Hz), 3.26 (2 H, m), 2.23 (3 H, s), 1.89-1.62 
(4 H, m), 1.37-1.20 (14 H, m); <5C (75 MHz, CDCl3) 169.5, 143.3, 137.8, 129.3,
128.7, 128.1, 128.0, 127.7, 127.5, 127.4, 127.2, 95.4, 92.7, 87.1, 83.9, 66.2, 64.3, 
45.1, 42.2, 32.6, 29.4, 29.1, 28.8, 28.4, 26.8, 25.7, 21.5, 21.3; HRMS (ESI) calcd. 
for C3 2 H3 8 ClNO4SNa (M+ + Na) 590.2102, found 590.2091.
11-Sulfanylundecyl 4-tosyl-1 ,2,7,8-tetradehydro-3,4,5,6-tetrahydro-4-benzazecine-5- 
carboxylate  (15)
To a stirred, cooled (-5 °C) solution of chloride 14 (48 mg, 0.084 
mmol) in dry THF (5 mL) were added hexamethyldisilathiane (21 
mg, 0.118 mmol) and TBAF (1.0 M in THF, 120 |iL, 0.120 mmol). 
The reaction mixture was allowed to slowly reach room 
temperature over a period of 4 h. All volatiles were removed in 
vacuo, and the resulting residue was taken up in EtOAc, dried
Ts
O
O<>SH
' ' 1 1
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over Na2 SO4 and filtered through a plug of silica. Concentration to dryness 
afforded the title compound as a light brown solid (42 mg, 0.074 mmol, 8 8 %).
Vmax (ATR) 2938, 2834, 2681, 1727, 1123, 711; <5h (300 MHz, CDCh) 7.81 (2 H, d, J 
=  8.3 Hz), 7.28-7.20 (4 H, m), 7.11 (2 H, d, J =  8.3 Hz), 4.74 (1 H, d, J =  19.2 Hz), 
4.31 (1 H, dd, J =  9.6, 3.3 Hz), 4.19 (1 H, d, J =  19.2 Hz), 3.52 (2 H, t, J = 6 . 8  Hz), 
3.36-3.17 (2 H, m), 2.67 (2 H, t, J =  7.4 Hz), 2.23 (3 H, s), 1.86-1.57 (4 H, m), 1.39­
1.18 (14 H, m); <5c (75 MHz, CDG 3 ) 169.5, 143.3, 137.8, 129.3, 128.7, 128.1,
128.0, 127.7, 127.5, 127.4, 127.2, 95.4, 92.7, 87.1, 83.9, 66.2, 45.0, 32.6, 29.6,
29.4, 29.2, 28.8, 28.5, 28.4, 26.8, 25.8, 21.5, 21.2; HRMS (ESI) calcd. for 
C3 2 H3 9 NO4S2Na (M++Na) 588.2218, found 588.2242.
M ixing of th iol 15 w ith gold n anopartic les
A solution of thiol 15 (30 mg, 0.053 mmol) in dry THF (3.0 mL) was split into two 
equal portions. To one part was added 50 |iL of a toluene solution of octanethiol- 
capped AuNPs (2-4 nm particle size, 2% w/v solution in toluene, SigmaAldrich), to 
the other part was added 500 |iL of the AuNP solution. Both batches were shaken 
at 1 2 0  rpm for 18 h at room temperature during which time a dark brown, tar-like 
precipitate formed. The resulting suspension was centrifuged and the supernatant 
was removed. Efforts to re-suspend the remaining pellet in THF, MeOH, toluene or 
CH2Cl2 were unsuccessful.
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1.1 Summary
N atu ra l enediynes belong to the most pow erfu l antitum or and antib iotic 
agents known to hum ankind. T he ir trem endous activ ity  and intrigu ing 
mode of action have garnered  the attention of scientists of d ifferent fields 
and continue to do so. F igu re  1 depicts the structures of ca licheam ic in  y i I 
and of the neocarzinostatin  chrom ophore, two of the most exhaustively 
studied enediynes.
Figure 1
The active  princip le  of the enediyne antib iotics resides in  the ir 
ab ility  to generate DNA-dam aging rad ica ls  upon therm al activation  in a 
process called  Bergm an  Cyclization  (Schem e 1).
A
Bergman
Cyclization
enediyne
DNA diradical h 
DNA damage
Scheme 1
Efforts  to harness the pow er of enediynes and put them  to m edical 
use have been ongoing since the first s tructu ra l e lucidations of natu ra l 
enediynes in  the mid-1980s. In  th is regard, the synthesis of sm all and 
versatile  enediyne derivatives is of genera l interest.
This thesis describes the author's research  on com bining the 
potentia lly cytotoxic enediyne m otif w ith  am ino acids that provide 
handles for fu rther derivatization, thus a rriv ing  at cyclic  enediyne- 
contain ing amino acids (F igu re  2).
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Figure 2
C h a p te r  1 provides a b rie f h istorica l overv iew  of the d iscovery of the 
natura l enediynes and explains the reaction  m echanism s by w h ich  they 
exert the ir cytotoxicity. Additionally, an overv iew  of applications of 
acetylen ic am ino acids w ith  re levance  to the study at hand is given.
The developm ent of a genera l m ethodology for the synthesis of cyclic 
enediyne-containing am ino acids is described in C h a p te r  2. M ost 
conveniently, they could be prepared  by a palladium -catalyzed coupling 
(Sonogash ira  reaction ) betw een  a halogenated enyne alcohol and a 
term ina l acety len ic am ino acid  bearing a sulfonam ide protecting group 
(Schem e 2). In tram o lecu la r cyclization  of the resu lting acyclic  enediynes 
by m eans of a M itsunobu reaction  gave rise to the desired  products in 
most cases. Unexpectedly, (partia l) racem ization w as observed during the 
cyclization step even under the v irtu a lly  neu tra l conditions employed. 
Furtherm ore, substrates accom m odating a hom opropargylic hydroxyl 
group underw ent dehydrative elim ination ra the r than cyclization. Cyclic  
enediyne-containing am ino acids w ith  ring sizes from  10  to 12  atoms have 
been p repared  v ia  the devised route.
HN CO2Me 
Ts
(/ \
' \
Ç
HO
Scheme 2
C h a p te r  3 explores the behavior tow ard  Bergm an  Cyclization  of the 
enediynes accessed in C hap ter 2. It  w as found, in  line w ith  the body of 
lite ratu re  on cyclic  enediynes, that an increase in  ring size w en t along 
w ith  a profound d im inishing of reactiv ity . Benzannulation  had a
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dece lerating  effect as w ell. In  term s of potential utility, the ten-membered 
benzofused specim en (coined "Ed y ") em erged as the most suitable 
cand idate as it w as stable at room  tem perature, and cycloarom atized at 
m odestly e levated  tem peratures (F igu re  3). D ipeptides of Ed y  have been 
prepared, and the ir k inetics w ere  studied as well.
CO2Me
Ts
Ts-Edy-OMe
T
room temp. 
52 °C  
80 °C
half-life
stable 
13.7 h 
59 min
time (min)
Figure 3
C a-Tetrasubstituted enediyn ic am ino acids based on a-Me-a-propargyl- 
g lycine are disclosed in C h a p te r  4 (Schem e 3). They w ere  conceived as a 
w ay  of c ircum venting  the p artia l racem ization in the u ltim ate synthesis 
step as encountered  during the p reparation  of a-H enediynes.
H-Ala-OMe
H2N CO2Me
CO2R 
Me
N 2
Scheme 3
Intrigu ingly, k inetic experim ents revealed  that a ll a-Me-substituted 
enediynes underw ent Bergm an  Cyclization  at a sign ificantly h igher rate  
than the ir a-H counterparts. The ve rsa tility  of the a-Me enediynic amino 
acids, however, appeared  to be lim ited as peptide couplings to these 
substrates could not be accom plished even  under ra the r forcing 
conditions.
C h a p te r  5 continues on the topic of C a-tetrasubstitution and outlines the 
synthesis of a-CF3-a-propargylglycine (T fm PG ) and a-CF3-a-homo- 
propargylg lycine. Functionalizations at the C- and the N-term ini of T fm PG  
w ere  conducted as w e ll as transform ations at the C= C  trip le  bond of this 
fluorinated  am ino acid  (Schem e 4). M oreover, k inetic enzym atic 
resolution afforded optica lly  enriched  Tfm PG . F ina lly , an a-CF3- 
contain ing cyc lic  enediyn ic am ino acid w as realized a lbeit in som ewhat 
im pure form.
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The final section of the thesis, C h a p te r  6 , addresses the se lective and 
localized triggering  of the Bergm an  Cyclization. Geared  tow ard  m edical 
applications of enediynes, the hypothetica l concept of inducing 
cycloarom atization  by m eans of p lasm onic heating of nanopartic les is 
presented (Schem e 5). P re lim inary  w ork  on the requ isite enediyne- 
nanopartic le  com plexes is disclosed.
V.e®'-
Scheme 5
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1.2 Samenvatting
N atuurlijke  eendiynen behoren tot de m eest sterke antib io tica en 
cytostatica. Dankzij hun enorm e activ ite it en in trigerende w erkw ijze 
trekken  zij, tot op de dag van  vandaag, de aandacht van  onderzoekers u it 
versch illende w etenschappelijke d isciplines. F ig u u r 1 geeft de structuren  
w ee r van  de tw ee m eest u itvoerig  bestudeerde natuurlijk  voorkom ende 
eendiynen, nam elijk  ca licheam ic in  y i en het chrom ofoor van  
neocarzinostatin.
Figuur 1
Door m iddel van  een therm isch  geïnduceerd proces, de zogenaamde 
"Bergm an-Cyclisatie", zijn deze eendiynen in staat rad ica len  te genereren  
die op hun beurt w ee r tot splitsing van  D N A  leiden (Schem a 1). Op dit 
laatste berust dan ook hun antib iotische w erking.
A
Bergman
Cyclisatie
e end iyn
Schema 1
DNA diradicaal H 
beschadigd DNA
Sinds medio ja ren  80 de eerste structuurophelderingen  van  natuurlijke 
eendiynen zijn u itgevoerd, hebben ve le  onderzoekers zich ingespannen 
om de indrukw ekkende activ ite it van  deze eendiynen doelgerich t in  te 
zetten. Daarbij is voornam elijk  gekeken naar m edische toepassingen, 
vaak  op basis van  laagm olecu la ire  deriva ten  van  natuurlijk  voorkom ende 
eendiynen. H ierb ij is de synthese van  m ultifunctionele eend iynderivaten  
van  algem een belang.
In  d it proefschrift is het onderzoek van  de auteur naar sterk  
gefunctionaliseerde eendiyn-houdende am inozuren beschreven  (F ig u u r
2). Deze verb ind ingen  com bineren in één m olecuul zowel de potentieel
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cytotoxische eendiyngroep als het am inozuurm otief dat vervo lgens 
verdere  deriva tisering  m ogelijk  maakt.
Figuur 2
H o o fd s tu k  1 geeft een beknopt h istorisch  overzicht van  de ontdekking 
van  natuurlijke eendiynen en tevens een verk la ring  van  het 
reactiem echan ism e w aarm ee zij hun cytotoxische w erk ing  uitoefenen. 
Bovend ien  w ordt e r  een overzicht gegeven van  toepassingen van  
acetyleen-houdende am inozuren die re levan t zijn m et betrekking tot dit 
onderzoek.
De ontw ikkeling van  een algem ene m ethodiek voor de synthese van  
cyclische eendiyn-houdende am inozuren staat beschreven  in H o o fd s tu k  
2. Deze konden effic iënt w orden  bereid  m iddels een palladium- 
gekata lyseerde koppeling (Sonogashira-reactie) tussen een gehalo- 
geneerde, eenyn-bevattende alcohol enerzijds en een eindstandig 
acetyleen-houdend am inozuur m et een sulfonam ide bescherm groep 
anderzijds (Schem a 2). R ingslu iting  van  de zo gevorm de acyclische 
eendiynen door m iddel van  een M itsunobu-reactie leverde in de m eeste 
gevallen  het gew enste product op. Ech te r, bij de cyclisatiestap  w erd  
onverw acht (gedeelte lijke) racem isatie  waargenom en, ondanks het feit 
dat onder v r ijw e l neutra le  condities w erd  gew erkt. D aarnaast b leken 
substraten, die een hom opropargylische hydroxylgroep bevatten, 
e lim inatie  in  p laats van  cyclisatie  te ondergaan. U ite ind e lijk  w erden  v ia  
deze route d iverse cyclische eendiyn-houdende am inozuren m et 
ringgroottes va rië rend  van  10  tot 12  atom en gesynthetiseerd.
^  ,CO2Me11=1,3 I
i \
HN CO2Me 
Ts
Sonogashira
reactie
(;)n
HO
HO
HN
Ts CO2Me
n  , 
Mitsunobu
ringsluiting
n = 2
racemisatie
Ts
CO2Me
Ts
racemisatie
Schema 2
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In  H o o fd s tu k  3 is de reactiv ite it van  de eendiynen u it hoofdstuk 2 ten 
aanzien van  de Bergm an-Cyclisatie  beschreven. In  overeenstem m ing m et 
de lite ra tuu r van  regu lie re  eendiynen w erd  gevonden dat vergro ting  van  
de ring tot een aanzien lijke verm indering  van  reactiv ite it leidt. Ook 
benzannulering resu lteerde in een verlag ing  van  de reactiesnelheid . M et 
betrekking tot potentiële toepasbaarheid  leek  de benzgeannuleerde tien- 
ring ("E d y "  genoem d) de m eest geschikte kandidaat. Deze is stab ie l bij 
kam ertem peratuur m aar cycloarom atiseert bij m atig verhoogde 
tem peratu ren  (F ig u u r 3). Tenslotte w erden  e r d ipeptiden van  Ed y  bereid  
en aan k inetische studies onderworpen.
CO2Me
Ts
Ts-Edy-OMe
T halfwaardetijd
kt 
52 °C  
80 °C
Figuur 3
stabiel 
13.7 h 
59 min
73
<D<D
O
tijd (min)
C a-Tetragesubstitueerde eendiyn-houdende am inozuren gebaseerd  op a- 
M e-a-propargylglycine vorm en het onderw erp  van  H o o fd s tu k  4 (Schem a
3). Zij w erden  ontworpen als een m anier om de gedeeltelijke racem isatie  
in  de laatste stap van  de synthese van  de a-H-bevattende eendiynen te 
omzeilen.
H-Ala-OMe
H2N CO2Me
CO2R 
Me
N 2
Schema 3
K inetische m eetreeksen wezen u it dat a lle  a-Me-eendiynen een 
aanzien lijk  hogere reactiesne lhe id  ten opzichte van  de Bergman- 
Cyclisatie  vertoonden dan hun a-H-analoga. De a-Me-eendiyn-houdende 
am inozuren b leken ech ter slechts beperkt inzetbaar, gezien het fe it dat 
peptidekoppelingen van  deze substraten, zelfs onder betrekkelijk  
rigoureuze om standigheden, zowel aan de N- als aan de C-terminus niet 
bew erkste lligd  konden worden.
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H o o fd s tu k  5 gaat ve rd e r in  op het onderw erp  van  Ca-tetrasubstitutie en 
rapporteert de syntheses van  zowel a-CF3-a-propargylglycine (T fm PG ) als 
a-CF3-a-homopropargylglycine. D eriva ten  van  T fm PG  w erden  verk regen  
door functionalisatie  van  de C- en de N-term inus evenals door 
transform aties van  de C= C driedubbele band van  dit gefluoreerde 
am inozuur (Schem a 4). V e rd e r leverde kinetische enzym atische resolutie 
optisch ve rr ijk t T fm PG  op. Tenslotte is e r een cyc lisch  a-CF3-houdend 
eendiyn-am inozuur gem aakt, ofschoon dit n iet in  geheel zuivere vorm  is 
verkregen.
II
Me
--'\_CF3 
HN CO2Me Boc
^ - c f 3
HN CO2HBoc 2
81% ee
- x- c f 3 
HN CO2MeBoc 2
HNiBoc
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CF3 
CO2Me
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CO2Me
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Schema 4
O
H et laatste hoofdstuk van  dit proefschrift, H o o fd s tu k  6 , is gew ijd  aan 
het se lectie f en lokaal tew eegbrengen van  de Bergm an-Cyclisatie. M et 
het oog op m edische toepassingen van  eend iynen w ordt het concept 
geschetst om cycloarom atisatie  door m iddel van  p lasm onische 
opw arm ing van  nanodeeltjes te induceren  (Schem a 5). Ook om schrijft dit 
hoofdstuk voorbere idend  w e rk  aan  de beoogde link tussen de eendiynen 
en nanodeeltjes.
Schema 5
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co n ten t o f  the p r in t vers ion .
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Appendix
Appendix: Color Illustrations
This supplem entary part contains seleceted  illustrations in fu ll color.
Chapter 2, Figure 3
Chapter 2, Figure 4
Chapter 3, Figure 6
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Chapter 4, Figure 2
Chapter 6, Scheme 2
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